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ABSTRACT
Evidence has suggested that diabetic peripheral neuropathy (DPN) is associated with
decreased quality of life (QoL) and impaired physical and emotional health. About 82% of the
diabetic population in Saudi Arabia show signs of DPN. However, it is under-recognized and
undertreated. Further, DPN is linked to several clinical and metabolic risk factors. However,
there is minimal evidence from Saudi Arabia on the impact of DPN on the individual’s QoL. The
aims of this current study were to (1) examine the impact of DPN symptoms on functioning,
health perception, and QoL and (2) explore the biologic and individual factors associated with
DPN symptoms. This study was guided by the revised Wilson and Cleary Health-Related Quality
of Life (HRQoL) Model and included assessment of the biologic functions, symptom status,
functional status, health perception, QoL, and the individual and environmental characteristics.
This was a cross-sectional descriptive study conducted at a regional diabetes center in Saudi
Arabia. The total sample size was 120 participants with T2DM who reported neuropathy
symptoms or had confirmed DPN diagnosis. Data collected included: biologic function (e.g.,
HbA1c), symptoms of DPN (Michigan Neuropathic Symptom Inventory, Numerical Pain Rating
Scale, Short-Leeds Assessment of Neuropathy Signs and Symptoms), functional status
(Summary of Diabetes Self-care Activities-foot care subscale), and health perceptions and QoL
(the Short Form-12v2). Individual (age and gender) and environmental characteristics (Medical
Outcome Study-Social Support Survey and Chronic Illness Resources) were also collected.

xvi

Regression analyses identified a significant relationship between DPN symptoms, foot self-care,
health perception, and QoL (mental and physical). Thus worse neuropathy symptoms were
associated with more foot self-care practice, poorer health perception, mental and physical QoL
among the population of people with T2DM living in Saudi Arabia. Furthermore, more
neuropathy symptoms were associated with poor glycemic control, presence of comorbidity,
being inactive and a male. The findings suggested that in Saudi Arabia, similar to other
countries, DPN causes mild to moderate QoL impairment. This study identified factors
associated with the development of neuropathy among the persons living in Saudi. These
findings have significant implications on nursing care, education, and future research. This study
was the first that explored the impact of DPN on QoL among the population of Saudi Arabia.

xvii

CHAPTER ONE
PROBLEM STATEMENT
Type 2 diabetes mellitus (T2DM), continues to cause significant global health problems
and increased healthcare costs. The number of persons living with diabetes is expected to
surpass 600 million by the year 2040. Currently, around 422 million adults are living with T2DM
(World Health Organization [WHO], 2018). T2DM is associated with multiple long and shortterm complications and detrimental sequelae (American Diabetes Association [ADA], 2018).
Long-term complications result from damage to large and small blood vessels and nerve fibers.
These complications involve conditions such as retinopathy, nephropathy, and neuropathy and
lead to blindness, kidney failure, heart diseases and lower limb amputations (ADA, 2018). The
healthcare utilization expenses associated with diabetes mellitus (DM) are among the highest in
the world, and complications substantially increase those costs. The cost of care for the person
with diabetes who has complications is 70% to 150% higher than that of a person with diabetes
who does not have the complication (Li et al., 2013). The expenses of DM management and
prevention in 2017 were estimated to be over $727 billion worldwide, 12% of expenditure on
adult care (International Diabetes Federation, 2017).
In Saudi Arabia, DM is the second leading cause of death following road traffic
accidents (Centers for Disease Control-Global Health, 2016a). T2DM poses a significant health
threat in the Middle East. Several studies have suggested that the prevalence of DM is higher in
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urban areas and is the highest in the Northern region of Saudi. The prevalence of T2DM in Saudi
has significantly increased over time. In 1982 the percentage of diabetics was about 2.5%, and
by 1997 it rose to 10.1% (Bacchus, 1982; Elhazmi & Warsy, 2000). By the year 2011, the
prevalence of DM had increased to 16.4% (AlNozha, Maatouq, AlMazrou, & AlHarthi 2004).
The prevalence estimates of T2DM in SA are projected to increase to up to 44% by 2022
(AlQwaidhi et al., 2014. Currently the prevalence of T2DM is around 18.5% (International
Diabetes Federation, 2019). These estimates are some of the highest in the world. This rapid
increase in the prevalence of DM can be attributed to the increase of food availability, lack of
physical activity, and cigarette smoking which lead to increase in obesity rates and cardiac risk
factors (AlNozha et al, 2004).
Diabetic Peripheral Neuropathy
One of the most debilitating complications of DM is diabetic peripheral neuropathy
(DPN). DPN is “the presence of symptoms or signs of peripheral dysfunction in people with
diabetes after the exclusion of other causes” (Vinik, 2006, p. 301). DPN is the most common
type of diabetic neuropathies and accounts for about 75% of all cases (Pop-Busui et al., 2017). It
is also the most common complication of DM. The prevalence of DPN varies widely mainly due
to different diagnostic criteria. Estimates of the proportion of individuals with T2DM who have
measurable DPN are up to 85% (Vukojevic et al., 2014). In the U.S. the prevalence of DPN
among people living with diabetes is 28% (Hicks & Silven, 2019).
The prevalence of DPN among the Saudis is also variable. While some preliminary data
from western Saudi suggests that DPN prevalence is as high as 79% (Mojaddidi, Aboonq,
AlNozha, Allam, & Fath ElBab, 2011), other cross-sectional studies have concluded that the
prevalence of DPN is lower, representing only 20% of participants (Wang, Bakhutmah, Hu, &
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Alzahrani, 2014). This variation is reported in the literature globally and is due to different
measurement instruments. The variation is also attributable to underreporting, lack of
recognition, and perhaps a lack of assessment by both patients and practitioners (Vinik, Nevoret,
Casellini, & Parson, 2013). Unfortunately, these estimates do not reflect the overall population of
Saudi as DPN is still not represented in the statistics of the Saudi national database.
Factors Associated with DPN
Biologic and Individual Factors
The development of DPN is multifactorial and involves biologic, environmental, and
individual variables (Hebert, Veluchamy, Torrance, & Smith, 2017). There appears to be strong
evidence implicating some biologic and individual variables in the development of DPN but not
others. For instance, evidence is conclusive that age, glycemic control, and the duration of
diabetes are major risk factors in the development of DPN symptoms (ALQuliti 2015; Clair,
Cohen, Eichler, Selby, & Rigotti, 2015; Halawa et al., 2010). This evidence includes a few
studies found among the Saudis. Both Saudi prospective and retrospective, cross-sectional
studies have confirmed that poor glycemic control, age, and the duration of T2DM are among the
risk factors for the development of DPN among the Saudis (Mojaddidi et al., 2011; Wang et al.,
2014).
There is less consensus, however, concerning the role gender, type of DM treatment
(insulin versus oral agents), hyperlipidemia, cigarette smoking, body mass index (BMI), and
comorbidities play in DPN. For instance, a couple of studies concluded significant gender
differences in the onset of DPN where males had earlier disease onset than females (D’Souza et
al., 2015; Won et al., 2012). Meanwhile, a couple of studies did not find a statistically significant
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difference between men and women with DPN (Bansal et al., 2014; Javed, Furqan, Zaheer, &
Kasuri, 2014).
Comorbid conditions are an essential component in examining DPN symptoms and
impact on QoL. Individuals with DPN often have several comorbidities. Those conditions may
not necessarily have a causal relationship with DPN. They may instead share the same
underlying etiology, in some cases. In other cases, however, the comorbid condition may occur
merely by chance and have no association with DPN. However, it is essential to examine various
comorbidities, since their association with DPN may impact and often worsen the individual’s
symptoms presentation, management approaches and QoL (Valderas, Starfield, Sibbald,
Salisbury, & Roland, 2009). Comorbidities include hypertension, cardiovascular diseases,
nephropathy, and retinopathy. In the case of microvascular comorbidities (nephropathy and
retinopathy), the same underlying etiology seems to share a plausible relationship with DPN.
Evidence shows a high prevalence of corneal nerve fiber pathology, the primary etiology of
retinopathy, in those with DPN (Bitirgen, Ozkagnici, Malik, & Kerminglu, 2014; Nitoda et al.,
2012). Similarly, nephropathy is a frequent condition in the presence of DPN. It was found that
persons with nephropathy have more severe symptoms of DPN (AlQuliti, 2015). Further, there
is accumulating evidence linking depressive symptoms and emotional well-being to neuropathic
symptoms (Vileikyte et al., 2005).
Environmental Factors and DPN
A patient’s efforts of compliance and adherence to diabetes management practices often
require various social and environmental contexts (Miller, & DiMatteo, 2013; Smalls, Gregory,
Zoller, & Egede, 2015). The social networks of patients influence their outcomes directly and
indirectly by providing a means to cope with an illness and assistance to adhere to their self-care

5
practices to avoid unfavorable events (Stopford, Winkley, & Ismail, 2013). Social support has
been found to improve adherence and enhance glycemic control by promoting patients’ selfesteem, emotional QoL, knowledge, and attitudes towards DM (Borhaninejad et al., 2017; Song,
Nam, Park, Shin, & Ku, 2017).
Another determinant of DPN symptoms is healthcare resources. The utilization of
healthcare resources plays a paramount role in determining the outcome of many health
conditions. It is as equally important as the individual and clinical factors. Healthcare resources
include the behaviors and attitudes of the provider and the communication of the providers with
patients. Especially in DM management, patient satisfaction and involvement in decision-making
have been reported as important predictors of better outcomes (Bezreh, Laws, Taubin, Rifkin, &
Wilson, 2012; Young, Azam, Meurer, Hill, & Cui, 2016). Communication with the provider was
found to positively and negatively influence patients’ outcomes (Almutairi, 2015; White et al.,
2016). Patients reported that trust in care of the providers was a facilitator in DM management
(Sohal, Sohal, King-Shier, & Khan, 2015). Meanwhile, hindrances of successful DM
management linked to provider-patient communication were fear of being judged and shame
surrounding dietary intake (Ritholz, Beverly, Brooks, Abrahmson, & Weinger, 2014). In
addition, adherence with the recommended medication was associated with receiving education
about the disease and the treatment plan from the healthcare provider (Graumlich et al., 2015;
Larkin, Hoffman, Stevens, Douglas, & Bloomgarden, 2015).
Given that DPN is a complication of DM, it seems sensible to hypothesize that the factors
involved in the development and progression of diabetes are also associated in the development
of DPN. Thus, this study is hypothesizing that social support and healthcare resources
are associated with of DPN symptoms and health-related Quality of Life (HRQoL).
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Symptoms of DPN
DPN affects the sensory and motor neurons of the peripheral nervous system. It manifests
with complete or partial loss of sensation and often with an insidious onset. To most patients, the
most distal parts of the body are the first to be affected (glove and stocking patterns). The
presence of DPN symptoms varies ranging from 22% to 78.5% in various parts of the
world (Pop-Busui et al., 2017; Tesfaye et al., 2010). Most DPN patients have predominantly
sensory symptoms like burning, tingling, shooting, or a lancing sensation (Vinik et al.,
2013; Vukojevic et al., 2014; Wang et a., 2014). Furthermore, patients may experience negative
symptoms which include numbness of the feet and legs with or without complete loss of
sensation. Others may experience mainly pain.
Pain is an important aspect of DPN. Given the nature of the disease, some patients report
severe pain while others report an absence of pain (AlQuliti, 2015; Pop-Busui et al., 2017;
Tesfaye et al., 2010). The prevalence of pain (neuropathic in nature) among those with DPN is
about 25% (Pop-Busui et al., 2017). Because symptoms including pain vary greatly among
individuals, the clinical diagnosis of DPN can be challenging. Some people have extremely
severe symptoms while others have a complete absence of symptoms despite the presence of
positive objective findings.
Most studies reporting about DPN in Saudi have been epidemiological (Algeffari,
2018; AlQuliti, 2015; Wang et al., 2014). One Saudi study of 263 persons aged 20 to 70 years
old who had diabetes for 5-22 years, reported that 63% of the patients were symptomatic while
37% were asymptomatic (Mojaddidi et al., 2011). Finally, an important and serious sequel of
DPN is ataxia, loss of full movement and control of the body parts. In turn, ataxia disposes to
unsteadiness, falls and fractures (Vinik et al., 2013).
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DPN and Foot Complications
Diabetes foot complications are conditions that involve injury, infection, ulcer, gangrene,
and amputation of a toe and/or the lower limb of a diabetic patient. The lifetime risk of foot
problems for a diabetic patient is as high as 25% in the US (Tesfaye et al., 2010). This risk is
also reported among the Saudi population with DM. A diabetic foot is the most common reason
for hospitalization among the Saudis. About 25% of persons who are admitted with diabetes
issues have diabetic foot problems (AlKhair Ahmed 2010; Yang et al., 2014). Diabetic foot is
defined as the penetration of the full thickness of the epidermis of the foot of a diabetic
individual (Abolfotouh, Alhafi, AlGannas, 2011). DPN is a significant risk factor for the
development of foot complications related to the absence of protective sensation. It is suggested
that numbness of the feet and legs is the primary mechanism by which DPN is leading in time to
painless foot ulcers. Other risk factors for foot complications are previous foot ulcers, peripheral
vascular disease, and foot deformities which are also common in DPN (Yang et al., 2014).
Diabetic foot problems are significantly preventable with early identification, proper screening,
and preventative foot care practices. However, once an ulcer has developed, treating and
preventing the second incident is challenging as about 70% of ulcers return within five years
(Dorresteijin, Kriegsman, Valk, 2010). The prevalence of non-traumatic lower extremity
amputation among patients with diabetic foot problems in Saudi is alarming even though the
evidence is limited. Diabetic patients have a 10-fold increase in the risk of lower limb
amputation. Studies reported that the incidence of amputation is between 19% to 34% for
persons in Saudi (AlTawfiq and Johndrow, 2009; Qari et al., 2000). In the U.S. there were about
108,000 lower limb amputations related to DM in 2014 (CDC, 2017a). This leads to emotional
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and physical burden on patients which results in decreased QoL, depression, and impaired
functioning.
Functional Status and Self-Care
Functional status refers to the ability to perform tasks in various aspects of life including
physical, social, work, and psychological functions (Ferrans et al., 2005; Wilson & Cleary 1995).
DPN patients’ ability to function physically, psychologically, and socially is a primary
determinant of their HRQoL. Research evidence indicated that DPN patients have compromised
functioning in some day-to-day life roles as a result of their sensory and motor impairments
(Dermanovic Dobrota et al., 2014; Riandini et al., 2017; Veresiu et al., 2015; Vukojevic et al.,
2014). Patients have reported difficulties with the simplest physical functions like walking,
standing, balance, and mobility. The specific aspects of daily life influenced were the overall
productivity, recreational activities, work, and chores. Meanwhile, the affected social and
psychological functions were related to fear, anxiety, and irritability (Dermanovic Dobrota et al.,
2014). Furthermore, patients have also had difficulties with sleep, falling asleep, and not feeling
rested upon awakening (Brod Pohlman, Blum, Ramasamy, & Carson, 2015).
To maintain therapeutic glucose levels and to prevent complications, T2DM patients
must perform certain practices that are collectively referred to as diabetes self-care management
(ADA, 2019). Those practices include behaviors like eating a healthy diet, performing physical
activity, and monitoring glucose levels regularly. Diabetes self-care management is complex and
involves permanent changes in lifestyle and serious commitment efforts from the patients.
Prevention of DPN relies heavily on promoting healthy behaviors to attain glycemic control and
to detect symptoms early. Patients’ ability to carry out self-care management practices is part of
intact functional status. Foot self-care behaviors are an essential component of self-care in
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persons with diabetes. Foot self-care includes behaviors like washing, drying, and inspecting the
feet daily. Several factors influence foot self-care behaviors. Positive foot self-care behaviors are
associated with an individual’s education level, gender, socioeconomic status (SES), body
weight, and positive attitude and awareness of DM (D’Souza et al., 2015). Barriers to effective
foot self-care practices include age, physical ability, perceived importance, communication with
provider, and social integration (Matricciani & Jones, 2015). Other factors are related to a
patient’s environment such as neighborhood violence, availability of healthful foods, aesthetics,
and facilities (Smalls, Gregory, Zoller, & Egede, 2015). Research on foot care habits, frequency,
and association with DPN symptoms among Saudis with T2DM is scarce (AlOdhayani, Tayel,
& Almadi, 2017; Yang et al., 2014) and indicates that most patients lack knowledge related to
the importance of foot care and risk factors for diabetic foot. Thus, efforts to carefully examine
this vital influence on QoL are needed.
Quality of Life in T2DM with DPN
Quality of life (QoL) is a multidimensional concept that has been researched extensively
and incorporates all factors that impact an individual’s life. Health-related QoL is the medical
outcome variable that is specific to health and treatment predictors of QoL. Considering the
confusion and inconsistency as to the distinct meaning and usage of the two terms (Karimi,
2016), in this study, while acknowledging that the theoretical framework that guided the study
uses the term HRQoL, the terms QoL will be used in reference to the studies variables and
results. However, when referencing other research studies the exact terminology used by the
authors will be reported herein. For instance, as applicable, studies used terms such as wellbeing, HRQoL, overall QoL, health, and QoL. The term HRQoL will only be used when
referencing the theoretical model.
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Research data from around the globe have shown that QoL in people with DPN can be
significantly compromised. The level of impact depends on the severity of symptoms. The effect
of DPN symptoms on patients’ lives spans physical, emotional, social health, and
functioning (Boyd, Casselini, Vinik, & Vinik, 2011; Bredfeldt, Altschuler, Adams, Portz, &
Bayliss, 2015; Hoffman, Sadosky, Dukes, & Avir, 2010; Lyrakos et al., 2013). Patients’ QoL
depends on the degree of discomfort and disability imposed by the symptoms. There is a
correlation between the number and intensity of symptoms and QoL scores. For instance, people
with mild DPN symptoms have mild to moderate impairment of QoL (Vukojevic et al., 2014).
Likewise, people with severe symptoms have worsened QoL. On all of the Short Form-36
questionnaire’s dimensions, it was found that patients with painful DPN scored significantly
lower, indicating worse QoL than patients without DPN (Dermanovic Dobrota et al., 2014).
Literature on QoL among the Saudis is limited to diabetes and is recent in nature
(Alaboudi, Hassali, & Shafie, 2016; AlHayek, Robert, AlSaeed, & AlSaban, 2014; AlShehri,
2014). In a cross-sectional survey, AlShehri (2014) studied a sample
of (n=75) T2DM patients using the SF-12 and concluded that patients scored significantly lower
than the average population. Married patients had lower QoL compared to non-married patients
(AlAboudi et al., 2016). Individual characteristics associated with lower HRQoL were female
gender (AlShehri, 2014), poor economic status, the presence of DM complications, and longer
duration of DM (AlHayek et al., 2014).
Among the Saudis, current evidence has not approached the study of DPN among
individuals with T2DM comprehensively or using a theoretical framework. The current study
aims to investigate the impact of DPN on physical and mental QoL guided an existing theoretical
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framework that delineates various influencers of symptoms, and consequently their functioning,
general health perception, and overall QoL.
Purpose
This study examined the degree to which DPN symptoms impeded functioning and QoL
of persons with T2DM living in Saudi. Furthermore, the study evaluated the individual and
environmental factors that contributed to the DPN symptoms in people with T2DM. The
revised HRQoL model (Ferrans et al., 2005; Wilson & Cleary, 1995) was the theoretical
framework that guided the study.
Theoretical Framework
This current study was guided by the revised Wilson and Cleary HRQoL Model
(Ferrans et al., 2005; Wilson & Cleary, 1995). This model was the conceptual basis that
guided the understanding of the nature of the relationship among several of the variables that
were expected to influence the QoL of DPN patients. The model comprises five levels of factors,
each of which plays a significant role in linking clinical variables with HRQoL (see Figure
1). Individual and environmental characteristics play essential roles and directly impact each
level. The Wilson and Cleary model has been revised, and the importance of the influence of
individual and environment characteristics has been highlighted (Ferrans et al., 2005).
The first factor is the biological/physiological influences. These include cellular and
molecular factors, such as laboratory values and diagnoses (Wilson & Cleary, 1995). The second
factor in the model is symptom status. Symptom status is a manifestation of biological changes
and a shift to the general impact on the human being. The symptoms exhibited by the individual
can be physical or psychological. The third factor is functional status, and it is a crucial
integration point into the previous factors. Functioning level describes an individual’s ability to
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perform physical, social, role, and psychological functions. The fourth factor in the model is the
general health perception. It is the patient's own beliefs about their abilities, limitations, and
satisfaction with health. The last factor is overall QoL, the endpoint of the model. All the factors
should lead into one another and end with the overall QoL.
According to the revised model, individual and environmental characteristics play a role
at all levels. Individual factors are related to demographics such as the level of education, age,
and gender. Environmental characteristics are geographical, sociological variables, and spiritual
values.
Application of the HRQoL Model to The Study
Biologic Functions
Biologic functions in this reported study of DPN among the Saudi population
reflected risk factors and comorbidity. Biological indicators included the level of glycosylated
hemoglobin (HbA1c) and cardiovascular risk factors. It also included past and current medical
history of chronic diseases like kidney, heart, and eye diseases, peripheral vascular insufficiency,
other comorbidities, smoking habits, and prescribed medications. The laboratory values were
obtained from patients’ medical records. Information related to medical history were collected
using a general health survey and the electronic records data.
Symptom Status
The current study assessed symptoms and signs that are commonly seen and reported by
patients. They were pain, increased/decreased sensitivity to touch, abnormal tendon reflexes,
tingling, and impaired sensation. Symptoms were measured using the Michigan Neuropathic
Screening Instrument (MNSI), Numerical Pain Rating Scale, and the Self-report-Leeds
Assessment of Neuropathy Signs and Symptoms (S-LANSS).
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Functional Status
According to the American Thoracic Society functional status is the ability to perform
normal daily activities that are required to meet basic needs and maintain health and well-being
(American Thoracic Society, 2007). Functional status in the HRQoL model is defined as the
ability to perform particular defined tasks (Wilson & Clear, 1995). Accordingly, in this current
study based on the aforementioned definitions, the ability to perform foot self-care practices was
considered the indicator of sufficient functional status and was measured using the foot selfcare subscale of the Summary of Diabetes Self-Care Activities (SDSCA) instrument. The
SDSCA is a 15-item tool that measures a diabetic patient’s level of self-care. The SDSCA was
used at least once on an Arabic speaking sample (AlJohani, Kendall, & Snider, 2015).
General Health Perception
General health perception is a subjective description of the degree of satisfaction of living
with an illness. For this current study of T2DM Saudis with DPN, health perception was assessed
using a single item in the SF-12. The single item asks participants to rate their understanding of
their health on a Likert-type scale from poor to excellent (Ware et al., 1996).
Physical and Mental QoL
QoL in this study reflected patient perspectives on their physical, emotional, and
social role functioning. The data of the dimensions of the QoL was collected using the SF-12v2
subscales (Ware et al., 1996).
Much attention has been directed toward identifying the risk factors and associated
conditions of T2DM and foot ulcers among the Saudis. However, DPN is under-recognized and
under-treated. DPN is a significant risk factor for the development of foot ulcers and almost all
people with diabetic foot ulcers have DPN. Evaluating the QoL of the Saudis within a
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comprehensive theoretical perspective aided in bringing attention to the importance of the
patient’s perspective within a treatment plan. It will also guide future research efforts to better
target environmental traits that are risk factors for neuropathy symptoms.
The Characteristics of the Individual and the Environment
The characteristics of the individual included the participants’ demographics which were
age, gender, education level, income/SES, marital status, family history, and type of
employment. General health survey measured the individual factors. The characteristics of the
environment comprised information about chronic illness resources, communication with
healthcare providers, and neighborhood aesthetics (walking facilities and access to healthy
foods). These were measured using the brief Chronic Illness Resources Survey (CIRS)
(Glasgow, Toobert, Barrera, & Stryker 2005). The CIRS is a self-report measure of the multiple
resources needed by chronic illness patients to attain healthful lifestyle behaviors.
Environmental factors about the level of perceived social support were measured by the
Medical Outcome Survey-Social Support Questionnaire (MOS-SSS) (Sherbourne & Stewart,
1991). The MOS-SSS is a widely-used measure of the amount of support perceived by patients
and assesses the four aspects of support: informational support, tangible support, positive social
interaction, and affectionate support.
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Figure 1. Study Conceptualization Using the Revised Wilson and Cleary HRQoL Model

Specific Aims
The primary aims and hypotheses were:
Aim 1: To examine the impact of DPN symptoms on patients’ functional status (foot care
practices), general health perceptions, and overall QoL (physical and mental QoL).
Hypothesis: Individuals with more symptoms have poorer functional status (less foot care
practices), negative health perceptions, and poorer physical and mental QoL (overall QoL).
Aim 2: To examine the biological (HbA1c, comorbidity, and cardiovascular risk factors)
and individual (age and gender) factors associated with DPN symptoms in persons with T2DM
living in Saudi Arabia.

16
Hypothesis: Longer duration of DM, poor glycemic control, increased age, female
gender, presence of hypertension, comorbidity, and dyslipidemia, and lack of physical activity
are associated with more DPN symptoms.
In summary, DPN has long been implicated in increased morbidity and mortality,
decreased satisfaction with QoL and high healthcare expenditures. There is conclusive evidence
on the impact of DPN on QoL globally. However, the effect of symptoms on QoL in the
population of Saudi diabetics has not been adequately studied. Furthermore, the association of
neuropathy symptoms, biologic functions, characteristics of the individual and the environment,
and functional status are less understood. Knowledge of these associations is important to inform
culturally sensitive guidance for individuals with T2DM and DPN to mitigate risk factors,
maintain health and QoL, and reduce cost of care.
Specific details about the study components are discussed in the following chapters.
Chapter 2 details the findings from the literature. Chapter 3 discusses the setting, design, and,
measurements. Chapters 4 and 5 discuss the results from the current study, study strengths and
limitations, and recommendations for future research.

CHAPTER TWO
REVIEW OF THE LITERATURE
The purpose of this chapter is to review the pertinent literature relating to DPN, risk
factors, and QoL. This chapter contains a discussion of the literature on the symptoms of DPN
among the Saudis and from around the world. This review of the literature presents research
findings and synthesizes the current literature on the different factors associated with the
symptoms. This chapter also has a review of the most recent literature concerning the impact on
the individual’s functioning and QoL.
Methods
A literature search was conducted to examine the evidence on the risk factors of DPN and
the impact on QoL. About 120 scientific articles were identified. Databases searched were
PubMed, CINAHL, PsychINFO, Scopus, and Google Scholar. The keywords used were type 2
diabetes, neuropathy, peripheral neuropathy, predictors, risk factors, determinants, self-care,
social support, quality of life, health-related quality of life, Saudis, and Saudi Arabia. Searches
were refined for various combination of these keywords. Search limits included English
language, and human subjects.
Results
The literature search yielded a combination of cross-sectional and interventional studies
examining the predictors of DPN development, systematic reviews, and narrative reports.
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It is worth noting that the terms diabetic peripheral neuropathy and polyneuropathy
were often used interchangeably. Many studies abbreviated DPN as diabetic peripheral
neuropathy, but some studies used DPN for diabetic polyneuropathy. The evidence herein is a
mixture of factors related to the development of diabetic neuropathies in general, painful diabetic
neuropathy, and diabetic peripheral neuropathy. It is yet to be determined whether diabetic
peripheral neuropathy and painful diabetic neuropathy/neuropathic pain in DM are the same
condition or two different conditions.
Further, the reviewed studies included mostly people with T2DM. A few studies
involved people with type 1 DM (T1DM). The articles listed in the table of studies were selected
based on the outcome variables. Some of the research studies in which either DPN or QoL were
the main outcome variables were chosen. The table of studies reports sample locations, sample
sizes, locations, and designs. Table G1 included only Saudi-based studies. Table G2 included
studies that were cross-sectional, and Table G3 contained interventional and systematic review
studies that addressed DPN from various parts of the world. Table G4 is supplemental including
the most recent articles. The evidence reviewed herein includes some studies that were specific
to the Saudi population (AlAboudi et al., 2016; Algeffari, 2018; AlHayek et al., 2013; AlJohani
et al., 2015; Almutairi, 2015; AlShehri, 2015; AlQuliti, 2015; Halawa et al., 2010; Y. Hu et al.,
2014; Mojaddidi et al., 2011; Sidawi & AlHariri, 2012; Wang et al., 2014). The rest of the
evidence comes from South Asia, Far East Asia (Bansal et al., 2014; Hussain et al., 2014; Yang
et al., 2015), as well as the United States and European countries (Dermanovic Dobrota et al.,
2014; Lyrakos et al., 2013; Yoo et al., 2015) see Appendix G for further information.
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Biologic Factors
The involvement of the biologic factors in the development of DPN has been examined in
the literature more than any other variable. The biologic variables linked to the development of
DPN that have been studied the most are glycemic control, cardiovascular risk factors, and the
duration of diabetes; all were implicated in the development of DPN.
Glycemic Control
Glycemic control was determined by either the HbA1c (the percentage of glycated
hemoglobin) or the fasting blood glucose (FBG; measured by both mmol/L and mg/dL).
However, HbA1c is a better indicator of glycemic control when compared to FBG (American
Diabetes Association [ADA], 2018; Mannarino, Tonelli, & Allan, 2013). The elevated glucose
levels lead to nerve axonal and microvascular injury (Juster-Swilyk & Smith, 2016). All of the
reviewed studies reported an association between DPN and HbA1c (Algeffari, 2018; AlQuliti,
2015; Bansal et al., 2014; Hussain et al., 2014; Khawaja et al., 2018; Lyrakos et al.,
2013; Mojaddidi et al., 2011), except for one Saudi-based study (Wang et al., 2014). There was
also some evidence implicating glycemic variability, in addition to hyperglycemia, in DPN
pathogenesis.
A few studies measured both HbA1c and FBG. For instance, a non-Saudi study assessed
the participants HbA1c, FBG, and postprandial glucose (Hussain et al., 2014). All the parameters
were significantly higher among those with DPN compared to patients without DPN, p <.05. The
average FBG for the DPN groups was 147. 88 ± 33.03 mg/dl. Meanwhile, for those without
clinical neuropathy, the FBG was 133 ± 20.31 mg/dl. Postprandial glucose was also significantly
higher for both groups with DPN (214.46 ± 39.31 mg/dl) compared with those without DPN
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(201 ± 32.89 mg/dl) (Hussain et al., 2014). Similarly, participants’ levels of HbA1c were higher
for those with DPN, mean = 7.9% ± 2.19 compared to mean = 6.6% ± 0.98 for those without
DPN (Hussain et al., 2014). On the other hand, Algeffari (2018) also measured these same
parameters on a sample of (n = 233) Saudis and found a significant association between HbA1c
level and painful DPN, odds ratio = 3.1, p <.05, but not with the FBG, odds ratio = 1.4, p =
.401.
One Saudi study concluded that the levels of the HbA1c were not significantly associated
with DPN symptoms. This Saudi-based study comprised of mostly T2DM (n= 524 of total 552)
reported that the level of HbA1c did not differ significantly between DPN and non-DPN
cases. However, there was a difference in the glycemic control in this sample between the DPN
and non-DPN groups as evident by the FBG levels. FBG levels of those having DPN was 9.7
mmol/L or 176.5 mg/dL, and 9.4 mmol/L or 169.3 mg/dL for those not having DPN, p = 0.002.
It worth noting that the lack of significance of HbA1c levels can possibly be explained by
the poor hemoglobin levels of the participants as only 21% of the sample had a near
normal hemoglobin level of 13.8 g/dL (Wang et al., 2014). The majority of the participants in the
study had hemoglobin of less than 13.8 g/dL indicating a possible iron deficiency anemia. Both
normal hemoglobin level and healthy red blood cells are important for a valid HbA1c
assessment. HbA1c represents the percentage of hemoglobin that binds to glucose. If the
hemoglobin level is decreased, it could affect the levels of the HbA1c. In the case of iron
deficiency anemia there are fewer hemoglobin molecules for glucose to bind to and thus the
HbA1c reading can be faulty. In a study on the effect of iron deficiency anemia on HbA1c
levels’ validity, investigators provided iron supplementation to (n = 50) non-diabetic
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participants with iron deficiency anemia. The mean HbA1c level of the anemic patients was
7.4% compared to 5.9% for those with healthy hemoglobin levels (p < .001). Following the
treatment, the HbA1c levels of the anemic patients dropped to 6.2% (p < .001) (Coban, Ozdogan,
& Timuragaoglu, 2004). This suggests that normal hemoglobin levels are essential for valid
HbA1c testing. Thus, referring to the earlier study by Wang and colleagues, one can speculate
that since most patients had lower hemoglobin levels, this might have affected the validity of the
conclusion on the association between HbA1c and DPN development (Wang et al., 2015).
Glycemic variability is a relatively new factor in the discussion of DPN development.
Glycemic variability refers to the fluctuations in glucose levels in the blood. Studies asserted that
with varying levels of glucose in the blood over a period of time, DPN starts to develop and
worsen even with normal FBG and HbA1c levels. For instance, in a small study in China (n=90)
participants developed DPN even with HbA1c < 7% (Xu et al., 2014). Glycemic variability was
measured by the standard deviation of blood glucose (SDBG), the mean of daily differences
(MODD), and the mean amplitude of glycemic excursions (MAGE). The study found that DPN
patients had greater SDBG (2.8 mmol/L, 50.4 mg/dL) compared with non-DPN patients
(2.1 mmol/L, 37.7 mg/dL), p < .001. They also had higher MODD (2.2 mmol/L, 39.6
mg/dL) compared with non-DPN patients (1.9 mmol/L, 34.2 mg/dL), p =.005. The DPN patients
also had higher MAGE (5.8 mmol/L, 104 mg/dL) compared with non-DPN patients (4.5
mmol/L, 81.0 mg/dL), p < .001. In this study, authors concluded that glycemic variability was
closely associated with DPN in well-controlled T2DM patients (Xu et al., 2014). Another study
reached similar conclusions. The study examined (n = 982) T2DM patients. Of the total sample,
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about 20% had DPN and they had significantly greater MAGE, MODD and SDBG than those
without DPN, p < .001 (Y. M. Hu et al., 2018).
Duration of DM
As with glycemic control, all of the reviewed studies (but one) on the duration of DM
concluded that the longer the individual lives with DM the more severe the DPN symptoms
become (AlQuliti, 2015; Halawa et al., 2010; Bansal et al., 2014; Hussain et al., 2014; Khawaja
et al., 2018; Lyrakos et al., 2013; Wang et al., 2014). It took a sample of (n = 125) T1DM and
T2DM Pakistani patients about nine years to develop DPN (Javed et al., 2014). Participants’
mean age at the diagnosis of DM was 41.6 years and 50.2 years at the onset of DPN.
In a large sample (n =1,039) of mostly T2DM persons from Saudi Arabia, it was reported
that those with painful DPN had a longer duration of DM. The duration of diabetes was defined
as < 1 year or > 1 year with an average of 10.2 years for painful DPN patients and 6.5 years for
non-painful DPN patients. In addition, they also had higher mean pain scores, using the 10item Dueluer Pain Questionnaire (DN4), with mean=10.2 ± 5.8 as opposed to non-painful DPN
participants with mean = 6.5 ± 5.0, p < .001 (Halawa et al., 2010).
Using nerve conduction velocity tests to quantify DPN symptoms, Hussain et al. (2014)
examined a small sample (n = 64) of non-Saudi T2DM patients with DPN. The investigators
grouped DPN into those who had a duration of diabetes of less than eight years, and those had
had a duration of greater than eight years. They reported a significant difference in the duration
of T2DM in both neuropathy groups. Those persons who had diabetes for less than eight years
had a lower neuropathy score (3.48 ± 1.77) compared to those having had diabetes more than
eight years (13.22 ± 4.46), p < .05. Furthermore, those with a longer duration of T2DM had
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significantly worse nerve function compared to those with a shorter duration, (p < .05). The
study is significant because it is one of the three studies that quantified and compared the number
of years with diabetes. The second study (non-Saudi-based), examined the duration of diabetes
by differing intervals: less than 5, 6–10, 11–15, and more than 15 years. In this study, the odds of
neuropathy for those with a duration of diabetes of more than 15 years was 8.03 (CI 95% 5.9610.8, p < .001) compared to those with less than five years (Bansal et al., 2014). The third study,
compared the duration of DM between ≥ 5 and < 10 years and that of ≥ 10 years on a sample of
(n = 1338) patients. The odds of DPN for the duration of DM of ≥ 5 and < 10 years was 1.31, p =
.03. Meanwhile, the risk of DPN increased to 1.63 with the duration of more than 10 years, p <
.01 (Won et al., 2012).
All the above-reviewed evidence had tested the presence of an association between DPN
and T2DM duration but not the strength of the association. The only study that reported the
strength of the correlation was in a sample of both T1DM (n = 39) and T2DM (n = 224) patients
from Saudi in which a moderate correlation between the duration of DM and the DPN symptoms
(r = .44) was found (Mojaddidi et al., 2011).
Surprisingly, one Saudi study did not conclude that there was an association between
T2DM years and DPN development despite using a validated instrument (MNSI) and having a
sufficient sample size (n = 242) (Algeffari et al., 2018). They reported that 35% of the sample
had painful DPN. The authors did not elaborate on the lack of significant association between
duration of T2DM and DPN or on the deviation from the mainstream literature. However, by
examining the sample, it looks comparable to other studies; multi-site, sufficient size, diverse
(gender-wise), average age was 56 years, mostly T2DM, and a range of duration of diabetes was
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5–10 years. Some of the possible reasons for the negative association between duration of
disease and DPN symptoms could be related the study’s power and the measurement tools.
Factors affecting the power of a study can be related to sample size, significance level, and the
effect size.
Modifiable Cardiovascular Risk Factors
Research data as to cardiovascular risk factors role in DPN development are variable.
Cardiovascular risk factors include obesity, lipid profile, hypertension, cigarette smoking, and
physical activity. The suggested pathogenesis involves small-fiber nerve dysfunction, impaired
pain perception, and reflex vasodilation (Papanas & Ziegler, 2015).
Obesity. In the reviewed evidence, obesity was determined by the participants’ BMI
according to the American Heart Association (Algeffari, 2018; Bansal et al., 2014; Halawa et al.,
2010; Khawaja et al., 2018; Mojaddidi et al., 2011; Wang et al., 2014). Only one study reported
both the BMI and the weight-height ratio as well as the waist/hip ratio (Hussain et al., 2014).
The Research data of the effect of obesity on DPN have been inconclusive. This
association between obesity and DPN has been asserted in the U.S. among the population of > 40
years old. The National Health and Nutrition Examination Survey concluded that a cluster of
obesity and two other cardiovascular risk factors (hypertension, hyperglycemia, low HDL, or
increased waist circumference) increase the likelihood of neuropathy odds ratio = 2.2, (CI 95%,
1.43–3.39, p < .005) (Ylitalo, Sowers, & Heeringa, 2011).
Among the Saudi population, however, the research findings were inconsistent. One
Saudi study with 263 patients concluded that BMI was a significant correlate of DPN (r2 = .92)
(Mojaddidi et al., 2011). Meanwhile, three other Saudi studies found that BMI was not a

25
significant correlate of DPN (Algeffari, 2018; Halawa et al., 2010; Wang et al., 2014). These
other studies were with similar or larger samples sizes (n = 242, 549, and 1,039, respectively).
Lipid profile. It has been confirmed that the individual’s lipid profile plays a significant
role in increasing the odds of neuropathy. However, the type of lipid varies; there is always at
least one kind of lipid linked to DPN. Most studies broke down the lipid profile into its
components (total cholesterol, triglycerides, low- and high-density lipoprotein (HD, LDL). Other
studies reported only whether the sample had dyslipidemia (Algeffari, 2018). One of the
suggested mechanisms by which lipids alter the neurons’ function is the change in plasma
membranes’ characteristics and the mitochondrial function (Perez-Matos, Morales-Alvarez,
Mendivil, 2017; Rumora et al., 2017).
In a six-year follow-up, longitudinal study of T2DM patients (n = 45) from Korea,
elevated triglycerides of > 177 mg/dL significantly increased the risk of DPN (odds ratio = 6.13,
CI 95% 1.05–35.52, p = .04) after adjusting for age and gender (Cho et al., 2014). Another nonSaudi study with a large sample (n = 2,005, T2DM, aged 54 years, 50% were males, and had
diabetes for average of 8 years) reported that the lipid profiles of DPN patients were significantly
different from those of non-DPN patients, although non-DPN patients had seemingly three
higher components of the lipid profile (total cholesterol, LDL, and HDL). Total cholesterol was
179 (mg/dL) for DPN patients compared to 190 (mg/dL) for non-DPN, p = .006. The LDL was
92 (mg/dL) for DPN patients compared to 108.1 (mg/dL) for non-DPN, p < .001. The HDL was
62.1 (mg/dL) for DPN patients compared to 45.4(mg/dL) for non-DPN, p < .001. Total
triglyceride was 163.8 (mg/dL) for DPN patients compared to 174 (mg/dL) for non-DPN,
p < .15. This study concluded that elevated total cholesterol, elevated LDL, and lower HDL but
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not elevated triglycerides were significantly associated with increased risk of DPN. The study
also included the presence of dyslipidemia as a variable and concluded that it was associated
with risk of DPN, (odds ratio = 0.43, CI 95%, 0.20-0.92), p= .03 (Bansal et al., 2014). Although
the authors did not include dyslipidemia therapy as a variable, they alluded to the fact that
participants were treated for dyslipidemia. It was not clear if both DPN and non-DPN cases
received dyslipidemia treatment.
On one hand, a study with a smaller sample (n = 86) found that lipids (triglycerides,
LDL, and very LDL, but total cholesterol) increased in those with DPN, p<.05 (Cho et al.,
2014). On the other hand, Khawaja et al. (2018) took a sample of T2DM patients (n = 1,003)
and measured the different lipid profile components. They found that LDL and HDL but not the
triglycerides to be significantly linked to DPN symptoms. Patients with DPN had an LDL of 102
(mg/dL) compared to 101 (mg/dL) for non-DPN, p < .001. The HDL was 41.9 (mg/dL) for DPN
patients and 39.5 (mg/dL) for non-DPN patients, p = .001. Finally, a large U.S. prospective
cohort study (n = 1,992) also found no significant link between lipids (HDL, LDL, and
triglycerides) and DPN in those with T2DM (Jaiswal et al., 2017).
Other cardiovascular risk factors linked to DPN are cigarette smoking and hypertension.
Both were indecisively related to DPN progression. Evidence was equally supporting and
refuting the relationship between DPN and hypertension.
Hypertension. Several studies linked elevated blood pressure to DPN. In one large
retrospective cohort Taiwanese study (n = 37,375) hypertension was found to correlate
significantly with DPN, p < .001. The effect of hypertension as a stand-alone variable and jointly
with the levels of the HbA1c was significant. The hazard ratios of DPN for HbA1c level (≤ 6.0
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to < 10.0), according to a systolic blood pressure of < 130 (mm Hg) and a diastolic blood
pressure of < 85 (mm Hg), are between 1.11 (CI 95%, 0.98-1.24) and 1.65 (CI 95%, 1.51–
1.81), p < .001 (Yang et al., 2015).
In another study, cohorts of individuals T2DM (n = 258) and T1DM (n = 1,734) were
followed for visits in years 1, 2, and 5. The study was called SEARCH for Diabetes Among
Youth. The age range of the participants was 14 to 27 years. Data were analyzed separately
according to the type of DM. DPN was assessed by the MNSI and was prevalent in 22% of
T2DM patients. Elevated blood pressure was not found to be a risk factor for DPN in T2DM
patients. However, for the youth with T1DM, hypertension was an independent risk factor for
DPN, p < .001 (Jaiswal et al. 2017).
In regard to the relationship between hypertension and DPN among the Saudis, two
studies found hypertension significantly associated with greater odds of DPN. In one study,
T2DM patients had 1.7 the odds (CI 95%, 1.07–2.99, p = .02) of developing DPN if hypertensive
(Wang et al., 2014). The other study concluded similarly that the odds of DPN increase 2.85
times (CI 95%, 1.57–5.17, p < .001) with hypertension (AlQuliti 2015). Two studies did not find
a significant relationship (Algeffari, 2018; Mojaddidi et al., 2011). Still another study did not
include hypertension in the analysis (Halawa et al., 2010). To conclude, although there is some
inconsistency in these studies’ findings, hypertension can be seen as potential risk factor for the
development of DPN. In addition, the two studies that found a negative association, as
mentioned later, have weaker methodological approaches (Algeffari, 2018; Mojaddidi et al.,
2011) than studies that found positive correlation (AlQuliti 2015; Jaiswal 2017; Yang et al.,
2015).
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Cigarette smoking. The evidence for smoking and DPN is inconclusive. One study
found the risk of DPN corresponded to the history of smoking (D’Souza et al., 2015) while
others did not support these conclusions (Algeffari, 2018; AlQuliti 2015; Bansal et al.,
2014; Halawa et al., 2010; Kisozi et al., 2017; Wang et al., 2014). In a cross-sectional design,
D’Souza et al. (2015) found that the risk of DPN was significantly increased with smoking (odds
ratio = 5.9, p < .001). The study included only people with T2DM. The evidence from Saudi
studies did not support the conclusion that smoking is associated with risk of DPN (Algeffari,
2018; AlQuliti 2015; Halawa et al., 2010; Mojaddidi et al., 2011; Wang et al., 2014).
In a systematic review of 38 studies with a large sample (n = 33,152), the research data
were also inconclusive. The 21 cross-sectional studies in this review reported that smoking was
associated significantly with DPN (pooled odds ratio = 1.42, CI 95%, 1.21 –1.65, p <
.001). However, 10 prospective cohort studies from this same review did not find smoking
linked to risk of DPN (Clair et al., 2015).
Physical activity. The level of the individual’s level of activity is seen as a potentially
modifiable risk factor. However, attention dedicated to studying physical activity and its impact
on DPN progression is limited. Studies claim that regular physical activity could slow the
progression of DPN or reduce the severity of symptoms.
In a US pilot study, exercise decreased patients’ perception of pain interference related
to DPN (Yoo et al., 2015). Sedentary, middle-aged participants (n = 14) engaged in a 16-week
aerobic exercise program that entailed a supervised aerobic exercise (cycle ergometers,
treadmills, recumbent steppers, and elliptical trainers) three times each week. The sessions
progressed from 30 to 50 minutes. There was a significant decline in the mean pain interference
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in four out of seven pain interference subscores; walking (4.93 ± 3.03 pre- to 3.29 ± 2.89 post, p= .016), sleep (5.11 ± 3.04 pre- to 3.5 ± 3.03 post-, p = .02), relationship with others (3.96 ±
3.53 pre- to 1.29 ± 1.27 post-, p = .02), and normal work (5,39 ± 3.32 pre- to 3.79 ± 3.04 post, p=.032). The participants’ overall perception of pain interference also decreased (4.65 ± 2.7
pre- to 2.97 ± 2.22 post-, p = .013) following the intervention. However, patients’ perceived pain
intensity pre- and post-intervention did not change significantly. Nonetheless, participants
reported feeling “less hindered” in some aspects of their lives. This study, however, did not
support the relationship between the level of physical activity and DPN development. It rather
implied that performing some level of exercise helps to alleviate the level of interference from
pain in DPN patients.
A study with a sample from China of 122 T2DM patients of whom 29% were females, 60
years old and had had DPN for 22 months examined the predictors of regular exercise among
DPN patients (Pei, Wang, Sun, & Zhang, 2016). This cross-sectional study measured knowledge
about DPN and physical activity, physical activity status, physical activity self-efficacy, and
DPN symptoms. Knowledge of physical activity and DPN was obtained by a self-designed
questionnaire. It had items about beliefs and perceived benefits of performing physical activity,
its effect on DPN, and DPN symptoms. DPN was assessed by the MNSI and foot examination.
Physical activity status was obtained by asking about frequency of physical activity per
week, the favorite physical activity practice, and the duration of physical activity. Regular
physical activity was defined according to the ADA recommendations: at least 150 minutes
spread over at least three days per week. Self-efficacy for physical activity was measured using
the self-efficacy for exercise, which measures the subjective confidence in one’s ability to carry
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out exercise in different situations. A score of zero indicates no confidence and 100 indicates
complete confidence. Social support was measured by the Social Support Rating Scale.
Participants were grouped into regular physical activity and not-regular physical activity. The
study found that half of the patients exercised alone and that walking was their favorite physical
activity modality. Most, about 60%, performed regular physical activity. Gender, duration of
DPN, exercise self-efficacy, HbA1c, and objective social support were associated with
exercise, p < .001. Furthermore, patients who performed regular physical activity had DPN for a
longer duration (average of 31 months) in comparison to those with not-regular physical activity
(average of 8 months), p < .001. However, the severity of DPN did not significantly differ
between the two groups.
Khawaja and colleagues (2018) examined physical activity and DPN among a sample of
patients from Jordan. The level of physical activity was categorized into regular, not regular, and
no physical activity. To examine the association between physical activity and other variables,
this study conducted two statistical analyses: an independent sample t-test and logistic
regression. The t-test model showed a significant difference in physical activity between the
DPN and non-DPN groups (p < .001) (no mean scores reported). In the logistic regression
model, performing regular physical activity (for 30 minutes for 7 days/week) was not found to be
associated with lower risk of DPN (odds ratio = 0.71 CI 95%, 0.40–1.25, p = .239). However,
those performing not-regular physical activity (being active 30 minutes for 1–3 days/week) were
less likely to have DPN compared to those who were inactive (odds ratio = 0.51, CI 95%, 0.350.75, p < .001). This means that being active even minimally is linked to less risk of DPN. It is
interesting in this study’s finding that preforming daily exercise did not decrease the risk of DPN
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the same way did not-daily exercising. Also, what needs to be further investigated is the
comparison between the two physically active groups (regular versus not regular).
To conclude on the biologic variables, there is evidence to link HbA1c and duration of
diabetes to the risk of developing DPN. Less conclusive evidence exists as to cardiovascular risk
factors. This was also verified in a review of all research reports from 1980 to 2015 that
examined predictors of DPN in which it was concluded that hyperglycemia and diabetes duration
had a robust association with DPN and that weight, smoking, and hypertension had a weak
association with DPN (Papanas & Ziegler, 2015).
Characteristics of the Individual
The individual risk factors that are linked to DPN are age and gender. Only age was
found to be considerably associated with DPN whereas gender had less conclusive evidence.
Age
The person’s age has always been one of the few factors that has been consistently linked
to the development of DPN both in Saudi and non-Saudi populations (Algeffari, 2018; AlQuliti,
2015; Bansal et al., 2014; D’Souza et al., 2015; Halawa et al., 2010; Khawaja et al.,
2018; Mojaddidi et al., 2011; Wang et al., 2014). Studies have shown that for each decade of
increase in age there is a worsening of nerve fiber conditions leading to the increased prevalence
of DPN. However, the mechanism of action is not fully understood (Papanas & Ziegler, 2015).
It is suggested that the natural decline in nerve function due to age consolidates the effect of
DPN. A non-Saudi study examined T2DM patients for association of age and DPN. DPN
patients mean age was significantly higher than those without DPN (mean = 57.1 vs. 52.5 years,
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p < .001). Age showed increased risk of DPN (odds ratio = 1.02, CI 95%, 1.01-1.03, p < .001
(Bansal et al., 2014).
Gender
Research studies of the relationship between gender and DPN have been
inconsistent. Cross-sectional studies (D'Souze et al., 2015; Gogia & Rao, 2017), including a
study from Saudi (Halawa et al., 2010) have concluded that male gender is linked to higher risk
of DPN. However, equal evidence from other studies (including Saudi) (Algeffari,
2018; AlQulti, 2015; Bansal et al., 2014; Khawaja et al., 2018; Wang et al., 2014) reported that
no relationship exists. For example, Gogia and Rao (2017) studied T2DM patients (n=273) in
India, using both the Diabetic Neuropathy Symptoms questionnaire and physical examination
measures, concluded that male gender was linked to neuropathy symptoms (p = not reported).
On the other hand, in a study (non-Saudi) composed of males (n = 57) and females (n =
68) with T1DM and T2DM, the research team aimed to study gender-based differences as they
pertain to the frequency of DM, age at diagnosis of DM, age at onset of DPN, and with respect to
duration of DM using electrophysiological studies. They found that in diabetic people with DPN
there was no significant difference between the mean age (when completing the survey) of males
and females. The mean age of females was 51.8 ± 10.04 years and of males 53.29 ± 9.39 years.
There was also no difference between the mean age of patients at onset of DPN; the age at onset
of DPN was 50.8 7 ± 9.43 years in males and 49.25 ± 10.6 years in females (Javed et l., 2014). A
study from Korea concluded otherwise (Won et al., 2012). The study found that DPN was more
prevalent in women than men, p < .01. Female gender increased the odds of DPN 1.26 times, p =
.02.
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In one of the earliest studies of gender-based differences, investigators concluded
differently from previous study. This retrospective US study examined the records of males (n =
156) and females (n = 220) with T2DM. The study found that the age of males was 63 ± 14.24
years and for females 67 ± 12.61 years at onset of DPN. Males developed DPN about four years
earlier than females, p=.006 (Aaberg, Burch, Hud, & Zacharias, 2008). This study had an
ethnically diverse sample with 69% Blacks, 19% Whites, and 1.6% Asians, but the association
between ethnicity and the onset of DPN was not significant. When comparing this to the first
study (Javed et al 2014), one might speculate that the very different racial make-up of the
samples could explain the different findings. In addition to the differing demographics of the
samples, there is more than eight years between the data collection of the two studies, which may
be a factor. Considering the racially and culturally diverse populations this review has examined
and also based on the fact that DPN development involves genetic components, interpreting the
lack of significance in the results is complicated.
Symptom Status
DPN manifests with complete or partial loss of sensation and often with an insidious
onset. To most patients, the most distal parts of the body are the first to be affected (toes and
fingertips) (Vinik et al., 2013). The evidence of the symptoms of DPN is challenging to interpret
since there is a lack of agreement on standardized measures. Many cross-sectional studies use
subjective measures. However, clinical trials use both objective and subjective measures. The
only gold standard test for DPN recommended by the ADA is the nerve-conduction velocity test,
which has been reported to be objective, repeatable, and sensitive (ADA, 2019). However, the
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applicability of the test in clinical practice and in research is limited as it is expensive and
unfeasible.
Neuropathic Pain
Neuropathic pain is one of the most bothersome symptoms that people with DPN report.
The pain can take the form of prickling, burning, sharp stabbing, or deep aching (Hebert et al.,
2017). Neuropathic pain in DM is typically bilateral, below knees, nocturnal, not related to
exertion, and not caused by other conditions such as vascular disease, arthritis, or sciatica (Vinik
et al., 2013). Patients with severe and moderate pain described it as deep pain with a constant
background with occasional breakthrough flare-up pain. Meanwhile, people with mild pain
reported it as surface pain (Davies, Brophy, Williams, & Taylor, 2006).
There is inconsistency on whether pain is the hallmark feature of DPN, and thus all DPN
symptoms should be referred to as painful DPN, or whether pain is one symptom among many
others like increased or decreased sensation, numbness, and unsteadiness. This widespread
inconsistency is evident in many of the reviewed studies. In many of these studies, the same
symptoms are referred to as either painful DPN, simply DPN, or as neuropathic pain in diabetes.
For instance, three of the five Saudi studies of DPN used the term painful DPN (Algeffari,
2018; AlQulti, 2015; Halawa et al., 2010).
The other two Saudi studies, despite using the same description and measurement tools
for the symptoms, opt to use the term DPN without the word painful (Mojaddidi et al., 2011;
Wang et al., 2014). Both Algeffari (2018) and Mojaddidi et al. (2011) used the same instrument,
the MNSI, to measure both seemingly same conditions but with different nomenclature (painful
DPN versus DPN). Although Mojaddidi et al. (2011) also used physical neurological
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examination to evaluate the symptoms, no pain intensity measures were used to evaluate the
intensity of symptoms nor to determine the severity of pain. While the MNSI is a good tool to
measure the presence and severity of symptoms, it was not designed to measure pain
intensity (Herman et al., 2012). Experts recommend that for the diagnosis and assessment of
neuropathic pain, all components of pain should be recorded (distribution, quality, severity,
associated symptoms, and relieving or exacerbating factors) (Vinik et al., 2013). This is also
evident in the international literature. Hebert and colleagues (2017) has described the clinical
manifestations associated with DPN as positive symptoms (tingling and itching), negative
symptoms (numbness and muscle weakness), and neuropathic pain (burning, and electric shock
sensation).
Additional evidence is found from a study reported from a sample of 269 T2DM patients
who were aged 67 years in the U.K. The researchers aimed to study the impact of painful DPN.
Performing clinical neurological examination allowed for the categorization of patients into
painful DPN, non-neuropathic pain, mixed pain, and no pain. Meanwhile, self-report surveys
(Toronto Clinical Scoring System) allowed for a determination of the presence and the degree of
peripheral neuropathy to be made: no neuropathy, mild, moderate, and severe neuropathy. The
diagnosis of painful DPN was made if the pain was bilateral, below the knee, and not caused by
other similar conditions. These authors suggested that peripheral neuropathy is a separate
symptom from neuropathic pain in that participants’ results were listed as two variables: painful
DPN and degree of neuropathy. The odds ratio for having pain for those with mild neuropathy
compared with no neuropathy was 3.4 (CI 95%, 1.4–8.0) and the odds ratio for having pain for
those with moderate-to-severe neuropathy was 15.6 (CI 95%, 6.8–35.5) (Davies, Brophy,
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Williams, & Taylor, 2006). The study concluded that increasing neuropathy severity is
associated with an increased risk of developing painful DPN.
Saudi studies have also reported gender differences in neuropathic pain with diabetes
(Algeffari, 2018; Halawa et al., 2010). Halawa et al. (2010) reported that women had a
significantly higher prevalence of painful DPN compared to men, 70% and 62%, respectively, p
= .02. Algeffari (2018) reported a similar finding; women were 66% of the painful DPN group.
However, the odds of DPN did not significantly increase with female gender (1.15, CI 95%,
0.63–2.1, p = .604).
Furthermore, the pain experience and the cultural beliefs of expressing pain among the
Saudis were important considerations for this current study. The religion of Islam, as practiced
by the people of Saudi, has distinctive ideology of pain and suffering. Islam views pain as a part
of the trials and tribulations of life and so Muslims strive to remain faithful and withstand pain
by assenting to the earthly trials. However, Islam does not condemn those who opt to voice their
suffering and find relief (Branden & Broeckaert, 2010). Despite this wide belief among Muslims,
many still report their pain. Thus there was no reason to believe that assessing pain among
T2DM patients in Saudi would be hindered by their religious or cultural viewpoints as there are
many research studies on the prevalence and attitudes associated with different types of pain. For
instance, a study surveyed 224 Muslim dental practitioners for the prevalence of lower back pain.
They found that 90% of the participants reported having musculoskeletal pain with women
reporting more shoulder pain than men (AlMohrej, Alshaalan, Albani, Masuad, & Almodainegh,
2016).
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Another study also had no issues recruiting patients with different causes of chronic pain.
A total of 200 patients, 64% were female, 49 years, and 75% married, completed the survey on
the effect of the severity of pain on depressive symptoms. About 50% had severe pain and only
1.5% had mild pain. As to the causes of pain, 33% and 69% had neuropathic pain and spinal
problems, respectively. Severe pain, increased age, being married, poor SES, and history of
depression were associated with higher risk of depression, p < .05 (AlMaharbi et al., 2018).
Sensory Symptoms
The DPN sensory symptoms involve numbness, paresthesia, hyperesthesia, and tingling.
Khawaja et al. (2018) used the MNSI to measure neuropathy symptoms and found that most
participants had at least one symptom. Numbness and pain with walking were reported as the
most frequent symptoms in 81% and 75% of their patients, respectively. Meanwhile, loss of
sensation while walking was the least common and reported by only 9.6%. A Pakistani
descriptive study on non-Saudi T1DM and T2DM patients (n = 800), also used the MNSI to
measure DPN symptoms. They reported that numbness was the most common symptom at 63%,
followed by dry skin/callus at 38% (Qureshi et al., 2017).
However, a study from India (n = 208) also using the MNSI, found that the most
common symptom reported by 72% of participants was a feeling of weakness all over most of
the time (D’Souza et al., 2015). Generalized weakness is attributed to muscle wasting, a possible
consequence of DPN (Vinik et al., 2013). The second most reported symptom was leg pain while
walking, reported by 65%. Prickling and numbness came next with 63% and 45%,
respectively (D'Souza et al., 2015).
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Among the Saudi population, two studies examined the characteristics and the commonly
reported DPN symptoms (Algeffari 2018; Halawa et al., 2010). In one study, 1, 039 T2DM
patients, with a mean age of 51 years, the DPN symptoms reported by the Saudi patients were
similar to those seen with other populations. Burning (67.6%), numbness (65%), and tingling
(60%) were the most frequently encountered DPN manifestations. Pain that feels like pins and
needles (48%), hypoesthesia to touch (34.8%), electric shock (34.5%), and painful cold (27%)
were also reported (Halawa et al., 2010. Meanwhile, in another study, T2DM Saudi patients (n =
242) reported burning pain in the legs or feet (91.7%) as well as prickling feelings (79.8%)
(Algeffari, 2018).
Some of the earliest research data on symptoms of DPN are from a US population-based
study, the National Health Interview Survey (NHIS) (Harris, Eastman, & Cowie, 1993). The
NHIS is a cross-sectional, nationwide survey that has been conducted annually since 1957. The
1989 study included T1DM and T2DM American patients 18 years and older (n = 84,572). The
study reported that 30% to 40% of the total sample (n = 2,405) had diabetes (n = 5% with T1DM
and n = 95% with T2DM). The prevalence of DPN among participants with T2DM was 36% for
males and 39.8% for females Twenty-eight percent of the sample reported numbness, 26.8%
reported pain or tingling, and 9.8% reported decreased ability to feel hot or cold. Most patients
(37%) reported more than one symptom. At the time, data were collected with none of the
validated questionnaires that are currently in use. For example, one of the items asked, “During
the past three months have you had numbness or loss of feeling in your hands or feet other than
from your hands or feet falling asleep?” (Harris et al., 1993).
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Similarly, the Rochester Diabetic Neuropathy Study (RDNS) was conducted from 1986
to 1989 with cross-sectional surveys and subsequent longitudinal study in Rochester, Michigan,
U.S. This was one of the earliest large-scale, longitudinal studies on the DPN population (n =
64,573), which included patients T2DM (n = 668) (Dyck et al., 1993). The study included not
only people with diabetes but also people with multiple causes of neuropathy. Non-diabetic
people served as controls. Various types of neuropathy, including DPN, were assessed using a
battery of surveys and physical examination measures like the Neuropathy Disability Score,
Neuropathy Symptoms Score, Neuropathy Symptoms Profile, nerve conduction studies, and
quantitative sensory examinations. In the RDNS, although 48% of the sample had objective
evidence of DPN, only about 15% were symptomatic.
DPN Symptoms, Falls, and Gait Disturbance
Recent evidence implicates DPN in some health concerns. Muscular and joint weakness
and instability due to DPN can cause disruption in the body’s sensorimotor functions (Alam et
al., 2017). Impairments of gait attributed to DPN are related to sensory loss, decreased lower
extremity strength, and changes in the central nervous system. Those changes have an effect that
extends beyond simple, functional impairment. One study looked at DPN, falls, and depression.
Vileikyte and colleagues (2005) studied 484 T1DM patients 70% were males, aged 61.8 years
with DPN patients from the U.K. and the U.S. who had had diabetes for an average of 17 years
and depressive symptoms. The sample included participants with moderate-to-severe DPN
symptoms. About 16% had active foot ulcers. The study evaluated DPN and depressive
symptoms using validated measures (NeuroQoL and the Hospital Anxiety and Depression
Scale). The study found that DPN symptoms and unsteadiness were predictors of depressive

40
symptoms. The severity of the DPN symptoms explained 39% of the variance in depressive
symptoms. The DPN symptom of unsteadiness, alone, accounted for 30% of the variance in the
model, p < .001 (Vileikyte et al., 2005).
Furthermore, DPN patients are at increased risk of falls. Falls in DPN patients occur as a
result of a combination of conditions, such as diabetic neuropathic arthropathy, loss of
proprioception, and autonomic neuropathy (affecting the cardiovascular system) (Handsaker et
al., 2016). Falls in neuropathic patients can also be attributed to muscle weakness and slower
movement of legs and feet. These processes lead to vasomotor changes and increased range of
motion of joints which lead to instability of the joints. Falls are serious health concerns for
people aged 65 and older due to the sustained injuries, recovery process, and burden to the
healthcare system (Crews, Yalla, Fleischer, & Wu, 2013). In large-scale studies, muscular
quality is found to be significantly lower among DPN patients, which causes impaired gait and
repeated falls (Andersen, 2014). These perceived alterations cause patients to have a fear of
falling.
A US study had a sample of 34 T2DM patients, average duration of DM of 15 years,
average age of 67 years, HbA1c of 7.9%, and males were 44%, investigated patients’ (DPN and
non-DPN) concerns about falling (Kelly et al., 2013). DPN was assessed using quantitative
measures including vibration perception threshold. Meanwhile, fear of falling was assessed via
the Falls Efficacy Scale International questionnaire (FES-1), and the gait spatiotemporal
assessment was performed with a validated wearable sensor technology (LEGSys). Participants
were instructed to walk for 20 minutes in their habitual shoes at their habitual speed, and their
balance and stride velocity were monitored. Most DPN patients (n = 28) reported a moderate-to-
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high concern about falling, p < .001. However, DPN and non-DPN patients had almost the same
level of fear of falling. In other words, the mean scores for fear of falling did not differ
significantly between DPN and non-DPN patients (30.2 ± 11.4 versus 31.7 ± 14.9, p =
.74). Furthermore, patients with DPN (regardless of severity) demonstrated a 22% longer
double-stance phase (p = .02), and 44% more steps to reach steady-state walking (p = .04)
compared to patients without DPN. The severity of DPN positively correlated with gait
initiation steps (r =.4, p = .03) and double-support percentage (r = .44, p = .01) (Kelly et al.,
2013).
Another study found evidence to support the association between DPN and falls. An
international study from Bosnia examined postural stability, walking speed, and fear of falling in
48 T2DM patients, aged 35-70 years, and with confirmed DPN. Participants had T2DM an
average of 11 years and DPN an average of six years. Assessment of fall risk was performed by
objective and subjective measures. The Functional Reach Test (FRT) was used to measure
participants’ dynamic balance. The Tinetti Falls Efficacy Scale (Tinetti FES) and the 10-Meter
Walk Test (10MWT) were used for the perception of balance and stability and functional
mobility. Neuropathy assessment was performed with the MNSI questionnaire and monofilament
testing. Participants were categorized into two groups based on history of falls in the past three
months: faller (1≥) and non-faller (zero). There was a significant difference between the two
groups in the duration of diabetes and the duration of DPN, p < .05. Twenty-eight participants
reported falls. Of the 28 participants who reported falls, half (n = 14) had one fall, a quarter had
two falls (n = 7), and another quarter had more than three falls. The absence of protective
sensation (monofilament testing) was higher in the faller group compared with the non-faller
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group, p < .05. In logistic regression analysis, the monofilament score was significantly
associated with the probability of falling (odds ratio = 1.37, p = .007). The study concluded that
the lack of protective sensation is a significant predictor of risk of falls (Bokan-Mirkovic, SkaricKaranikic, Nejkov, Vukovic, & Cirovic, 2017). There was no similar literature among the Saudis
that examined DPN and falls.
DPN and Overall QoL
The level of functioning of individuals with DPN varied considerably depending on the
degree and severity of symptoms. Functioning includes physical, mental, emotional, and social
practices. It also involves patients’ ability to perform self-care behaviors. This section is
organized so that the different domains of QoL are listed separately. The review of the studies in
each section included the respective subscores of that domain. For example, to discuss the
physical functions, the pertinent subscores of the SF-12v2 (physical composite score) were
addressed. QoL as a total score as well as the general perception of health were discussed ending
with a summary of the impact of DPN symptoms.
Physical and Mental QoL
Using the SF-12v2, a study from Greece examined the predictors of QoL in 53 T2DM
patients with DPN. The sample included 40 females with mean age of 66 years and duration of
DM of 23.5 years. Assessment measures included the MNSI, Depression Anxiety Stress Scale,
Multidimensional Fatigue Inventory, Visual Analogue Scale, and the SF-12v2. The study found
that DPN patients scored a mean of 34.4 ± 11.5 on the physical composite score (PCS) of the SF12v2 compared to the normative data of 50 (however, the level of significance is unknown).
Moreover, PCS correlated with general fatigue (r= -.316), MNSI (r = -.492), and total score of
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diabetes complications (r= -. 412), p < .001. The study concluded that DPN symptoms, reduced
activity, mental fatigue, and poor glycemic control were associated with poor physical
functioning (Lyrakos et al., 2013).
Another large, non-Saudi study of mostly T2DM participants (n = 21,261) from Romania
also confirmed the negative impact of DPN on physical health. In the study, T2DM patients were
surveyed using the Norfolk QoL-DN, which assesses DPN symptoms and their effect on QoL.
The Norfolk total score range between - 4 and 136, with higher scores indicating impairment.
The cut off scores are five and 0.5 for the total QoL and physical functioning, respectively. The
results show that 65% (n=13,854) reported DPN. The total score of the Norfolk QoL-DN for
those with DPN was 38.39 versus 13.71 for those without DPN, p < .001. The physicalfunctioning mean score for patients with DPN was 18.8 compared to 7.93 for those without
neuropathy, p < .001 (Veresiu et al., 2015). The study concluded that DPN patients had lower
QoL scores compared to healthy patients. Furthermore, women compared to men had
significantly higher scores, indicating worse physical functioning, 17.6 and 14.7, respectively, p
< .001.
Another recent study came to a similar conclusion. Riandini et al. (2017) concluded that
the individual’s functional status mediated the relationship between neuropathy and
HRQoL. This non-Saudi study sampled 160 T2DM patients, 42% were female; with Indian and
Asian ethnicity; aged 62 years; and with mean duration of T2DM of 13 years to examine the
impact of DPN on HRQoL and association of the functional status. Participants were grouped
into DPN (n = 80) and non-DPN (n = 80). This study is noteworthy because of the detailed
measurements used for the functional status. Physical-functioning assessment encompassed
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biophysical approaches that include muscle strength (dynamometer), range of motion
(inclinometer), functional capability (timed up and go, five times sit-to-stand, and functional
reach), average body sway velocity, and balance confidence (activities-specific-balance
confidence scale). DPN was assessed by the MNSI and using foot physical examination.
Individuals’ HRQoL was assessed by the generic measure EQ-5L. Findings indicated that
individuals with DPN had significantly lower functional status scores (lower ankle dorsiflexion
strength (p = .068), great toe extensor strength (p = .023), poorer timed up and go (p < .001), and
higher body sway velocity (p = .002) and lower HRQoL. The study concluded that body sway
velocity, five times sit-to-stand, and balance confidence mediated the association between DPN
and HRQoL and explained 37.8% of the variance in HRQoL.
Further evidence came from a non-Saudi, Bosnian study of 60 T2DM patients, 50% were
male who are aged 56 years, and with duration of DM of 12 years (Vukojevic et al., 2014). The
study used nerve conduction studies as a quantifying measure of DPN and the SF-36 to measure
HRQoL. Of the total 60 patients, 51 had DPN. The results of the nerve conduction studies of the
motor peroneal nerve correlated with physical-functioning domains of the SF-36 (r =.34, p =
.009). The scores of the sural nerve testing correlated with the individual’s vitality (r = .30, p =
.013). In this study, clinical parameters of the severity of DPN correlated with the SF-36 scores.
The study concluded that DPN symptoms caused mild to moderate impact on physical health (M
= 70 ± 5, p < .05) and thus on HRQoL.
Likewise, Dermanovic Doborotah et al. (2014) worked with a sample of T2DM nonSaudi patients (n=160, aged 62 years and 48% females). The patients were grouped into: painful
DPN (n = 80) and non-painful DPN (n = 80). To measure DPN symptoms, objective and
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subjective measures were used. QoL was measured by the SF-36 survey and depressive
symptoms were measured by the Beck Depression Inventory (BDI). The average score of the
BDI was 19.1 for the painful DPN group compared with 9.6 for the non-painful DPN group, p <
.001. The painful DPN group was significantly more depressed compared with the non-painful
DPN group. They found that patients with painful DPN had a much lower physical functioning
score compared with the general population, mean = 28 and 69, respectively (p < .05). Compared
with those with DPN, the non-painful DPN group had a physical-functioning score mean of
61.9, p < .001.
Similarly, neuropathy symptoms can impair an individuals’ emotional health. In that
same study mentioned earlier, Dermanovic Doborota et al. (2014) examined the components of
the mental functions in DPN patients. As with physical health, mental health and mental
composite scores were significantly different between the painful DPN and the non-painful DPN
groups. The mean mental health score for the painful DPN group was 52.9 compared with 71.9
for the non-painful DPN group, p < .001. The mean mental composite score for the painful DPN
group was 47.8 compared with 55.2 for the non-painful DPN group, p < .001. This study
accounted for the effect of comorbidities on QoL. Comorbidities like sleep disorders and
micturition and defecation disorders, angina, and blindness affected multiple subscales of the SF36 (e.g., physical functioning, general health, and physical role limitations).
Depression and Mood Changes
Diabetic patients are, disproportionately, at increased risk of depression. Older adults
with T2DM have a two-to-four times higher risk of depression compared with the general
population (Roy & Lloyd, 2012). In T2DM patients, depressive symptoms are associated with
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the presence of long-term complications, cardiovascular disease, hypertension, poor physical
functioning, and increased hospitalization (Papanas & Ziegler, 2015).
Evidence that links depressive symptoms and mood swings to symptoms of DPN is
mounting. Although evidence has established that long-term complications of diabetes (DPN) are
associated with depressive symptoms, the evidence is less clear regarding the pathophysiology of
the two comorbidity conditions (DPN and depressive symptoms) and whether the occurrence of
both conditions is interrelated or merely incidental. Nevertheless, the evidence supports the
relationship.
As mentioned earlier (in symptoms and falls), Vileikyte and colleagues (2005) studied
the impact of having DPN on depressive symptoms. Demographic and other comorbidities
accounted for about 3% of the variance in depressive symptoms, p < .001. When DPN symptoms
were added to the model, they accounted for an additional 28%. Pain and unsteadiness were
related to higher levels of depression, p = .001. Furthermore, an important finding that this study
identified was the significant relationship between the episodic-unpredictable timeline scale and
depressive symptoms. The episodic-unpredictable timeline explains the cognitive representation
of DPN symptoms in terms of unpredictability. This positive relationship implies that, possibly,
the unpredictable nature of DPN symptoms is what worsens patients’ mood and increases their
anxiety and depressive symptoms.
In a Croatian study, patients with mostly T2DM (n = 140 of 160) and DPN symptoms
were recruited. They were grouped into painful DPN and non-painful DPN groups. The painful
DPN group scored higher on the depression scale BDI (mean = 19.1) compared with the nonpainful DPN group (mean = 9.6), p < .001, indicating more depression (Dermanovic Dobrota et
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al., 2014). Also, the painful DPN group scored lower on the emotional role subscale of the SF-36
survey (indicating worse) (mean = 43.4) than the general Croatian population (mean = 72.4) and
the non-painful DPN group (mean = 74.2).
A study from Korea came to a similar conclusion in a sample of 200 T2DM with DPN
(Kim, Jeong, Mok, Kim, and Lee, 2015). This study assessed DPN symptoms using the MNSI
for neuropathy symptoms, and the Brief Pain Inventory (BPI) and Visual Analogue Scale for the
severity of pain. The EuroQoL (EQ-5D) was used to measure participants’ QoL. About (n = 82)
41% of the patients had painful DPN. The average pain and worse pain scores were 4.6 and 6.3,
respectively, p<.001. Kim and colleagues found that patients with painful DPN had functional
impairment that was significantly substantial across multiple life domains (social, recreational,
self-care, relations, and sleep). Of particular importance is that the most reported impairment in
the individual’s life was mood stability score. It was reported that about 80% (n = 62) of the
total 200 patients had mood swings and emotional instability secondary to painful symptoms.
Self-Care Activities and DPN
The evidence on association between self-care activities, DPN, and QoL is multifactorial
and complex. In the context of neuropathy, self-care can be viewed as an antecedent. The degree
of compliance in performing activities like following a healthful diet or inspecting feet and shoes
plays a role in enhancing or limiting the development of DPN. Self-care has a significant impact
on the relationship between glycemic control and neuropathy. For instance, an observational
study from Pakistan assessed a sample of 400 older adults over 60 years of age with T2DM for
the predictors of glycemic control. Forty-six percent were males and had a mean duration of DM
of 7 years. Participants responded to a battery of questionnaires (Lawton Instrumental Activities
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of Daily Living Scale, Self-care Inventory, Geriatric Depression Scale, and Mini-Nutritional
Assessment). Self-care behaviors were found to be strong predictors of glycemic control,
adjusted odds ratio = 0.96 (CI 95% 0.95–0.98), p < .05) (Atif, Saleem, Saghar, Malik, & Ahmed,
2019). This study provides evidence that performing self-care activities affects glycemic control
and impacts the individual’s probability of developing DPN symptoms.
On the other hand, symptoms of DPN play a role in the patient's ability to perform selfcare behaviors. For instance, if the patient has moderate or severe, painful DPN, he or she may
not be able to carry out the routine of cooking healthy meals or performing exercise regularly.
However, research to support this important perspective has not become evident as the literature
is inconclusive as to the impact of DPN symptoms on the individual’s self-care behaviors. Yet,
the individual’s ability to perform proper self-care behaviors depends on physical health (i.e.,
walking and climbing stairs), mental health (mood, and anxiety), and cognition (memorizing and
comprehension).
In the context of the Wilson and Cleary HRQoL model, it can be seen that self-care
behaviors are influenced by the characteristics of the individual and the environment. Individual
variables such as age, gender, and educational level are associated with readiness and ability to
execute self-care behaviors (Wilson & Cleary, 1995; Ferrans et al., 2005). By the same token,
social support and healthcare resources are important factors in self-care. Finally, if self-care is
seen as a domain of functioning, then it would be influenced by the individual’s physical, social,
and emotional health. The interaction among these domains in addition to other variables
predicts the overall QoL.
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The most important subset of self-care behaviors relevant to the development of DPN is
foot self-care. The literature on the association of foot self-care and neuropathy symptoms is
scarce since DPN is considered among the complications of DM. Some studies, mainly from
Saudi Arabia and the Middle East, examined foot self-care activities in relation to diabetic foot
ulcers, omitting that DPN is a significant risk factor for foot problems.
For instance, one study focused on foot self-care practices among T2DM patients
(AlOdhayani et al., 2017). A sample of 350 T2DM Saudis, 64% were males, aged 58 years, was
surveyed to explore the knowledge and practices of foot self-care. Descriptive statistics were
used to address the foot self-care practices. They reported that: 28% of the sample soaked their
feet; 41% moisturized their feet; 53% wore socks and shoes regularly; half, 50%, were
knowledgeable about diabetes and foot self-care. They also stated that there was a lack of
education from health care providers as the majority of the patients obtained knowledge about
proper foot care from non-medical sources (magazines and the internet).
Another study of 598 Saudi patients, 95% had T2DM, 62% were males, who had had
diabetes for 15 years, examined the predictors of foot complications (Y. Hu et al., 2014). DPN
was a predictor rather than an outcome variable. The study found that DPN along with peripheral
arterial disease increased the odds of foot complications. Patients with DPN had greater risk of
developing foot complications compared with patients without the DPN (odds ratio = 3.2, CI
95%, 1.69–6.1, p < .01).
One Saudi, descriptive study aimed at exploring knowledge, attitudes, and practices
regarding foot care. They surveyed a sample of 74% T2DM patients (n = 229) about their
knowledge of foot ulcers and practices of foot self-care and found that more than 60% of the
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patients had proper knowledge of the risk factors of diabetic foot and the role diabetes
management plays (AlHariri et al., 2017). The most common foot care practice was washing the
feet regularly (95%), followed by inspecting feet (85%). The practices least adhered to were
wearing stockings, 17%, and trimming nails, 33%. The findings of this study suggest that most
patients in the Eastern region of Saudi have satisfactory foot self-care practices.
AlJohani and colleagues (2015) surveyed a Saudi sample (n = 210) T2DM patients, aged
39 years, 50% were female, using the Summary of Diabetes Self-care Activities (SDSCA) to
determine the self-care practices (where 1= once a week and 7= every day of the week).
Generally, participants showed low-to-moderate levels of self-care with a mean of 3.72. The
most followed practice among this sample was taking medications with a mean of 6.2.
Meanwhile, foot care varied between participants (3.49 ± 2.37). This suggests that, on average,
patients inspected their feet and the inside of the shoes about three times/week, with greater
variation implied by the large standard deviation values. Finally, the t-tests (differences in mean
scores) of foot care were significant with regard to younger age, female gender, higher income,
and positive smoking status, p < .05. Younger patients, patients with higher income, and females
performed foot care more often than did males, lower income, and older patients (AlJohani et al.,
2015). Interestingly, smokers were more compliant with foot care practice compared to nonsmokers.
Some studies have also focused on the nature of knowledge and practice of foot self-care
among DPN patients. A (non-Saudi) study was conducted to measure the level of foot care
knowledge, practices, and DPN symptoms using self-report measures on a sample of (n = 250)
individuals who were aged 54 years old and had had DM for 8 years (Saber and Daoud,
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2018). To assess DPN, they used the MNSI questionnaire and examination. Assessment of the
knowledge and practices was obtained by an 11-part, self-designed questionnaire with possible
scores=0–11, a score < 5 indicates poor practice, 6–7 satisfactory practice, 8–11 good practice.
The prevalence of DPN among this sample was 31%. The mean knowledge score was 6.1 ± 2.6.
As for the subscores for knowledge, 76% had good knowledge about washing feet daily, 73%
had good knowledge about inspecting feet daily, and 71% had good knowledge about the
importance of socks. The lowest score in knowledge was for wearing slippers at home with 31%.
The participants’ practice scores were expectedly lower than their knowledge scores at 5.8 ± 2.1,
although no test of significance between the two scores was reported. Almost everybody (95%)
washed their feet daily, 62% examined their feet daily, and 61% cut their toenails straight and
across. Again, the lowest score of practice was for wearing slippers at home at 23%.
Furthermore, with regard to the type of footwear, about 44% wore round-toe shoes and
33% wore sandals. The majority of patients with low knowledge scores had low practice score
too, p < .001. In addition, it was found that persons with DPN and high foot care knowledge
were 32% compared to persons without DPN and high foot care knowledge which were 61% of
the sample. However, there were no significant differences between DPN and non-DPN patients
in the foot care practice, p = .11 (Saber and Daoud, 2018).
A (non-Saudi) study examined the relationship between foot self-care practices and the
development of diabetic foot ulcers among 290 DPN patients. This study was a longitudinal
design with baseline, 3-month, and 1-year follow-up periods. Assessment of DPN was performed
by the MNSI questionnaire and by foot examination, using the monofilament and vibration tests.
The newly developed Diabetes Foot Self-care Behavior Scale (DFSCBS) was used to determine
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the frequency of foot care. At baseline, participants lacked sensitivity, as evident by the
monofilament testing, but had no existing foot ulcers. By the one-year follow-up, 29% (n = 85)
had developed foot ulcers. In the Cox univariate regression analysis, there was a significant
difference in the MNSI scores between DPN patients who developed foot ulcers and those who
did not. Diabetic foot ulcer patients had a mean score of 2.64 ± 0.79 compared with those who
did not = 2.34 ± 0.82, p = .009. The hazards ratio of developing foot ulcers increased by 1.43
times in DPN patients (CI 95%, 1.43, 1.09–1.86, p =.009).
Moreover, the two groups (foot ulcers and no foot ulcers) were also significantly different
in their foot care practice. Foot care practices were significant predictors of foot ulcers:
inspection of bottom of the foot, p = .002; inspection between toes, p = .021; and moisturization
of foot, p = 0.04. The predictive power of the foot care practices remained significant after
controlling for demographic variables. However, after controlling for both demographic
variables and risk factors (including DPN), only moisturizing the foot remained significant
(Chin, Liang, Wang, Hsu, & Huang, 2014). This suggests that DPN patients with dry and
callused feet are at major risk for developing foot ulcers. Inspecting the foot may not prevent
ulcers due to injuries from cracks and fissures, but moisturizing the feet may have an effect. This
study is significant because while it does not examine the correlation between foot care practices
and DPN development, it does show that having DPN along with improper foot care increases
the risk of ulcers and injuries.
Some studies examined the influence of mood symptoms on self-care. Beverly and
colleagues (2012) found that depressive symptoms can lead to social withdrawal and
compromised self-care practices. They found that T2DM adults (n = 316) with elevated
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depressive symptoms were reluctant to discuss their self-care with the provider. Moreover,
participants with greater depressive symptoms had less frequent self-care practices (p = .005) and
lower QoL (p = .002) (Beverly et al., 2012). These findings suggest that changes in mental
health contribute to worse self-care practices.
To conclude, studies (discussed earlier) have focused on measuring the pattern and
frequency of performing foot care among T2DM patients (Muhammad-Lutfi, Zaraihah, &
Anuar-Ramadan, 2014; Saber & Daoud, 2018). Four studies from Saudi populations examined
pattern of foot care regardless of DPN presence (AlHariri et al., 2017; AlJohani et al.,
2015; Alodhayani et al., 2017; Y. Hu et al., 2014). There was only one non-Saudi study reviewed
herein that included DPN patients and evaluated foot care practices (Chin et al., 2014).
Characteristics of the Environment
Social Support
The direct examination of the association of social support and DPN is limited. Evidence
found discussed ways in which social support impacts people with T2DM by affecting patterns
of compliance in self-care, compliance with medication, and diabetes management outcomes.
Given that DPN is a complication of uncontrolled DM, this current study hypothesized that this
relationship extends to DPN. Social support factors that affected the management of T2DM also
extend to affect DPN development.
In the effect of social support on T2DM management outcomes, a piece of substantial
evidence comes from one of the few, although dated, meta-analysis. Van Dam and colleagues
(2005) reviewed randomized controlled trial studies (n = 6) on social support from (1980–2003)
with a total of (n = 712) T2DM patients who were aged 60 years old, and had a mean duration of
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DM of 9 years. Those studies examined varied forms of social support interventions: support
from peer patients in group visits and telephone calls, organized internet peer groups, support
from spouses, and support from family and friends in diabetes education—all compared with
usual diabetes care or education without social support. The interventions were measured by
various means: perceived social support, diabetes support scale, adherence to social support
questionnaire for partners, and social involvement and depression scales. The outcome variables
examined ranged between biophysical measurements (HbA1c and physical activity level) and
physical and emotional well-being and QoL. The review concluded that the effect of the social
support was general or specific depending on the source of support. There were a few
conclusions. First, support from peers in group sessions, internet-based, and telephone enhanced
patients’ lifestyle modifications. Second, support from family and friends participating in
diabetes education groups and social support groups had no effect on diabetes control for older
men. Third, support from a spouse may have a positive impact on obese women but not on men.
Finally, biomedical outcomes only improved in two out of four studies. Also, both positive and
negative effects of social support were found. One study in the review reported that men might
respond negatively to spouse participation in diabetes education groups (van Dam, 2005).
A recent study from China had a non-Saudi sample of (n = 122) T2DM patients who had
DPN for 22 months examined the predictors of regular exercise among DPN patients (Pei, Wang,
Sun, & Zhang, 2016). The study aimed to assess the association between social support and
patients’ patterns of physical activity. DPN and exercise measurement were discussed earlier in
DPN and physical activity. Participants were grouped into regular and non-regular physical
activity. Social support was measured by the Social Support Rating Scale-Chinese, which
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includes 10 items: subjective support (experience of receiving support and being understood),
objective support (visible and practical support), and support availability (the degree of support
utilization). Higher scores indicate greater support. The study found that the scores of total
social support, subjective, and support availability did not significantly differ between the regular
and non-regular physical activity groups, p =.179. However, the regular physical activity group
scored generally higher than the non-regular activity group in the total and subjective social
support (means = 38.6 and 22.2 vs. 37.1 and 21.4). This means that DPN patients who exercised
regularly did so with help and support from family and friends. Thus, objective social support
(actual support) increased the odds of performing regular physical activity 2.1 times (CI 95%,
1.08-4.24, p = .029) (Pei et al., 2016). This suggests that receiving support from family and
friends predicted a better performance of regular exercise, which was discussed earlier (DPN and
physical activity) to slow the progression of DPN.
A recent systematic review has also concluded that social support was associated with
self-care practices. The authors evaluated the evidence from 28 studies (n = 5, 242, T1DM and
T2DM patients). Social support was significantly associated with self-care in DM patients (r =
.28, CI 95%, .21-.34, p < .001). This association was stronger among T2DM patients compared
with T1DM, r = .30 versus .22 (Song, Nam, Park, Shin, and Ku, 2017).
A study from Iran of an elderly sample examined whether social support was a predictor
of self-care. The sample included 374 persons with T2DM, who were 60% female and mean age
of 67 years. Self-care was measured using the SDSCA Scale. Social support and self-efficacy
were measured by the Perceived Social Support Questionnaire (PSSR) and the Diabetes
Management Self-Efficacy Scale. Overall, 67% of the patients had poor diabetes self-care. The
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most performed self-care domain was monitoring of blood sugar by 64% of the participants.
About half, 55%, had satisfactory foot care practices. Performing physical activity was generally
acceptable with 68% of the sample noting regular exercise (Borhaninejad et al., 2017a). In a
different publication, on the same sample, the authors examined the association between social
support, self-care and self-efficacy. The results of the step-wise hierarchical multiple regression
showed that adding social support to the model explained 9.9% of the variance in self-care, p <
.001 (Borhaninejad et al., 2017b).
To conclude, evidence indicated that social support is linked to positive health outcomes
for T2DM patients by mediating the relationship between DM and self-care behaviors.
Furthermore, evidence showed that social support improves the self-care practices of patients
with T2DM, including performing regular physical activity.
Chronic Illness Resources
Living with a chronic illness such as diabetes affects the individual in every dimension of
life. The integration of chronic disease into existing roles and responsibilities, the need for
continuous self-care, diet modification, exercise, and much more is not only exhausting but also
requires a tremendous amount of resources. The resources the individual include communication
with healthcare providers mainly nurses and physicians, neighborhoods and community
conditions.
Communication with providers. The interaction with the healthcare provider is an
essential element in the management of chronic diseases. It has a significant influence on the
patient’s emotional well-being and, thus, has either a negative or positive effect on the patient’s
adherence to professional advice. Proper education and technical and behavioral training
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empower patients to perform better self-care. Patients often feel overlooked and ignored in the
decision-making process. Patients described aspects of favorable relationships with a provider
that involves support, collaboration, and encouraging communication strategies outcomes
(Bezreh et al., 2012; Young, Azam, Meurer, Hill, & Cui, 2016).
On the negative aspects of communication with providers, a US-based study of AsianIndians who are first generation US immigrants aimed to explore the patients’ perceptions of the
influence of social and healthcare provider support on DM management (Venkatesh &
Weatherspoon, 2013). The qualitative study of 30 individuals with T2DM with a duration of DM
of 10 years, who were aged 60 years old, and 49% were females, grouped participants according
to their HbA1c levels into the acceptable (AC) group with HbA1c < 7% and the unacceptable
(UC) group > 7%. Data were collected by in-depth interviews using semi-structured
questionnaires with open-ended questions and probes. Regardless of their glycemic control,
participants expressed that the provider should have provided clearer communication about the
challenges related to their condition. UC HbA1c patients were more likely than AC to report that
providers should regularly monitor and follow up with them to achieve target glycemic control.
Furthermore, the UC group wished for more attention from providers and more time spent with
them (Venkatesh & Weatherspoon, 2013). Considering the cultural differences, patients reported
lack of culturally sensitive care regarding dietary counseling. Most patients recognized factors
like a disconnect between recommendations and everyday life, lack of support, and inadequate
access to the healthcare provider, as in time-limited visits. The expectations of daily glucose
monitoring, physical activity, and healthful diet seemed impractical to some patients (Venkatesh
& Weatherspoon, 2013).
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Poor communication and time constraints may lead to inadequate patient education and
less than optimal DM management. For instance, patients often perceive that there is conflicting
information about medication, signs and symptoms between the physicians, media sources, and
internet which leads to lessened adherence (Carpenter, Elstad, Blalock, & DeVellis, 2014).
Another dimension pertinent to the patient-provider relationship is trust in the provider
and healthcare system (Polinski et al., 2014). Lack of trust seem to be also an underlying factor
contributing to non-adherence with appointments and medications. Patients with higher mistrust
and low health literacy perceived worse communication than did mistrustful patients with higher
literacy (White et al., 2016).
Among Saudi patients, the challenges of free-access to healthcare can be a barrier for
patients to receive optimal diabetes care. The provision of free services along with the growth in
population has led to inadequate numbers of healthcare personnel and decreased patient
resources to accommodate growing needs (AlMutairi, 2015). Consistent turnover due to stressful
work environments and the employment of expatriates has led to instability and low-health
outcomes (AlMalki et al., 2011).
Furthermore, among the Saudis, the patient-provider relationship is influenced by
individual characteristics. Patients’ own beliefs, education levels, and ethnic backgrounds have
all influenced the dynamic of this relationship (AlAboudi et l., 2016). Due to the differing
religious, geographical, and ethnic combination of the Saudi population, people have developed
different outlooks and expectations when receiving healthcare services. Some people are
generally indifferent; others depend on medications alone to improve diabetes outcomes and to
prevent complications. In one study of T2DM patients (n = 75), 77% were male, who had a mean
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duration of DM of 12.6 years, and were aged 54 years, researchers explored the association
between knowledge, attitudes, and QoL among Saudis with DM (AlAboudi et l., 2016). Data
were collected using the Brief Diabetes Knowledge questionnaire and the Attitude Toward Selfcare questionnaire. The study found that 77.3 % of the participants were afraid of their diabetes,
and 40% were depressed and unhappy. Denial and unacceptance influenced 45% of them.
In addition, diabetes knowledge varies among the Saudis depending on the region and the
individual (AlMutairi, 2015). Poor knowledge is most apparent with food and medications. The
majority of the participants thought that carbohydrates should be removed entirely from the diet.
Other participants felt that bitter foods are an alternative to medication and would neutralize
hyperglycemia (AlMutairi, 2015). The gap created by improper patient-provider communication
has led to suboptimal outcomes, lack of adherence, progressive complications, and ultimately
increased healthcare costs.
Neighborhood conditions and community resources. Another dimension of
diabetes resources involves the general support and empowerment patients can obtain from their
environment. This is the broader environment and a potential influencer in living with a chronic
illness. Examples of these resources include the neighborhood’s safety, a pleasant environment
like sidewalks and parks, access to information in the community, and availability of healthy
foods. The evidence on the association between DPN and neighborhood resources is limited. The
reviewed studies are based on the established evidence of the impact of neighborhood conditions
and community resources on public health with some studies specific to the diabetes population.
Again, this evidence is presented to support the hypothesis that factors affecting T2DM extend to
being factors affecting DPN (Sidawi & AlHariri, 2012).
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One piece of evidence comes from a confirmatory factor analysis on the neighborhoodspecific variables that affect health. This US study examined a sample (n = 615, T2DM, aged =
45–64 years, males = 62%, non-Hispanic Black, unemployed = 65%, income < $20,000 = 41%)
where the data were collected using a demographic and neighborhood questionnaire, the Medical
Outcomes Study Social Support Survey (MOS-SSS), food insecurity, and self-reported
Medication Adherence Scale (MAS), and the SDSCA (Smalls, 2015). The measurements for
neighborhood characteristics were as follows: aesthetic environment, walking environment, food
insecurity, access to healthy foods, and neighborhood problems index. Moreover, participants
reported higher scores for social support and social cohesion. The study concluded that
neighborhood factors explained the variance in self-care practices. For instance, for medication
adherence, 14.2% was explained by food insecurity, and 11.6% was explained by social support.
For general diet 20% of variance was explained by social support. For variance in foot self-care,
14.9% was explained by neighborhood activities, and 10.7% was explained by social support.
Social cohesion was significantly associated with glycemic control, p < .05 (Smalls et al., 2015).
This study verified that neighborhood conditions and community characteristics are predictors of
diabetes self-care behaviors and health outcomes to varying degrees.
Additional evidence comes from the U.S. in an analysis of data from the Panel Study of
Income Dynamics longitudinal study from 1999–2013. This cross-sectional analysis included a
community-based sample of older adults (n = 3,240, mean age = 56 years, males= 48%,
homeowners = 83%, White = 76%, Black = 18%). Participants were asked to rate their
perceptions of their own health using the Self-Rated Health questionnaire. The built environment
of the neighborhood was rated based on the availability of health supportive services and
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commercial decline in zip codes. Short- and long-term impact of the built environment were
measured by single and cumulative typology. On average, participants had fewer than one
chronic condition and fewer than one functional limitation. The most common environment was
the average density, 41%, followed by low density (census demographic). The commercially
declined environment was prevalent in only 3% of the sample. The study findings showed that
long-term exposure to neighborhood environments that lack supportive services (physicians,
grocery stores, and recreational facilities) and have a negative built environment (liquor stores,
pawn shops, and fast food stores) increased the risk of poor self-rated health, p < .05. In addition,
the built environment influences healthy aging (Spring, 2018).
Among the Saudi population, only one study was found that addressed the impact of a
neighborhood’s context on diabetes (Sidawi & AlHariri, 2012). In this study (n = 30, T2DM,
males = 100%, aged = 45 years, had DM = 12 years), data were collected using questionnaires
on performing physical activity, diet, lifestyle habits, and neighborhood conditions. Most of the
participants did not have problems with their environments. Nevertheless, participants reported
neighborhood conditions that were bothersome: difficulty wandering around within the
community, pollutants, noise, noise from traffic, and lack of cleanliness of the
neighborhood. The findings, although not significant, showed that the built environment
(sidewalks and parks) has a substantial influence on enforcing the adoption of a healthy lifestyle,
physical activity, and psychological well-being.
In addition to the built environment, other chronic illness resources included training
programs and support systems. The Diabetes Self-Management Education and Support (DSME)
is such a service provided for all people with diabetes in the U.S. and is reimbursed by major
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health insurance companies like Medicare and Medicaid (Beck et al., 2018). One of the
objectives of this program is to help patients develop the critical skills and problem-solving
techniques needed to manage their condition and delay or prevent complications. Studies showed
that the services provided via the DSME, such as online peer support and electronic health tools,
allowed for the implementation of a thorough feedback circle indispensable to enable continuing
self-care (Ceriello et al., 2012; Greenwood, Gee, Fatkin, & Peeples, 2017). This service
combines multiple factors (social support, community resources, and professional advice) to
enable patients to make better health choices.
DPN, Perceived Health, and Overall QoL
In the context of neuropathy, QoL has been affected by the severity of symptoms. The
overall QoL of patients with DPN is cumulative and is based on the variables mentioned earlier.
Based on the accumulating evidence, T2DM individuals living with DPN have decreased overall
QoL. The evidence is found in the effect of symptoms on physical, emotional, and social wellbeing and sleep disorders.
Emphasizing the same earlier reported studies, evidence presented herein is to highlight
the impact on overall HRQoL. Veresiu et al. (2015) assessed the QoL of patients (n = 21, 261),
of whom 65.2% had neuropathy symptoms. Of those, 22.7% had severe neuropathy symptoms
and developed foot ulcers. The total HRQoL score for those with severe DPN, as measured by
the Norfolk QoL-DN, was threefold higher than those without DPN (38.39 versus 13.71, p <
.001) suggesting worse QoL. Similarly, a study in Greece, discussed earlier, measured the
participants’ health perceptions and HRQoL using the SF-12v2 physical and mental composite
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scores. The study concluded that DPN symptoms negatively affected the overall perceived
HRQoL, and thus patients generally perceived their health as poor (Lyrakos et al., 2013).
Another report that illustrates the effect of DPN on QoL came from a controlled trial that
investigated the effect of new DPN investigational drugs, ruboxistaurin, topiramate, versus
taking a placebo treatment by measuring nerve-fiber pathways and improvement of
QoL dimensions. A sample of 54 T2DM patients with DPN, 20% females and were mostly
White was surveyed using the Norfolk QoL-DN to measure QoL. The Neuropathy Total
Symptoms Score, Neurological Symptoms Score, Quantitative Sensory Testing, and
Neurological Impairment Scores-Lower Limb were used to define and measure DPN symptoms.
Participants were randomized equally into three arms (n=18 in each group). Participants
received either one of the investigational drugs or a placebo for >18 weeks and completed
baseline and posttreatment visits. Changes in neurological functions were significantly higher
among the topiramte group compared with the ruboxistaurin group. Both treatment groups
improved neurological and QoL scores compared to the placebo group, p < .001. Total QoL
scores improved significantly in both active treatment groups (mean = 9.56 and 12.22, p < .001
and p < .04), compared with (mean = 5.56) for the placebo group (Boyd et al., 2011). The study
also found varying degrees of positive correlation between total QoL and DPN subjective and
objective measures, p < .05.
Some evidence of the impact of DPN on QoL comes from interventional studies. Two
studies in which patients were treated with either vitamin D3 (Alam et al., 2017) or vitamins B1,
B6, and B12 supplements (Hakim et al., 2018) showed patients’ QoL improved secondary to
improvement of symptoms. In the case of vitamin B complex, participants received the
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supplements for 12 weeks. Their QoL, as measured by the SF-8, improved from the baseline 44
to 51 at visit five, p < .001. In the vitamin D supplementation study, participants received a
single dose of 600,000 international units of vitamin D intramuscularly. The study concluded
that participants had improved emotional subscale scores in the NeuroQoL, p = .04 even though
there was no improvement in painful symptoms (Alam et al., 2017).
Another domain of QoL that has been studied and affected by DPN is sleep patterns. In a
cross-sectional study from Korea, a sample of 200 patients with T2DM were assessed for impact
of DPN on sleep and QoL (Kim, Jeong, Mok, Kim, & Lee, 2015). The degree of sleep
disturbance was measured using the MOS-Sleep Scale. Patients with painful DPN had impaired
sleep as evidenced by worse scores of sleep adequacy, respiratory problems during sleep, sleep
initiation, sleep maintenance, and somnolence.
Studies on Saudis were limited to the effect of DM and foot ulcers on patients’ QoL
(AlAboudi et al., 2016; AlHayek et al., 2014; AlShehri, 2014). No evidence was found for the
effect of DPN symptoms on QoL among the Saudis. Thus, this finding has provided evidence as
to the important need to conduct research in DPN for this population.
Summary and Evaluation of the Evidence
The review of the literature confirmed that the strongest factors associated with DPN
were age, duration of DM, and HbA1c. A weaker association was found between DPN and
gender, BMI, smoking, hypertension, and physical activity. Considering that the evidence
reviewed herein is primarily from cross-sectional designs, determining the nature of the
association (causal versus incidental) might be limited. Further, the results of the studies differed
based on the different measurements of predictors. For instance, in reviewing the effect of
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smoking on DPN, some studies defined smoking exposure by “ever smoker” (current or former)
and “never smoker”. Other studies compared non-smokers (may include former smoking) to
never smokers. Other studies simply had smoking as a variable with no specifying definitions.
This wide range of measurement scales considerably affects the validity of the outcome
measurements.
Moreover, some studies, like Gogia and Rao (2017), concluded that male gender is
associated with the risk of DPN although the level of significance was not reported in the
research article. Such weaknesses in the methodology makes the conclusions drawn about the
risk factors challenging. It should be noted that poor methodological rigor was observed in some
of the Saudi-based studies. One study had discussed the different predictors of DPN and
concluded that some variables were correlated to DPN while others were not (Mojaddidi et al.,
2011). However, the significance level was not discussed. Also, the authors did not explain
which statistical tests were used to test the hypotheses. For instance, the study reports that the
HbA1c level was higher among the symptomatic group compared to the non-symptomatic group
without discussing whether this difference is significant or not. Also, the study failed to provide
the mean scores for each variable. Reporting detailed description of the methods, including
statistical tests is imperative and can impact the validity of the study findings and implications.
Conclusion
Evidence has been presented herein to support the relationship of DPN symptoms to
individual and environmental factors and to impaired QoL. Biologic factors have been identified
as risk factors for DPN. Evidence globally has identified several risk factors such as age,
duration of diabetes, and glycemic control as the strongest, independent predictors of DPN
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symptoms. However, there was less consensus concerning the roles that gender, hypertension,
BMI, and physical activity play in DPN. Research on foot care habits, frequency, and association
with DPN symptoms among Saudis with T2DM, albeit scarce, indicated that most patients lack
knowledge related to the importance of foot care and that DPN is a risk factor for diabetic foot.
What has not been further investigated was the effect of DPN symptoms, considering severity,
on QoL among the Saudis with diabetes and neuropathy. Further, the relationship of glycemic
control, comorbidity, age, and gender, and DPN need to be examined.
This reported study added to the body of literature in the nursing discipline and the
scientific community the association of neuropathy symptoms and individual and environmental
risk factors in a comprehensive perspective guided by a theoretical framework. In
addition, this reported study made a unique contribution to science and humankind, particularly
for those individuals living in Saudi Arabia.

CHAPTER THREE
METHODS
This was an observational study examining the factors associated with DPN symptoms
and the impact of symptoms on the QoL. The aims of the study were (1) to examine the impact
of DPN symptoms on patients’ functional status (foot care practices), general health perception,
and the physical and mental QoL and (2) to examine the biological (HbA1c, comorbidity, and
cardiovascular risk factors) and individual (age, gender) factors associated with DPN symptoms
in persons with T2DM. This chapter addressed the study design, the setting, the sample, data
collection, data analysis, and the protection of human subjects.
Design
This study was non-experimental and utilized a cross-sectional survey to examine the
factors associated with DPN symptoms. This study involved obtaining measurements
prospectively on a single occasion with no follow-up period. According to Hulley et al. (2013),
the cross-sectional design has the advantage of being fast and inexpensive and avoids the issues
of adherence and follow-up which are associated with longitudinal studies. This study employed
a non-experimental descriptive approach because this design is appropriate for establishing an
association before other advanced designs are to be used. Generally, an investigator establishes
this association before venturing into a more advanced design (Levin, 2006) especially, when
there is a paucity of literature available about a population.
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Setting
Background of the Country of Saudi Arabia
The population census. Saudi Arabia is located in the Middle East and is the largest
country of the Arabian Peninsula. As of 2017, the population of the country of Saudi Arabia was
a little over 32 million people with about 20.5 million people (74.1%) with citizenship. The
population is mostly youth and young adults with about 70% of the Saudi population below the
age of 35 years. The percentage of people aged > 65 is 2.6% (General Authority for Statistics,
2016). In Saudi, there are 13 administrative regions which represent the entire urban and rural
areas. Each region has a capital city that hosts the municipality as well as several smaller
governorates.
Housing and living conditions. As of 2010, the number of households stretched to 4.7
million with an average of 6.4 individuals in each household (Abdul Salam, Elsgaey, Khraif, &
Almutairi, 2014). Considering the rate of births and the aging population, the number of
inhabitants in a single household is expected to continue at the same rate (Ashwan, Abdul Salam,
Mouselhy, 2012). Economically, the vast majority of the Saudi people work for the government.
The average annual income of Saudis is $54,770 (about 205,387 Saudi Riyals). About 21 million
persons in Saudi have an ownership status of their houses, and about 1.3 million persons are
renting. The majority of households are apartment units (43%); followed by 29% larger homes
(villa); and around 18% are living in traditional (mud or stone-made) houses. The size and type
of household reflect the individual’s SES. Accordingly, those who live in apartment units reflect
a moderate SES or are middle-class citizens. The housing conditions are standard with blocks,
bricks, and concrete as the basic construction materials. The households have accessible
amenities and services such as public water, electricity, gas, and sewage networks (General

69
Authority for Statistics, 2016). The principal means of transportation in the country is cars with
an average of 3 cars owned by a household.
Health and well-being in Saudi. Many Saudis are living with common metabolic and
cardiac conditions such as obesity, coronary artery disease, hyperlipidemia, and heart failure.
Besides, other chronic illnesses like hypertension, kidney failure, and peripheral vascular
diseases are also prevalent among the Saudis. Further, diabetes is a common health problem
among the Saudis. According to the International Diabetes Federation, there were around 4
million cases of DM in Saudi in 2017 (International Diabetes Federation, 2019).
Further, as far as healthcare services, the majority of healthcare services (> 60%) are
provided by the Ministry of Health (MoH) free of charge for those with citizenship. Healthcare
services include hospitalization, emergency room visits, outpatient visits, medications, home
health care, and tertiary care (General Authority for Statistics, 2016). The MoH employs the
majority of healthcare personnel working at major referral hospitals, in-patient pharmacies,
primary care centers, and rehabilitation facilities. The total number of healthcare workers in
primary care centers (nurses, physicians, and pharmacy and laboratory technicians) is 72,473
workers with 19,863 being nurses. There are about 2,325 primary healthcare centers with an
average of 150 centers per each administrative region (13 regions). The primary function of
those centers is the provision of preventative services, chronic illness care, and as referring
facility to advanced specialty centers. The clinics at the primary care centers include well-child
clinic, perinatal, dental health, and chronic illnesses clinics. Also, a few centers have health
educators’ clinics which are run by nurses.
Cost of healthcare services. Since its development in 1950, the MoH has provided full
medical care free of charge. The MoH is responsible for planning, formulating the policies and

70
guidelines, and monitoring the healthcare system in the nation. The centralization of decisionmaking and the financial demands brought pressure and overwhelmed the MoH. For instance,
the expenditure of the national budget on MoH has risen from 2.8% to 6.2% between 1970 and
2009. This budget is more than 29 million Saudi Riyals (about 7.3 million dollars) of the 475
million Saudi Riyals of government’s budget (Saudi Arabia Health Statistical Yearbook, 2009).
Data Collection Site
Data were collected at the Prince Abdul-Aziz bin Majid Diabetes and Endocrinology
Center in King Fahad Hospital, Almadinah Region, Saudi Arabia. It is the second largest center
of its kind in the country and the referral center for the Almadinah region. The diabetes center is
considered the treatment and referral facility for the administrative region and its seven
governorates. The population served at the center is the population of Almadinah region, the
third largest municipality in the country, about 1.3 million people. The center provides diabetes
and endocrinology medical and nursing care which includes a quarterly follow up, DM regimen
changes, wound management, and lifestyle and dietary counseling. The center’s physicians
provide care for patients upon referral from their primary care physicians. Typically, each patient
is followed up regularly every 3 to 6 months. On each follow-up visit, patients undergo
biochemical tests that include (HbA1c, lipid profile, kidney and liver functions, and complete
blood count) among other diagnostic tests.
Sample
The study used a convenience sampling approach which is a non-probability sampling
technique to obtain a representative sample of the DPN population.
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Inclusion Criteria
Participants were included in the study if they were men and women who have the
diagnosis of T2DM with confirmed diagnosis of DPN or reported experiencing pain, numbness,
and tingling sensations. The participants’ age range had to be between 18 and 80 years old.
Moreover, participants had to be on diabetes-control regimens, that is, insulin or anti-diabetic
medications, regardless of adherence. Participants had to have their most recent HbA1c levels (≤
6 months) listed in their charts.
Exclusion Criteria
The exclusion criteria included: (1) presence of co-morbid and debilitating illnesses
(cancer and end-stage renal disease; blindness, major lower limb amputations, and other causes
of neuropathy (chemotherapy-induced neuropathy, fibromyalgia, history of nerve root
compression, and spinal stenosis syndromes) that might obscure the assessment of DPN
symptoms and worsen QoL; (3) pregnancy; and (3) persons who could not read or write in
Arabic.
Sample Size Estimation
In calculating the sample size, the following criteria were applied: the level of
significance of p < .05, a power of 80%, and a medium effect size (.15-.5). Two preliminary
sample size analyses were performed based on each aim to obtain the minimum sample size for
the study.
To address the first aim (the correlation between symptoms, functioning, and QoL),
where linear regression was used, the minimum sample size needed was 80 participants: about
30 participants for each predictor variable + 50 minimum starting size (Wilson, Voorhis, &
Morgan, 2007). DPN symptoms predicted the value of functioning, health perception, and QoL.
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To address the sample size for aim 2 (the impact of DPN predictors on symptoms), the estimated
minimum sample size was 118. This calculation was based on the number of variables=10,
significance level of p < .05, statistical power of 80%, and an effect size of .15 (Soper, 2019).
Therefore, the minimum total sample size was 120.
Data Collection
Recruitment Strategies
This study used several recruitment strategies. Volunteer subjects were recruited via: (1)
direct approach at the center; (2) flyers posted at the diabetes center and distributed to the
center’s visitors and staff; (3) social media outlets (WhatsApp application); (4) phone calls to
potential patients prior to their appointments; and (5) referral from the center’s practitioners. The
recruitment flyers included a brief description of the study, inclusion criteria, incentives, the time
needed to complete the survey, and the investigator’s contact information. Further discussion on
the most effective approach is detailed in Chapter 4.
The Procedure of Data Collection
Participants were met at the diabetes center, and the investigator explained the study to
them. Also, depending on the means of contact with some participants, the initial meeting was
also done through phone calling. When potential participants showed interest in taking part in the
study, the investigator discussed means of screening. For some participants, we scheduled an
appropriate time to meet at the clinic. For other participants, the investigator performed the
screenings over the phone. Interested people were screened using the inclusion/exclusion criteria.
The criteria were written in a sheet and patients were asked about each criterion with simple
question with a yes or no answer. To make sure patients were able to understand the
questionnaires, item 2 of the SF-12v2 was used to verify readability. If the patients read the

73
question and were able to explain it back to the investigator they were considered for
participation. Potential subjects were then consented and handed the questionnaire packets to
complete. Depending on their preference, some patients took the packets home and returned it at
a later time while some returned using email. Other patients filled out the questionnaires at the
center and had their foot examined at the same time. The data collection procedure for the study
visit included: (1) self-report questionnaires that took about 30 minutes to complete, and (2) a
foot physical exam that lasted for about 10 minutes. The physical exam included inspection of
feet, ankle reflex testing, tuning fork, and the monofilament testing. Data collection procedures
took place at the diabetes center. A designated room was provided by the administration to
ensure patients’ privacy. No data collection involving physical examinations was performed in
waiting areas. Since the investigator is not associated with the clinic, temporary access to
information in the medical record was provided for the duration of the data collection.
Measurements
All self-report questionnaires were collected in Arabic. For the tools that were available
in Arabic, the investigator approached the developers and obtained permission to use them. The
CIRS was forward and backward translated into Arabic by a group of bilingual academicians for
this study. It was also reviewed by an independent certified translation company. See further
details about each tool in Appendix H.
Biologic Functions
The biologic data collected for the study were the HbA1c, BMI, total cholesterol, HDL,
LDL, height, weight, and triglyceride, and list of current medications. These were obtained from
the patients’ medical records. The majority of data about biologic functions were within 6
months. There are several cases where some patients’ information dated back close to 6 months.
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HbA1c Levels
The most recent levels of the HbA1c reflected the average glucose level in the red blood
cells on the last two to three months. The HbA1c was obtained from the patients’ medical
records. The standard of care at the center’s clinics was in concordance with the ADA
recommendations. Patients’ HbA1c levels were obtained by serum blood draw every 3-6 months.
Patients are often asked to fast over-night 8 to 12 hours before the tests were performed. Nurses
always perform the venipunctures using peripheral veins. Samples were then sent to the main
hospital’s laboratory for analysis. Results took about 2-4 days to show in the system. The HbA1c
criterion was defined according to the ADA. For a diabetic non-pregnant individual, the HbA1c
levels should be kept < 7% (ADA, 2019). The HbA1c levels was used as continuous variable.
Duration of T2DM
The survey included a question about the number of years the patients lived with T2DM.
This variable was categorical: < 5 years, 5-10 years, 10-15 years, and >15 years.
BMI
BMI is the persons’ weight in kilograms divided by the square of height in meters and
represented with kg/m2. BMI was defined according to the CDC. The normal range is 18.5-25.0
(CDC, 2016b). BMI of 25.1 or more was considered overweight. BMI of >30. 0 is considered
obesity. For this study, the BMI was coded as a continuous. Patients data on BMI were obtained
from the medical records.
Lipid Profile
Patients lipid profile included levels of the total cholesterol, HDL, LDL, and triglyceride.
The CDC and the ADA’s criteria were followed to define normal lipids: total cholesterol < 200
mg/dL, LDL < 100 mg/dL, and HDL < 40 mg/dL. For the triglyceride, a value of < 150 is
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recommended (CDC, 2017b). The criterion by which to define dyslipidemia in this reported
study was if the patient was prescribed lipid-lowering agents. This variable was dichotomous
with either yes or no answers.
Hypertension
The presence of hypertension was ascertained by the documented diagnosis of
hypertension and also by the prescription of blood pressure controlling medication. This was
dichotomous variable (yes or no).
Cigarette Smoking
Information about smoking history was collected in the general health survey and was
coded as current, ever, and never smoker. This was categorical variable.
Physical Activity
The possible levels of individual physical activity were as follows: regular physical
activity is when a patient performs a moderate intensity workout like fast pace walking, running,
and swimming for 30 minutes for 4-7 days per week. Not regular (or some exercise) physical
activity was defined by physical activity 1-3 days per week, and no physical activity was when
no activity is performed per week. Information about physical activity was collected by two
questions one in the general health survey and one as part of the SDSCA exercise subscale. Both
variables are identical, however, the analysis included the responses from the general health
survey. Physical activity was a categorical variable.
Diabetes Management Medications
This variable included the treatment the patient received for DM and included oral agents
alone, insulin alone, and a combination of oral agents and insulin. The DM management
information were collected as self-report and then verified from the patients’ record.
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DPN Management Medications
This variable indicates whether DPN symptoms were managed with medications or not.
Including this variable was an important covariate in the analysis of DPN symptoms. This
variable was coded as dichotomous (yes or no).
Comorbidity
Comorbidity refers to any other diseases and conditions (besides hypertension and
dyslipidemia) that the participants may concurrently have. Comorbidity includes diseases like
nephropathy, retinopathy, depression, and cardiovascular disease. To examine the effect of the
comorbidities, the Functional Comorbidity Index (FCI) was used. The FCI was specifically
developed for use with the general population bearing in mind the importance of measuring
functionality rather than mortality. The FCI is one of the few practical comorbidity indices
available for clinical and research usage and is the only measure that adjusts for the effect of
comorbidity on physical functioning (Groll, Bombardier, & Wright, 2005). The index comprises
diseases like visual impairment, osteoporosis, diabetes, and arthritis which have an impact on the
physical health and functioning. The FCI is a sum of 18 self-reported conditions including
obesity and diabetes. The possible score is 0 to 18; one point is given to every yes answer. A
high score indicates greater comorbidity and impairment. Limited information was found about
the psychometric evidence of the FCI. Nevertheless, the reliability of the FCI was found on one
study that evaluated the tool on acute lung injury patients (n = 421) by correlating it with the SF36 physical subscale (Fan et al., 2012). The inter-rater reliability score was high at -.91.
Unfortunately, there were no Arabic-studies found that used the Arabic version of the measure.
The FCI items were coded as yes/no for data collection, however, a total of the items marked
“yes” was summed for one FCI total score which was used in the analysis.
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Characteristics of the Individual
Characteristics of the individuals included age, gender, marital status, SES, and level of
education. These variables were collected using a demographic survey in Arabic. Other
noteworthy characteristics of the individuals included family history of DM and physical
activity. To learn about family history of DM, participants were asked about any family member
with the diagnosis of DM; this response were coded as dichotomous variables.
Characteristics of the Environment
Social Support
Data related to social support was collected using the Medical Outcome Survey- Social
Support Survey (MOS-SSS) Arabic. The MOS-SSS is a Likert-type scale that is reliable and
valid. It is a widely-used measure of the amount of support perceived by patients and assesses
the four aspects of support: informational, tangible, positive social interaction, and affectionate
support. Emotional/informational support has questions on empathy, understanding, expressing
of feelings, offering advice and guidance (Sherbourne, & Stewart, 1991). Tangible support refers
to the availability of support systems for physical needs and medical care assistance.
Affectionate support involves love and tenderness. Lastly, positive social interaction concerns
the ability of a person to perform recreational activities alongside others. The obtained (raw)
scores for each subscale was computed and transformed to calculate the total score. The MOSSSS has a total score of 100 with higher scores suggesting better social support. The MOS-SSS
has been translated into Arabic and psychometrically tested on Arabic sample. The Cronbach’s
alpha of the Arabic version was at .78 (Dafallah et al., 2016).
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Chronic Illness Resources
The level of support for DM patients was assessed using the Arabic CIRS. The CIRS
uses a Likert-type scale and has 22 items in 8 subscales. The CIRS evaluates the different
support outlets that enable individuals with chronic diseases to maintain a healthful lifestyle and
to perform self-management behaviors (Glasgow et al., 2005). The development of the CIRS was
based on the social-ecological and social support theories. The CIRS has items grouped into
eight different resources for support: support from healthcare, family and friends, neighborhood,
organizational, personal, diet, exercise, and the media. The CIRS has a total mean score for the
entire scale that can be calculated based on the number of items in the measure. Also there is a
mean score per each subscale as (total score/number of items). The score ranges between 1 and 5
with higher scores indicating better resources. The psychometrics of the CIRS have been tested
on a few populations among which is a population of postmenopausal women with T2DM. The
reported reliability estimates for the test-retest was .70 and .82 for the Cronbach alpha. The
subscales of the CIRS inter-correlate significantly at .17 and .56 (Glasgow et al., 2005). The
CIRS was translated into Arabic for the purpose of this current study.
Symptom Status
Three instruments were used to measure DPN symptoms. The MNSI questionnaire
(MNSI 1) and examination (MNSI 2) were the first measures used to determine the presence and
severity of neuropathy symptoms among patients. The primary investigator performed the
physical examination according to the description provided by the authors. The MNSI is used in
clinical trials with a focus on diagnosing, intervening, and evaluating outcomes (Feldman et al.,
1994; Lyrakos et al., 2013). The MNSI 1 has 15 self-report questions addressing the most
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common DPN symptoms (numbness, prickling sensation, temporal nature, and pain). The total
possible score is 15, and a score of > 4 is an indicator that someone would test positive for DPN.
The MNSI has been used on Arab populations (Algeffari, 2018; Khawaja, 2018). The
psychometric properties of the MNSI have been proven sufficient. The reliability assessment of
the MNSI included interrater reliability with an intraclass correlation coefficient of .91. Validity
testing included the testing of sensitivity and specificity. Both assessments were low-tomoderate, ranging between 38% and 72%. This reduced sensitivity and specificity are reported to
be due to a high published cut-off point of > 7.0. According to some studies, the most sensitive
and specific abnormal MNSI questionnaire score was >4 (Herman et al., 2012). Thus, for this
study, the score of ≥4 was utilized to determine the severity of the symptoms. Also, for this
study, the psychometrics of the MNSI were further tested.
The Leeds Assessment of Neuropathy Signs and Symptoms (LANSS) was the second
instrument that was used to collect data on pain and neuropathy symptoms. The study used the SLANSS which is the self-report version of the LANSS and was developed with the aim of
discerning neuropathic from nociceptive pain and provides sensory description of symptoms.
The original publication which describes the LANSS uses a clinician’s objective assessment of
neuropathy symptoms (Bennett, 2001). However, the S-LANSS is a self-report assessment
accounting for subjective report of neuropathy symptoms by the patients which was used in the
study (Bennett, 2005). The S-LANSS has a high accuracy rate for neuropathic pain. The measure
is a 7-item scale based on grouped sensory descriptions (dysarthria, autonomic, evoked,
paroxysmal, and thermal) which are written in a plain language that patients can understand and
respond to. This measure asks if patients are experiencing symptoms such as numbness,
prickling, warmth of skin, and discomfort when pressures applied. The S-LANSS has been
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translated and culturally adapted into Arabic. However, The Arabic version of the S-LANSS was
not psychometrically tested (Garoushi, Johnson, & Tashani, 2017).
The numeric pain rating scale which is a numerical 6-item self-report questionnaire was
the third instrument used to measure DPN symptoms. The Pain Rating Scale was developed by
the British Pain Society. It has several language versions including Arabic. The Pain Rating
Scale is reasonably easy to use with five items on the severity of the current and most recent
(previous week) pain. Also, there are items on whether the pain is bothersome, and the degree of
interference with life (British Pain Society, 2014). The Pain Rating Scale uses a numeric scale
where the responses to each item ranges between zero and ten. A score of > 5 suggests
moderate-to-severe pain (Ferraz et al., 1990). As numerical data, the scores were averaged to
generate a mean score. There were no reports on this measure’s psychometrics. However, as a
numerical pain scale, there was established evidence of its validity. For instance, in a group of
patients with rheumatoid arthritis, the test-retest reliability was .95 and .96 for literate and
illiterate individuals, respectively. Likewise, the validity of the numerical pain scale is adequate.
The construct validity was tested on patients with chronic pain of greater than 6 months which
ranged between .86 and .95 when correlated with the Visual Analog Scale (Ferraz et al., 1990).
Moreover, the numerical pain scale is superior to the Visual Analog Scale because it provides an
accurate assessment of pain with measurable data, unlike the visual analog where the results are
qualitative and converting them into numeral values is cumbersome. Table H2 details a
comparison of the DPN tools and includes the characteristics and the items of each one. Table
H3 shows the reliability estimates of each tool as indicated by the Cronbach alpha as reported in
the literature.
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Physical Examination (MNSI 2)
Inspection of feet. The examination of the foot included inspection of the appearance of
the foot for deformity and signs of ulceration.
Semmes-Weinstein Monofilament Test (SWMT). The SWMT is one of the standard
tests and is recommended for diagnosing DPN. The 5.07/10-g SWMT is a thin plastic filament
covered by a plastic handle that was applied lightly perpendicular to the skin on several areas to
detect the loss of protective sensation (LOPS). The use of the SWMT provides highly sensitive
and accurate results compared to other tests of protective sensation (pinprick and light touch).
Whether or not a patient senses the touch from the test is an indicator of nerve function. The
evaluation was performed on ten sites on each foot as this has been reported to increase the
sensitivity and the specificity of the findings, relative to a single site (Singh, Armstrong, &
Lipsky, 2005).
Ankle reflexes and vibration perception. The assessment of ankle reflex on both feet
was performed using a queen square reflex hammer. The vibration sensation performed with 128
Hz tuning fork on the great toe unsupported. Physical exam variable was continuous.
Functional Status, General Health Perception and Overall Quality of Life
Diabetes Foot Self-Care Practices
The frequency of performing foot self-care is an indicator of functional status. Foot selfcare practices is a subset of self-care and for this study, data on patients’ self-care behaviors were
collected using the self-report, Summary of Diabetes Self-care Activities-Extended (SDSCA) in
Arabic. SDSCA is a Likert-type scale and asks about the number of days on the previous week
patients performed certain self-care behaviors (0-7 days/week) (Toobert, Hampton, & Glasgow,
2000). A score of zero indicates performing the activity zero day/week and a score of 5 indicates
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a frequency of 5 days/week (higher score is better). However, not all items are scored the same
way. The extended Arabic-SDSCA has 15 questions covering the five recommended self-care
practices for people with DM (diet, exercise, medication taking, foot care, and glucose
checking). An example of a question is “How many times per week did you check the inside of
your shoes?” The frequency of performing foot self-care is an indicator of functional status. Foot
self-care subscale of the SDSCA has five items (checking feet, washing feet, drying between
toes, inspecting inside of shoes, & soaking feet). Further details about the foot care subscale can
be found in Chapter 4.
The psychometric properties of the SDSCA are found to be adequate. Glasgow et al.
(2005) reviewed the results of several studies (five interventional and two observational) that
used the measure and concluded that the reliability and the validity of the measure are
appropriate. The reliability using inter-item correlation was moderate, r=.4-.8. The validity of the
measure was tested by correlation with other self-care measures. Its validity was established
based on those correlations and on its responsiveness to change. Those correlations were around
r=.58. The Arabic version has also been psychometrically tested on a population of Saudi
diabetics; the Cronbach’s alpha of the tool was at .76 (AlJohani et al., 2015). Appendix H
summarizes the reliability estimates of the tools used in this study as reported in the literature.
Medical Outcome Short-Form-12 Version 2 (SF-12v2)
The physical and mental composite scores of the SF-12v2 were used to determine the
participants’ levels of overall quality of life. Physical and mental QoL were determined by the
PCS and MCS, respectively. The SF-12v2 is a widely used generic scale for assessing functional
health and well-being. It has been used with a vast array of health conditions and across all age
groups. It has been proven to be useful and easy to use with many populations and across
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cultures. The scores of the SF-12v2 were used to measure the perceived level of health, including
physical, emotional, and role functioning (Ware et al., 1996). The SF-12v2 is a 12-item Likerttype scale that is self-administered. The final scores depend on combining scores, weighing each
item, and generating two subscales (mental health and physical health composite scores). The
scores are standardized with a mean of 50 and a standard deviation of 10. The SF-12v2 has been
used on the Arab population with various conditions and diseases. The SF-12v2 is available in
different Arabic dialects (AlShehri, Taha, Bahnassy, & Salah, 2008).
Data Entry and Cleaning
After data collection has been completed, the de-identification process took place. Data
was entered from the questionnaire booklets into the REDCap software. A detailed discussion on
the approach to data entry, cleaning, and information on the missing data can be found in
Chapter 4.
Data Analysis per Aims
Data analysis using inferential statistical modalities for each aim included:
Aim 1: To examine the impact of DPN symptoms on patients’ functional status (foot care
practices), general health perception, and physical and mental QoL. The analysis used for this
aim was the multiple linear regression. Linear regression is the appropriate statistical analysis
because the outcome variable is numerical (Nayak & Hazra, 2011). It is also appropriate because
it is a multivariable analysis to test the correlation between one dependent variable (foot care
practices subscale, health perception, or QoL) and one or more independent variables (DPN
symptoms).
Aim 2: To examine the biological (HbA1c, comorbidity, and cardiovascular risk factors)
and individual (age and gender) factors associated with DPN symptoms in persons with T2DM
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living in Saudi Arabia. The analysis of this aim was performed using multiple regression.
Multiple regression is the appropriate analytical approach for finding an association relationship
between one continuous outcome variable and more than one independent variable (Nayak, &
Hazra, 2011).
Human Subjects Protection
Research on human subjects included face-to-face and telephone screenings, responding
to surveys, and a brief physical exam of the feet. The investigator approached all possible
participants regardless of their gender, skin color, ethnicity, SES, and educational level.
Participants were offered educational handouts about peripheral neuropathy. Also, participants
received tote bags and coffee mugs as an appreciation for their time and interest in the study.
Participants’ privacy and personal information were protected during the data collection process
of this current study. The investigator stored medical records numbers, names, and contact
information in a locked cabinet at the diabetes center. During data collection, all questionnaires
and biologic values were de-identified for maximum anonymity, and codes were used instead of
personal identifiers. Signed consent forms were also stored separately at the investigator’s office.
For the electronically accessed data, the investigator ensured safe handling of computer screens
while examining patients records to guarantee that there was no access to unneeded information
and also that the information was not shared with anyone. Finally, the investigator put significant
efforts into ensuring the protection of the completed surveys, informed consents, data storage,
and statistical software.
Risks and Benefits
While the investigator acknowledges the ethical issues raised by some research, this
study carried relatively no risks. However, potential physical, psychological, or social risk were
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possible. This study, carried a possible risk of loss of privacy; this risk was addressed earlier.
The investigator made sure that participants were well aware that there were no benefits gained
from taking part in this study. This has been explained in full details in the informed consent
form that this study was non-experimental, and the purpose was to examine the association
between neuropathy symptoms, quality of life, and the specified predictors.

CHAPTER FOUR
RESULTS
This chapter addresses the results from the study. This chapter starts with a description of
the sample, data entry, and missing data and ends with the details of the results of the study aims.
The purposes of this study were to examine the impact of diabetic peripheral neuropathy (DPN)
symptoms on quality of life (QoL) and to explore the factors affecting the development of
neuropathy symptoms.
Recruitment Information
Patients were recruited from a regional diabetes center in Saudi Arabia. The main
approach of recruitment was the direct approach by talking to patients who had appointments at
the center to explain the study and to solicit participation. The total number of patients contacted
during the time of data collection was 249 patients. Of these, 8% (n = 20) did not show interest
and thus never returned phone calls or declined to discuss the study. Thus, 92% of the
participants’ pool (n = 229) was approached for participation. Of those, 36% (n = 83) were
unable to participate. About 10% (10.9%, n = 25) refused to participate, and 25.3% (n = 58) were
excluded according to the exclusion criteria. Thus, about half of total number of people
originally contacted (n = 146) agreed to be interviewed and participate in the study. Of those,
18% (n = 26) did not complete the process; the final sample size was 120 participants.
The most effective methods for recruiting the final sample were directly approaching
them in the clinic (58.3%), referrals from clinics (30%), and phone calls (16.6%) (see Table 1).
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Table 1. Number and Percentage of Participants from each Recruitment Source
Recruitment Source

Approached Patients %
(n)

Excluded/Refused/Did
not Respond % (n)

Final Sample
% (n)

Direct approach

56.2% (140)

54.2% (70)

58.3% (70)

Phone calls

28.1% (70)

38.7% (50)

16.6% (20)

Referrals from clinics

15.6% (39)

6.9% (9)

30% (25)

Total

100% (249)

100% (129)

100% (120)

Missing Data
Missing data were limited to < 7% because all booklets were reviewed upon completion.
Participants provided their contact information and agreed to receive a call back for the purpose
of querying about missing information. For instance, some participants chose two responses for
the same question. In other instances, participants would forget to answer a question or two.
Most participants with missing data were called and clarified missing data points. In those cases,
the investigator suggested that the participants come to the clinic to complete them. If they
refused to or were unable to come, the investigator did read those questions to them on the phone
and marked the answers following a strict script according to which she only read the questions
and explained the meaning of the Likert-type answers. Moreover, 4.2% (n = 5) of participants
were not able to have their feet examined as they opted to complete the booklets at home and
then have the exams performed when they returned the booklets. Unfortunately, the investigator
was not able to meet with those patients to complete the exams because of scheduling conflicts.
There were also a few questions consistently missing on the Chronic Illness Resources Survey
(CIRS). These were questions pertaining to access to health care, and, since medical care is
provided for all citizens, most patients 87.5% (n = 105) left them blank. The other missing data
in the CIRS pertained to the work environment, and, thus, were only applicable to employed
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participants. These questions were not applicable to 75.8% (n = 91) of the sample. According
to the authors of the instrument, individual subscales can be removed with no impact on the
overall scale (Glasgow et al., 2004).
The largest number of missing data was seen with the low density lipoprotein levels as
45% (n = 54) of patients were missing this test despite having had other lipid measures assessed.
The center officials verified that for people with no evidenced hyperlipidemia and are not on
treatment, only the triglycerides and cholesterol levels were checked quarterly. However, the
remainder of indicators of lipid profiles were complete. Finally, there were about 6.6% (n = 8)
missing data on the HbA1c. In these cases, patients were being seen at the diabetic foot clinic
where they got foot ulcers assessed, dressings changed, or prescription for foot moisturizers
filled and did not come to the study site for routine medical visits very often. These patients may
have up to a year gap with missing routine medical visit appointments and, thus, did not have upto-date HbA1c on records.
To utilize the full collected data, missing values were replaced by a single group mean.
Data were reviewed and screened manually giving the limited amount of missing data. Although
the missing completely at random hypothesis testing was done the decision to impute the missing
values was based on manual screening of data (on SPSS and physical booklets) to determine that
the missing values occurred completely at random and that they do not follow specific pattern.
For instance, the total scores (used in the analysis) of the key variables (MNSI 1, S-LANSS, PCS
& MCS had no missing data. MNSI 2 (foot exam) had 4.1% (n = 5) missing data. Thus, the
investigator examined the reasons for those missing data by reviewing the missing data manually
from the survey and on SPSS. The reasons for the missed data were understood and explained.
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Data Entry
As data were being collected, they were de-identified and entered into the Research
Electronic Data Capture (REDCap) system, which is a data collection and storage platform. Each
participant was given a study identification number. After completing data entry, all records
were verified and screened twice to ensure completeness and accuracy. Data were then exported
into IBM SPSS Statistics Version 26 for analysis. Data were then screened again, and missing
values were identified. Then, the negatively worded questions of the Michigan Neuropathy
Screening Instrument (MNSI) and the Summary of Diabetes Self-care Activities (SDSCA) were
recoded in SPSS. For instance, items 7 and 13 of the MNSI were reversely phrased and thus had
to be recoded. Other computations and transformations that included creating new variables of
tools were also conducted.
Characteristics of Overall Sample
The study sample comprised 120 patients with the diagnosis of T2DM and symptoms of
DPN. The majority, 67.5% (n = 81), were Native people (those who had always resided the
Arabian Peninsula and had no other racial background), who had an average age of 54 years.
Seventy percent (n = 84) were married, 70.6% (n = 84) were unemployed/retired, 40.2% (n =
47), had lived with T2DM > 15 years, and about 70% (n = 83) had never smoked. Females made
47% of the sample.
Since falls are an issue in persons with T2DM, this was explored and it was noted that
12.9% (n = 15) of patients reported having fallen within the previous three months. Eleven
people (9.2%) reported falling only once. A couple of people (1.7%) said they fell around three
times. The most frequent reason for falls was loss of balance, which was reported 40% (n = 6
times) of the time. The demographic characteristics of the sample are described in Table 2.
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Table 2. Sample Demographic Characteristics
Variable
Age (years)
Variable
Gender (n=119)
Female
Male
Race (n=120)
Native people
North African
Black
Middle Eastern
South Asian
Multiracial
Other
Prefer not to answer
Marital status (n=120)
Married
Widowed
Divorced
Single
Separated
Prefer not to answer
Income (n=120)
< 5,000 SR
5,000-10,999 SR
11,000 – 15,000 SR
> 15,000 SR
Prefer to not answer
Level of Education (n=120)
< 6th Grade
6th Grade
Intermediate school
High school
Associate degree
Baccalaureate
Higher education
Prefer not to answer
Employment status (n=119)
Unemployed/Retired
Employed
Duration of DM (n=117)
<5 years

Mean (SD)
54.0 (9.4)
Percentage% (n)
47.1 (56)
52.9 (63)
67.5 (81)
10.0 (12)
1.7 (2)
4.2 (5)
5.0 (6)
1.7 (2)
5.8 (7)
4.2 (5)
70.0 (84)
16.7 (20)
10.8 (13)
0.8 (1)
0.8 (1)
0.8 (1)
49.2 (59)
21.7 (26)
10.8 (13)
6.7 (8)
11.7 (14)
25.8 (31)
13.3 (16)
20.0 (24)
8.3 (10)
5.0 (6)
20.0 (24)
4.2 (5)
3.3 (4)
70.6 (84)
29.4 (35)
12.9 (15)
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5-10 years
26.5 (31)
11-15 years
20.5 (24)
>15 years
40.2 (47)
Relatives with DM (n=115)
80.0 (92)
*Treated dyslipidemia (n=116)
Yes
62.9 (73)
No
37. 1 (43)
*Hypertension (n=114)
Yes
51.8 (59)
No
48.2 (55)
History CVD (n=116)
19.0 (22)
Smoking History (n=119)
Never smoked
69.7 (83)
Current smoker
16.0 (19)
Former smoker
14.3 (17)
Exercise for 30 minutes/day: (n=118)
No exercise
54.2 (64)
Some exercise (1-3 days/week)
27.1 (32)
Regular exercise (4-7 days/week)
18.6 (22)
T2DM Treatment (n=116)
Oral agents only
41.4 (48)
Injections only
55.2 (64)
Combination Therapy
50.0 (58)
Note: * indicates data obtained from medical records; other data are self-reported
Data Analysis of Key Study Variables
The key variables used in this study were DPN symptoms (MNSI 1, MNSI 2 and SLANSS); QoL indicators (general health, foot care, PCS, and MCS); biologic variables (HbA1c,
dyslipidemia, comorbidity, level of physical activity, and hypertension); characteristics of the
environment (social support and chronic illness resources); and characteristics of the individual
(age and gender).
Biologic Factors
The biologic factors were mostly obtained from the medical record. The most important
biologic factor in the study was the HbA1c which was measured in the clinics laboratories
quarterly. The average HbA1c level of the sample was 8.89%. The mean levels of lipid profiles
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in mg/dL were as follows: triglycerides = 154.2, total cholesterol = 171.7, HDL = 40.6, and
LDL = 96.3. These values reflect converted levels since the standard measurement system at the
diabetes center was the mmol/L. To perform the conversions, Omni Calculator was used (Omni
Calculator sp. z o.o., 2020). Omni Calculator has over 950 different calculators for more than a
hundred types of measurement for health, physics, chemistry, and statistics, and many nonscience-related values. In addition, the conversions of height and weight, as well as the random
glucose sugar were also performed by the website (see Table 3). The variable treated
dyslipidemia was used instead of the 4 lipid types in the regression models. Information about
treated dyslipidemia was obtained from the medical records and it represented the number of
people who received lipid lowering agents (see Table 2).
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Table 3. Mean Scores and Standard Deviations of Key Variables
Instrument

Mean (SD)

Min.

Max.

Lab values conversions

S-Leeds Assessment of
Neuropathy Signs and Symptoms
Michigan Neuropathy Symptoms
Inventory
Average pain during previous
week
HbA1c (%)
Random blood sugar (mmol/L)
Height (cm)

13.2 (6.11)

0

24

7.6 (2.8)

0

14

4.80 (3.09)

0

10

8.89 (1.73)
11.80 (5.20)
163.4 (9.65)

5.6
12.5
4.0
24.6 212.4 (93.6) mg/dL
140.0 190.0 5.36 (0.31) ft.

Weight (kg)
BMI
Triglycerides (mmol/L)
Cholesterol (mmol/L)

83.21 (21.68)
30.81 (6.57)
1.74 (1.09)
4.44 (1.35)

41.0
18.7
0.25
1.0

149.0 183.45 (47.79) lbs.
49.5
6.4
154.12 (96.55) mg/dL
7.9
171.7 (52.2) mg/dL

HDL (mmol/L)
LDL (mmol/L)
Foot care (SDSCA subscale)
Functional Comorbidity Index

1.05 (0.26)
2.49 (1.02)
4.74 (1.32)
3.1 (1.49)

0.50
0.40
0.20
1.0

1.90
4.8
7.0
8.0

Overall social support
MNSI 2 (foot exam)

70.70 (27.28)
3.57 (2.59)

3.95
0

100
10

40.6 (10.05) mg/dL
96.29 (39.44) mg/dL

DPN Symptoms
DPN symptoms were measured with three different instruments (MNSI, S-LANSS &
Numeric Pain Rating Scale). Both the MNSI and the Self-Report-Leeds Assessment of
Neuropathy Signs and Symptoms (S-LANSS) are self-report measures of the neuropathy
symptoms that patients experience. MNSI and S-LANSS are both composed of dichotomous
items with either “yes” or “no” answers, and the total score is based on the number of “yes”
answers that a person selects. For the MNSI, the score represents the presence and the severity of
the symptoms. A score between 0 and 4 indicates mild neuropathy, whereas a score of 7 and
above (total possible score is 15) is indicative of severe neuropathy (Feldman et al., 1994). For
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this study, the participants had a mean MNSI score of 7.6 ± 2.8, which indicates severe
neuropathic symptoms.
On the other hand, on the S-LANSS a higher score, > 12, is suggestive of a neuropathic
origin of pain, and a score of < 12 suggests that the pain is likely non-neuropathic. For this
study, the participants had a mean S-LANSS score of 13.6 ± 6.11, which suggests that the
sample had symptoms caused by neuropathic mechanisms (Bennett, 2001). Table 4 summarizes
the descriptive data of the total scores of both measures.
Table 4. Total Scores of MNSI and S-LANSS
DPN Measure

Mean (SD)

Median (Mode)

Range

Min.

Max.

MNSI (n=120)

7.65 (2.86)

8.00 (9.00)

13

1

14

S-LANSS (n=120)

13.28 (6.11)

14.00 (19.00)

24

0

24

The analysis of the S-LANSS results showed that the symptom most complained about
was tingling, pins and needles sensations with a little over 90% (n = 107) of the participants
reporting it. The least reported symptom was that of noticing a change in skin color, which was
only reported by 19.5% (n = 23) of participants (see Table 5).
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Table 5. Description of Neuropathy Symptoms as Per the S-LANSS
Symptoms

Yes (n)

Tingling, pins and needles sensations (Q1)
90.7% (107)
Sudden, unexpected pain (Q4)
80.5% (95)
Skin warmth sensation (Q5)
60.2% (71)
Numbness when pressure applied Q7)
55.6% (65)
Skin sensitivity (Q3)
52.6% (61)
Discomfort with massage (Q6)
52.1% (61)
Change of skin color (Q2)
19.5% (23)
Note: Q(n) signifies the order of the item in the questionnaire.

No (n)
9.3% (11)
19.5% (23)
39.8% (47)
44.4% (52)
47.4% (55)
47.9% (56)
80.5% (95)

The MNSI has a similar symptoms inventory and has more descriptors when compared
with the S-LANSS. According to the MNSI analysis, the symptoms patients reported most were
numbness 80% (n = 96) and tingling, pins and needles 79.7% (n = 94). The least common
symptom was the history of amputation with only 7.6% (n = 9) reporting it followed by the loss
of temperature sensation 21.7% (n = 27) (see Table 6).
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Table 6. Description of Neuropathy Symptoms as Per the MNSI Questionnaire
Symptoms Questions

Yes (n)

No (n)

Are your legs or feet numb?
Do you have a prickling, pins &
needles sensation?
Do you feel generalized weakness most
of the days?
Are your feet too sensitive to touch?
Do you ever have any burning pain in
your feet or legs?
Do the symptoms get worse at night?
Do your feet hurt when you walk?
Do you get muscle cramps in your legs
or feet?
Is the skin of your feet so dry that you
get fissures?
Have you ever had open ulcers in your
feet?
Do you have pain when bed covers
touch you?
Has the doctor ever told you that you
have DPN?
Do you feel your legs when you walk?
Can you tell the difference between
heat and cold sensation?
Have you ever had an amputation?

80.0% (96)
79.7% (94)

20.0% (24)
20.3% (24)

75.6% (90)

24.4% (29)

68.9% (82)
65.8% (79)

31.1% (37)
34.2% (41)

65.5% (78)
65.0% (78)
60.0% (72)

34.5% (41)
35.0% (42)
40.0% (48)

56.7% (68)

43.3% (52)

33.3% (40)

66.7% (80)

32.5% (39)

67.5% (81)

31.9% (38)

68.1% (81)

24.4% (29)
21.7% (27)

75.6% (90)
77.3% (92)

7.6% (9)

92.4% (110)

Another instrument used was the Numeric Pain Rating Scale (NPRS) to capture aspects
of pain, such as intensity and how bothersome, on a scale of 0-10, where 0 is no pain and 10 is
the worst pain (British Pain Society, 2014). For this sample, the average pain intensity for the
current pain was 3.93 ± 3.23. The large standard deviation suggests there was significant
variability on this measure as would one expects when assessing level of pain (see Table 7).
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Table 7. Numeric Scale of Pain and Degree of Bothersome
Pain Scale

Mean (SD)

Median

Pain intensity (now) (n=120)
Average pain intensity (last week) (n=119)
Degree of bothersome (now) (n=120)
Degree of bothersome (last week) (n=119)
Degree of interference with life (n=118)

3.93 (3.23)
4.80 (3.09)
4.38 (3.71)
5.13 (3.38)
4.97 (3.56)

4.00
5.00
4.00
5.00
5.00

Foot examination. Participants foot exams were performed by the investigator guided
by the MNSI 2 directions. It is composed of five items: appearance of feet, presence of ulcers,
perception of vibration, ankle reflexes, and the monofilament testing. The assessment of foot
appearance and presence of ulcers were performed by inspection. Meanwhile, a 180 Hz tuning
fork was used to assess the perception of vibration on the great toe. To elicit ankle tendon reflex
response a reflex hammer was used. The investigator followed the MNSI 2 developers detailed
description of the methodology of conducting foot examination as detailed in Chapter 3 above.
The investigator also received guidance and feedback from the physician overseeing the diabetic
foot clinic. The mean foot exam score was 3.57 ± 2.59 which shows mild DPN according to the
scoring of the test (Feldman et al., 1994). The foot exams of more than two-thirds of participants
(n = 83) showed abnormal appearance due to structural deformities (e.g., Charcot foot, hammer
toe, and overlapping toes), callus, infection, fissure, and non-pitting edema (see Table 8).
Table 8. Frequency of DPN Symptoms According to MNSI 2 (not mutually exclusive)
Foot Exam (n=115)
Appearance of feet
Normal (both feet)
Abnormal (either foot)
Ulceration
Absent (both feet)
Present (either feet)

% (n)
27.8 (32)
72.2 (83)
90.4 (104)
9.6 (11)
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Ankle reflex
Present (both feet)
Reinforced (either foot)
Absent (either foot)
Vibration perception
Present (both feet)
Decreased (either foot)
Absent (either foot) (n=114)
Monofilament test (n=114)
Normal (both feet)
Reduced (either foot)
Absent (either foot)

33.0 (38)
40.9 (47)
24.3 (28)
32.2 (37)
47.0 (54)
30.7 (35)
57.0 (65)
24.6 (28)
21.9 (25)

Foot ulceration was evident in 9.6% (n = 11). Also, the majority of participants, 48.7% (n
= 56), had mild to moderate neuropathy with total scores of ≤ 7. Only about one tenth (n = 11)
had severe DPN with a score of > 7. Tables 8 and 9 have further information on the clinical
findings. Also, during the foot examination sessions several field notes were made that will be
referred to in the discussion of implications for nursing in Chapter 5.
Table 9. Severity of DPN Based on Foot Examination
Foot Exam Scores/10
0 (normal)
≤2 (mild)
>2≤7 (moderate)
7.5-10 (sever)

% (n)
13.0 (15)
28.7 (33)
48.7 (56)
9.5 (11)

Gender-Based Differences in Neuropathy Symptoms
There were no gender differences between the mean symptom scores of DPN. The
percentage of males reporting DPN was 53% (n = 63) compared to 47% (n = 56) of females (see
Table 10).
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Table 10. Mean and Standard Deviation of Neuropathy Symptoms of Males and Females
Gender S-LANSS

MNSI 1

Avg. Pain Last Week

Avg. Current Pain

Male

13.5 (6.56)

7.69 (2.89)

4.33 (3.07)

3.48 (3.01)

Female 13.0 (5.67)

7.57 (2.87)

5.33 (3.09)

4.43 (3.45)

Simple student t-test results showed that there was no significant difference in the mean
DPN scores between males and females for the S-LANSS, the MNSI, or the average pain,
though the average level of pain during last week was trending towards significance, p =.083
(see Table 11) and with a larger sample perhaps we may achieve significance.
Table 11. Gender-Based Differences in DPN Symptoms Between Groups

S-LANSS
MNSI
Average pain (last week)
Average pain (current)

F

p-value

0.174
0.057
3.04
2.58

.677
.811
.083
.111

Physical and Mental Quality of Life
Indicators of QoL were measured by the Medical Outcome Study Short Form-12v2. The
SF-12v2 comprises of 12 items asking patients about their perception of their health status;
degree of symptoms interference in everyday life; and other physical, emotional well-being and
functioning-related questions. The scoring was performed using a software provided by Optum
Inc. in which the 12 items were combined into eight health domains. The eight health domains
(general health, physical functioning, role functioning, bodily pain, role emotional, mental
health, role physical, and social functioning) were transformed and combined into to summary
scales, the mental composite scores (MCS) and the physical composite scores (PCS). All of the
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eight domains were used to score both the PCS and the MCS (Maruish, 2012). To measure
the patients level of physical and mental/emotional QoL, the PCS and MCS were used. The
mean value of the MCS was 47.29 ± 11.35 and the PCS was 40.21 ± 9.75. The SF-12v2 follows
a standardized t-score in which the mean is 50 and the standard deviation is 10. A score below
the mean indicates poor health whereas a score above the mean indicates better health (see Table
12).
Meanwhile, the single item of general health was used to assess the patients perceived
health. The combination of the two variables represents the overall QoL. Of means of the health
domains, patients mean physical role limitations score was the lowest at 39.15 ± 10.43 while the
highest mean was for mental health, 49.08 ± 11.18, followed by vitality, 46.20± 11.07.
Furthermore, the exploration of the SF-12v2 data showed that few of the domains had a
significant difference between the mean and the median, for example, MCS, vitality, mental
health, and social functioning. This prompted a skewness assessment to determine the presence
of significance level of skewness and, thus, the test for normality of the distribution in the
variables was done. Skewness refers to the lack of symmetry in a distribution caused by the
presence of extreme scores (outliers). A perfect, normal distribution would have a Fisher-Pearson
coefficient of zero, and any symmetric data would have a value of near zero. Generally, the
acceptable Fisher-Pearson coefficient of skewness is below 2 for a reasonable degree of
skewness (Gravetter et al., 2011). The SF-12v2 domains had Fisher-Pearson coefficients as
follows: MCS = -.558, bodily pain = -.318, social functioning = -.536 and mental health = -.410.
A positive sign indicates positive skewness (right tail) while a negative sign indicates negative
skewness (left tail). Accordingly, those domains showed no significant skewness. As is also
noted in the boxplot of the domains, the vitality had four data points that were considered
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outliers with a value of 100. The exploration of the mental health domain showed several
data points in the 75th percentile which might have been the cause of some skewness. The social
functioning domain had generally higher values compared to other domains which resulted in
shifting of the mean to the right. The MCS had a few data points in the lower end of the
distribution which resulted in shifting of the mean. However, since these observations were not
significant, the analyses progressed as planned.
Table 12. Descriptive Statistics of the SF-12v2 Domains and Composite Scores
Composite Scores

Mean (SD)

Mode

Median

Minimum Maximum

30.63*
46.94

41.4
47.0

16.82
9.50

60.45
68.34

Vitality
46.20 (11.07)
50
Role physical
39.15 (10.43)
50
Physical functioning
40.40 (9.74)
25
Bodily pain
41.42 (11.05)
50
General health
45.10 (11.03)
60
Role emotional
40.08 (12.20)
100
Social functioning
44.34 (12.22)
100
Mental health
49.08 (11.18)
75
*Multiple modes existed, the lowest value was reported.

50.0
50.0
50.0
50.0
60.0
62.5
75.0
75.0

0
0
0
0
0
0
0
0

100
100
100
100
100
100
100
100

Physical composite scores 40.21 (9.75)
Mental composite scores
47.29 (11.35)
Domains scores

Social Support
The level of perceived social support the patients was measured using the Medical
Outcome Study-Social Support Survey (MOS-SSS). As discussed in Chapter 3, MOS-SSS is a
19-item measure grouped into four subscales. Table 13 below describes the mean and standard
deviation of each subscale and the comparison to published scores (Sherbourne & Stewart,
1991). Each subscale is calculated by adding the scores of individual items and transforming
them into a scale of 0-100, where higher scores suggest better social support. In addition, the
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survey has an overall perceived support index that reflects all the items on the scale. Chapter
5 has further discussion on this comparison.
Table 13. Descriptive Statistics of MOS-SSS

Overall Support Index (n=119)

Current study

Min.

Max.

Published data a

70.7 (27.28)

3.95

100

70.1 (24.2)

Min.
0.0
0.0
0.0
0.0

Max.
100
100
100
100

69.6 (25.5)
69.8 (28.5)
73.7 (28.3)
69.8 (26.0)

Subscales
Mean (SD)
Informational/Emotional (n=112) 64.50 (31.82)
Tangible (n=115)
73.96 (30.26)
Affectionate (n=117)
79.20 (29.79)
Positive social interaction
74.43 (31.6)
(n=119)
Note: a indicates Sherbourne & Stewart (1991).
Foot Care Practices

The variable foot care represented a form of the functional status in this study. Self-care
practices were assessed using the SDSCA. The SDSCA-Arabic has 15 items under 5 subscales
(diet, exercise, medication taking, glucose checking, and foot self-care practices). Each item was
scored on a Likert-type scale of 0-7 days/week. Each subscale was calculated by averaging the
items within. The foot care subscale has 5 items (see Table 14). Higher scores suggest better
self-care practices. For this study, the mean frequency of foot care activities performed by the
sample was 4.74 ± 1.32. In other words, the patients performed foot care about 65% of days of
the week—see Tables 14 and 15 for further details of the foot care subscale. More discussion on
the comparative data can be found in Chapter 5.
It is important to note that items 4 (consuming high fats) and 10 (soaking feet) were
reversely phrased and needed to be recoded for the calculations of subscales. It is noteworthy
that scoring high in a reversely phrased item in the SDSCA suggests a pattern of unrecommended practice compared to the normally phrased items, in which, higher scores indicate
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compliance with the recommended practice of self-care. For instance, having a score of five
in soaking feet indicates that the patient is practicing foot-soaking five days/week (more
frequency= high compliance). Meanwhile, a score of five days/week in drying feet item suggests
that the patient is following the recommendations. Soaking feet is discouraged for diabetics due
to increased risk of dryness, burns, and injuries (American Family Physicians, 2020). For the
purposes of descriptive statistics, the authors suggested no re-coding of the reversely phrased
items be done (Toobert et al., 2005). Thus, in Table 15, the item soaking feet was left as
originally scored, though it was recoded in the subscale computations in Table 14.
Table 14. Description of the SDSCA Subscales
Subscales (n)

Mean (SD) % of days/week Published % of
in this study
days/week a

% of
days/week for
the Saudi
Population b
51.42±24.28%
43.14±31.00%

Diet (n=117)
3.69 (1.24) 52.7 ±17.7%
58.25±28.7%
Exercise
2.12 (2.31) 30.3±33.0%
34.3±31.9%
(n=120)
Blood sugar
3.52 (2.50) 50.28±35.71% 69.034.9%
32.00±27.14%
testing (n=118)
Foot care
4.74 (1.32) 67.71±14.28% 47.1±21.4%
49.85±33.85%
(n=115)
Medication
6.15 (1.93) 87.85±27.57% 95.0±15.4%
98.42±8.42%
(n=118)
Note: a indicates (Toobert et al., 2005); b indicates (AlJohani et al., 2015)

As can be seen in Table 15, this study mean frequency of soaking feet was 1.39 ± 2.35
suggesting that patients were generally adherent as to not soaking their feet per the ADA (2019)
recommendations.
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Table 15. Mean and Standard Deviation of Foot Care Subscale Individual Items
Foot care subscale
Individual items
Checked your feet
Checked inside of shoes
Washed your feet
Soaked your feet*
Dried between your toes
*The original reversely phrased item

Mean (SD)
4.74 (1.32)

Median
4.60

Mode
5

Mean (SD)
3.86 (2.99)
3.58 (3.06)
6.64 (1.27)
1.39 (2.35)
3.93 (3.27)

Median
4.00
3.50
7.00
7.00
6.00

Mode
7
7
7
0
7

Chronic Illness Resources
The varying resources a chronic illness patient needs to maintain and promote their health
was measured by CIRS which has 22 items grouped into 7 subscales encompassing health care,
family and friends, personal factors, neighborhood and community, work environment, media
and policy, and the organizational resources. Each subscale has a score of 1-5 with 5 indicating
better resources. The media/policy subscale was omitted from the analysis as mentioned earlier
since the items were not applicable to the population of Saudi. According to the authors of the
instrument, individual subscales can be removed with no impact on the overall scale (Glasgow et
al., 2004). Since the CIRS has no total score, calculating a mean score for the entire scale
depends on the number of items included, deleted subscales do not impact the total mean score.
Comparative data were retrieved from the (Glasgow et al., 2004) to provide a context for our
results. Table 16 below describes the mean scores for each subscale of the CIRS. Participants
had low to moderate chronic illness resources based on their means scores.
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Table 16. Mean and Standard Deviation of CIRS Subscales
Current
Study
Scale mean score
Subscales
Health care (n=115)
Family/Friends (n=118)
Personal (n=114)
Neighborhood/Community
(n=116)
Organizations (n=114)
Work environment (n=28)

Glasgow et al. (2004)
Data

Mean (SD)
2.41 (0.68)

Min. Max. Mean (SD)
1.18 4.71 2.71 (0.6)

3.32 (1.21)
2.18 (1.12)
2.88 (1.25)
2.23 (0.97)

1.0
1.0
1.0
1.0

5.0
5.0
5.0
5.0

3.64 (1.1)
2.37 (1.0)
3.06 (0.9)
2.14 (0.8)

1.5 (0.76)
3.04 (1.14)

1.0
1.0

4.3
5.0

1.71 (0.8)
3.06 (0.9)

Comorbidity
The number of illnesses patients had, including T2DM, was assessed by the Functional
Comorbidity Index (FCI). The FCI is a “select all that apply” measure and includes 18 conditions
that affect the level of functioning of the individual (Groll et al., 2005). It takes into
consideration all the different illnesses and was included for the goal of controlling for other
comorbidities when predicting QoL (see Table 17). For this study, participants had an average
of 3 co-morbid conditions, including diabetes.
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Table 17. Functional Comorbidity Index Results
Scale
FCI total score (out of 18)
Mean (SD)
Median (Range)
Individual items
DM
Obesity
Arthritis
Visual impairment
GERD/Upper GI disease
Degenerative disc disease/Lower-back pain
Peripheral vascular disease
Asthma
Angina
Depression
Anxiety
Hearing impairment
Chronic obstructive pulmonary disease
Heart attack
Neurological diseases (Parkinson, MS)
Cerebrovascular accidents (TIA, stroke)
Congestive heart failure
Acute respiratory distress syndrome

3.1 (1.49)
3 (0-7)
% (n)
100.0 (120)
50.0 (60)
40.0 (48)
28.3 (34)
20.8 (25)
15.0 (18)
10.8 (13)
8.3 (10)
8.3 (10)
7.5 (9)
7.5 (9)
5.8 (7)
1.7 (2)
1.7 (2)
0.8 (1)
0.8 (1)
0.8 (1)
0.00 (0)

The Reliability Assessment of the Study Variables
Following the descriptive analysis, the reliability of the measures was assessed. Table 18
describes the estimation of internal consistency by the Cronbach alpha of the key variables. The
estimation of internal consistency of DPN measures was low with both MNSI and the S-LANSS:
Cronbach alpha = .58 and .65, respectively. This is below the acceptable value of the Cronbach
alpha of .7 (Cronbach, 1951). Both the numeric pain score and the MOS-SSS showed stability,
with Cronbach alpha of .94 and .95, respectively. The SF-12v2 Arabic version showed stability
as well with Cronbach’s alpha of .81 for both composite scores.
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The monofilament-testing reliability assessment was performed by the test-retest
correlation as indicated by the intraclass correlation coefficient between the right and left foot.
Since this study is cross-sectional, it was not possible to perform a test-retest assessment on the
same foot; instead the right foot was compared to the left foot by the investigator.
Table 18. Reliability Assessment (Internal Consistency) of Key Study Instruments
Instrument

Current Estimations

SF-12v2 (MCS & PCS) .81
S-LANSS
.58
MNSI
.65
SDSCA foot care
.50
MOS-SSS
.95
CIRS
.76
NPRS
.94
Monofilament
ICC=.90
Note: ICC: interclass correlation coefficient.

Published Estimations No. of items
.85 and .83
.76
.91
.77
.78
.82
.95
ICC=.92

8
7
15
5
19
20
6
NA

Bivariate Correlations Among Study Variables
The Pearson correlation (r) was run to detect association between select study variables
with a two-tailed significance level of 0.05. The results of the correlations of the main variables
showed significance. Neuropathy symptoms as measured by the MNSI 1, MNSI 2, S-LANSS,
and the average pain during the previous week correlated significantly with a number of the
study variables. QoL (PCS & MCS) also correlated with key variables.
The MNSI correlated significantly with QoL domains, and composite scores. The
correlations between MNSI and the subscales were as follows: MCS (r = -.238, p = .007), PCS (r
= -.303, p = .007), vitality (VT) (r = -.235, p = .010), role physical (RP) (r = -.211, p = .021),
bodily pain (BP) (r = -.460, p < .000), general health (GH) (r = -.322, p < .001), role emotional
(RE) (r = -.226, p = .013), mental health (MH) (r = -.308, p < .001), and physical functioning
(PF) (r = -.220, p =.016). These correlations, suggest a low-to-moderate negative association
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between DPN symptoms and the QoL domains that ranged between -.211 to -.460, were
expected. To explain, the reverse association indicates that as the DPN scores increased (worse
symptoms), the QoL indicators decreased, suggesting poorer physical and emotional health. For
instance, the association of MNSI and MCS is (r = -.246, p = .007). This means that there was
weak association in which as DPN symptoms increase, the worse is the patient’s mental health
status, as one would expect. The frequency of foot care practices was associated with more DPN
symptoms (S-LANSS), poorer health perception, and more illness resources. For further details
on correlations see Table 19.
Table 20 describes the association of the health domains of the SF-12v2 with the other
outcome variables of the study and among each other. As it appears in the correlation matrix,
there were expected positive correlations among the domains and with their respective composite
scores. As previously mentioned, PCS is a physical composite score that is made up of varying
degrees of contributions from all of the eight domains. This also applies to the make-up of the
MCS. These correlations were as expected in direction and strength in that whenever a health
domain decreased the respective composite score decreased as well suggesting poorer overall
health.
For instance, the overall physical QoL correlated more with the domains physical
functioning, role physical, bodily pain, and vitality. Patients with poorer physical functioning
who were unable to climb a flight of stairs, were in much pain, and had impaired ability to
perform their daily activities would had poorer physical QoL. Meanwhile, patients mental QoL
correlated more with the domains mental health, role emotional, and social functioning. So that
persons with anxiety and depressive symptoms and decreased social functions had worse mental
QoL compared to those who did not. Further discussion on these correlations are Chapter 5.

1
1

.017

S-LANSS

1

.473**

.031

MNSI

1

.326**

.141

-.006

GH

1

.074

.190*

.083

.257**

MNSI
2

-.278**
1

.525**

-.303**

-.247**

-.195*

PCS

1

.041
-.160

-.316**

-.238**

-.090

.004

MCS

1

.082

.004
-.090

-.243**

.131

.248**

.056

Foot
care

1

-.187

-.092

-.020
.150

.122

.180

-.008

-.060

HbA1c

-.014

.270**

.050

-.020
.217*

-.259**

-.122

.010

-.188*

CIRS

-.125

.083

.093

.098
-.188*

-.211*

-.067

.116

.257*

MOSSSS
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CIRS
1
.108
MOSS-SS
1
* significant correlation at .05 (two tailed); ** Significant correlation at .01 (two tailed); S-LANSS; Self-Report-Leeds Assessment of
Neuropathy Sings and Symptoms; MNSI Michigan Neuropathy Symptoms Inventory; PCS: Physical Composite Scores; MCS: Mental
Composite Scores; HbA1c: hemoglobin A1c; CIRS: Chronic Illness Resources Survey; MOS-SSS: Medical Outcome Study-Social
Support Survey; GH: General Health.

HbA1c

Foot care

MCS

MNSI 2
PCS

GH

MNSI

S-LANSS

Age

Age

Table 19. Bivariate Correlation Among Study Variables
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1

.327**

.321**

.297**

.349**

.241**

.376**

VT

.242**
1

.852**

.262**

.348**

.252**

.202*

-.188*

MH

1

.105
.577**

.760**

-.304**

.442**

.463**

312**

.160

RE

.539**
1

.156
.542**

.760**

.225**

.171

.217*

.180

.008

SF

* significant correlation at .05 (two tailed); ** Significant correlation at .01 (two tailed). PCS: Physical Composite Scores;
MCS: Mental Composite Scores; VT: Vitality; RP: Role Physical; SF: Social Functioning; BP: Bodily Pain; GH: General
Health; MH: Mental Health; RE: Role Emotional; PF: Physical Functioning.

RE
SF

VT
MH

.246**

.233*

.234*

.314**

.394**

.525**

GH

MCS

1

627**

.464**

.627**

BP

1
.188*

1

.603**

.779**

RP

GH

BP

.033

1

PF

RP

.808**

PCS

PF

Table 20. Correlations Among SF-12v2 Domains and Summary Scale
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Regression Analysis of the Study Aims
Data were analyzed using multiple regression as it is the appropriate test for the type of
variables used and the research questions. Data met the eight assumptions of multiple regression.
The first two assumptions were met at the stage of designing the study as the dependent variable
was continuously measured and the independent variables were continuous or categorical. The
other six assumptions were tested, using the recommended criteria, in SPSS, as a part of the
hypotheses testing as they relate to the nature of the data.
The data passed the Durbin-Watson statistic, which checks the assumption of
independence of observation. This test affirms that the residuals (errors) of the adjacent
observations were not correlated. The data were also established for the assumption of linearity
by plotting the studentized residuals against the unstandardized predicted values and the partial
regression plots. Moreover, the data met the assumption of homoscedasticity by showing equal
error variance along the line of best fit. Assumption six of multicollinearity was also met as
determined by the correlation coefficients and tolerance/variance inflation factor values. These
tests were met as the correlations among the independent variables were less than r =.7, and the
tolerance values were greater than 1.0 (Laerd Statistics, 2020).
Outliers were assessed, and we found no values exceeded ± 3 standard deviations. There
were also no high-leverage points, nor any highly influential points in the data as assessed by the
casewise diagnostics, studentized deleted residuals, and the Cook points. High influential points
refer to outlier that greatly affect the regression line and thus bias the conclusions. Finally, the
assumption of normality of residuals distribution was also met by the data observed using
histograms and the probability P-P plots.
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A series of univariable analysis tests were performed to establish the individual predictive
patterns between the dependent and independent variables in isolation of the effect of other
variables. This was guided by the constructs of the revised HRQoL model by Wilson and Cleary
(Ferrans et al., 2005), as discussed in Chapter 3. The results of the univariable analyses can be
found in Appendix I, Tables I1 and I2.
Data Analysis of Aim 1
Multiple regression models were used to assess the study aims. First, the univariable
analysis of the independent variable (DPN) and each dependent variable was run. There were no
covariates included in this initial regression model, often referred to as the unadjusted model.
Subsequently, a multivariable (adjusted) model was run which adjusts for the covariates that
were identified that could impact the outcome variables. For the primary aim, the environmental
factors of resources (CIRS) and social support (MOS-SSS) and the individual variables of age
and gender were the covariates. The primary aim was: To examine the impact of DPN symptoms
on (1) patients’ functioning (foot care practices), (2) general health perception, and (3) overall
QoL (PCS and MCS). The hypothesis to be tested was: Individuals with more symptoms have
poorer foot care practices, negative health perception, and poorer physical and mental overall
QoL.
First, the impact of DPN on diabetes self-care of the feet (foot care practices) was
examined as delineated in the HRQoL model (Figure 1). On univariable analysis, only one of the
DPN measures, the S-LANSS, had a relationship with foot care practices (see Appendix I, Table
I1). The multivariable model was significant, R2 = .116, F (7, 112) = 2.102, p = .049 (see Table
21). The standardized beta coefficient of the S-LANSS was 0.203 meaning that for each point
increase in S-LANSS the predicted foot care value increases by 0.203 after holding the other
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variables constant, p = .050. This suggests that more neuropathy symptoms were associated with
better foot care practices. The model explains 11.6% of the relationship between DPN and foot
care practices. Although this did not support the hypothesis that more symptoms would be
associated with worse self-care, it is logical that as DPN symptoms worsen, persons may be
more engaged to participate in better foot care practices, and is discussed in Chapter 5.
Table 21. Impact of DPN on Foot Care Practices
Variable

Standardized coefficients

Constant
Key Variables
S-LANSS
MNSI 1
MNSI 2
Covariates
Age
Gender (Female)
CIRS
MOS-SSS
R2= .116
n=120

2.334 (0.955)

p-value

0.203 (0.022)
0.040 (0.047)
0.015 (0.048)

.050
.701
.875

0.046 (0.013)
-0.008 (0.238)
0.183 (0.175)
0.138 (0.005)

.633
.930
.050
.145

Note: Standard errors are reported in parentheses
Next, the impact of DPN and foot care on health perception was tested. On the
univariable analysis, MNSI 1, S-LANSS, and foot care practices were significantly associated
with health perception as noted in Appendix I, Table I1. The multivariable model was
significant, R2 = .236, F (8, 111) = 6.244, p < .001 (see Table 22). The standardized beta
coefficient of the MNSI 1 was -0.240 meaning that for each point increase in MNSI 1, the
expected health perception value decreases 0.240 points, after holding the other variables
constant p = .015. The standardized beta coefficient of foot care was 0.218 indicating that for
each point increase in the frequency of performing foot care practices the expected health
perception increases 0.218 points, after holding the other variables constant p = .015. Meaning,
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the more patients cared for their feet, the better they felt about their health. Fewer neuropathy
symptoms and better foot care practices were associated with positive health perception. The
results of the regression model supported the second part of the hypothesis in which we
hypothesized that DPN and foot care would be associated with health perception. This model
explained 23.6% of the variance in health perception.
Table 22. Impact of DPN and Foot Care Practices on Health Perception
Variable

Standardized coefficients

Constant
Key Variables
S-LANSS
MNSI 1
MNSI 2
Foot care

40.447 (19.569)

Covariates
Age
Gender (Female)
CIRS
MOS-SSS
R2=.236
n=120

p-value

-0.134 (0.442)
-0.240 (0.944)
-0.070 (0.968)
0.218 (1.887)

.170
.015
.431
.015

-0.046 (0.266)
-0.073 (4.744)
0.157 (3.565)
0.176 (0.096)

.605
393
.076
.051

Note: Standard errors are reported in parentheses
Then, the impact of DPN and foot care on physical QoL (PCS) was examined. On
univariable analysis, all DPN symptoms as measured by MNSI 1, S-LANSS, MNSI 2 were
associated with PCS (see Appendix I, Table I1). The multivariable regression model was
significant, R2 = .282, F (8, 111) = 5.440, p < .001. The standardized coefficient of the MNSI 2
was -0.214 meaning that for each point increase in MNSI 2 the expected PCS value decreases by
0.214 points after holding the other variables constant, p = .014. The standardized beta
coefficient of S-LANSS was -0.182, that is for each point increase in S-LANSS the expected
PCS value decreases by -0.182 points after holding the other variables constant, p = .057. That is
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more neuropathy symptoms was associated with lower physical QoL (see Table 23). This model
also supported the primary hypothesis that DPN and foot care practices are associated with
poorer physical QoL. This model explained explaining 28.2% of variance in physical QoL.
Table 23. Impact of DPN and Foot Care Practices on Physical QoL
Variable

Standardized coefficients

Constant
Key Variables
S-LANSS
MNSI 1
MNSI 2
Foot care

46.388 (6.671)
-0.182 (0.151)
-0.154 (0.322)
-0.214 (0.330)
0. .076 (0.643)

Covariates
Age
-0.098 (0.091)
Gender (Female)
-0.180 (1.617)
CIRS
0.269 (1.215)
MOS-SSS
-0.006 (0.033)
R2= .282
n=120
Note: Standard errors are reported in parentheses

p-value

.057
.105
.014
.375
.259
.032
.002
.941

Lastly, the impact of DPN and foot care on the mental QoL (MCS) was examined. On the
univariable analysis, MNSI 1 was significantly associated with MCS (see Appendix I, Table I1).
The multivariable model was significant, R2 =.259, F (8, 111) = 4.860, p < .001. The
standardized coefficient of the MNSI 1 was -0.196 suggesting that each point increase in MNSI 1
was associated with 0.196 points decrease in MCS values, after holding the other variables
constant, p = .044 (see Table 24). Thus fewer neuropathy symptoms were associated with better
mental health. The results of this model supported the primary hypothesis that DPN was
associated with poorer mental QoL. This model explained 25.9% of the variance in mental QoL.
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Table 24. Impact of DPN and Foot Care Practices on Mental QoL
Variable

Standardized coefficients

Constant
Key Variables
S-LANSS
MNSI 1
MNSI 2
Foot care

50.868 (7.880)
-0.061 (0.178)
-0.196 (0.380)
0.027 (0.390)
0.034 (0.760)

Covariates
Age
-0.117 (0.107)
Gender (Female)
-0.210 (1.910)
CIRS
-0.039(-1.436)
MOS-SSS
0.435 (0.039)
R2= .259
n=120
Note: Standard errors are reported in parentheses.

p-value

.524
.044
.755
.698
.185
.014
.648
.000

Data Analysis of Aim 2
The aim of this analysis was to establish a relationship between a number of independent
variables and the key outcome variables, the S-LANSS, MNSI 1, and the MNSI 2. The
hypothesis to be tested was as follows: Longer duration of T2DM, poor glycemic control,
increased age, female gender, presence of hypertension, comorbidity, and dyslipidemia, and lack
of physical activity are associated with more DPN symptoms. Similar to approach for the first
aim, for each outcome variable a univariable analysis was run with each independent variable to
establish a relationship before adjusting for other variables (results are in Appendix I, I2). After
running individual analyses for each outcome variable a series of multivariable (adjusted)
regression analyses were run to establish relationships between the outcome and the independent
variables. The independent variables were HbA1c, age, and comorbidity (FCI), duration of
diabetes group with 4 levels (< 5 years, 5-10 years, 11-15 years, & > 15 years). Other variables
were treated dichotomously with hypertension (yes = 1, no = 0), treated dyslipidemia (yes = 1,
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no = 0), level of exercise (none = 0, not-regular = 1, regular = 2), and gender (female = 1, male =
0).
Impact of Key Variables on DPN (S-LANSS)
The S-LANSS entered the regression model as the outcome variable and all other
variables were entered as independent variables. The results of the univariable analyses showed
that FCI was associated with the S-LANSS scores (see Appendix I, Table I2). However, the
multivariable model, was not significant (F-value (9,110) = 1.292, p = .249). The beta coefficient
for both models had FCI as important in contributing to DPN symptoms. The results of this
model did not add information to support the hypothesis that DPN was associated with the key
variables.
Table 25. Impact of Key Variables on DPN (S-LANSS)
Variable

Standardized coefficients

p-value

Constant

11.535 (5.075)

HbA1c
FCI
Hypertension
Duration of DM
Exercise
Regular
Not-regular
Treated Dyslipidemia
Age
Gender (Female)
R2=.096
n=120

0.059 (0.407)
0.230 (0.407)
-0.038 (1.395)
-0.087 (0.579)

.557
.022
.736
.391

-0.114 (1.539)
-0.186 (1.376)
0.085 (1.242)
-0.018(0.068)
-0.075 (1.186)

.247
.066
.381
.866
.443

Impact of Key Variables on DPN (MNSI 1)
Next, the association of key variables with the MNSI 1 was assessed. On the univariable
analysis, hypertension, FCI, and not-regular exercise were significant. HbA1c and treated
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dyslipidemia were marginally significant (see Appendix I, Table I2). The multivariable model
was significant, R2 = .266, F (9, 110) = 4.421, p < .001 (see Table 26). The standardized beta
coefficient of the HbA1c was 0.237 meaning that each point increase in HbA1c was associated
with 0.237 points increase in MNSI 1 scores, after holding the other variables constant, p = .009.
This means that higher HbA1c levels were associated with worse DPN symptoms. The
standardized coefficient of the FCI was 0.322 indicating that with each point increase in
comorbidity the predicted MNSI 1 value increases 0.322 points, after holding the other variables
constant, p < .001.
The standardized beta coefficient of performing regular exercise was -0.115 and trending
towards significance, p = .089. This finding suggests that performing regular exercise may be
associated with 0.115 points decrease in the expected MNSI 1 value compared to not performing
any physical activity, after holding the other variables constant. The beta standardized coefficient
of performing not-regular (some) exercise was -0.183 indicating that performing some exercise
was associated with 0.183 points decrease in the expected MNSI 1 value compared to not
performing any physical activity, after holding the other variables constant, p = .044. Thus
expectedly, higher HbA1c levels, more comorbidities, and being less active were associated with
worse neuropathy symptoms. The findings of this model supported parts of the secondary
hypothesis in which higher HbA1c levels, more comorbidities, and being less active were
associated with worse neuropathy symptoms. Gender, age, hypertension, treated dyslipidemia,
and the duration of DM were not associated with DPN. This model explained 26.6% of the
variance in the MNSI 1.
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Table 26. Impact of Key Variables on MNSI 1
Variable
Constant

Standardized coefficients
3.769 (2.141)

HbA1c
0.237 (0.153)
FCI
0.322 (0.172)
Hypertension
0.144 (0.589)
Duration of DM
0.057 (0.244)
Exercise
Regular
-0.115 (0.649)
Not-regular
-0.183 (0.580)
Treated Dyslipidemia
0.095 (0.524)
Age
-0.127 (0.029)
Gender (Female)
-0.086 (0.500)
2
R =.266
n=120
Note: Standard errors are reported in parentheses.

p-value
.009
.000
.154
.535
.089
.044
.280
.181
.328

Impact of Key Variables on DPN (MNSI 2)
This model included the MNSI 2 as the outcome variable with the selected independent
variables. The MNSI 2, as mentioned earlier, is the second part of the MNSI and is a foot
examination that was performed by the investigator. The univariable analysis showed that age
and gender were significantly associated with MNSI 2. Hypertension and exercise were
marginally significant (see Appendix I, Table I2). The multivariable model was significant, R2 =
.162, F (9, 110) = 2.361, p = .018 (see Table 27). The beta standardized coefficient of
performing not-regular (some) exercise was -0.222, meaning that performing some exercise was
associated with 0.222 points lower MNSI 2 values compared to not performing any activity, after
holding the other variables constant, p = .023. The beta standardized coefficient of treated
dyslipidemia was -0.172 indicating that treated dyslipidemia may be associated with 0.172 points
lower predicted MNSI 2 values compared to non-treated dyslipidemia, after holding the other
variables constant, p = .068. The beta standardized coefficient of age was 0.185 meaning that for
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each point increase in age the predicted MNSI 2 value may be increased 0.185 points, after
holding the other variables constant p = .069.
Lastly, the beta standardized coefficient of gender was -0.220 indicating that females had
0.220 points lower MNSI 2 values compared to males, after holding the other variables constant
p = .020. Thus, performing some exercise (compared to no exercise) and female gender were
associated with lower foot exam scores. The findings of this model supported parts of the
secondary hypothesis in which gender and physical activity were associated with worse
neuropathy symptoms. HbA1c, comorbidity, age, hypertension, treated dyslipidemia, and the
duration of DM were not associated with DPN. This model explained 16.2% of the variance in
foot exam scores.
Table 27. Impact of Key Variables on MNSI 2
Variable

Standardized coefficients

Constant

1.397 (2.032)

HbA1c
0.005 (0.145)
FCI
0.041 (.163)
Hypertension
0.010 (0.559)
Duration of DM
0.099 (0.232)
Exercise
Regular
-0.066 (0.616)
Not-regular
-0.222 (0.551)
Treated Dyslipidemia
-0.172 (0.497)
Age
0.185 (0.027)
Gender (Female)
-0.220 (0.475)
R2= .162
n=120
Note: Standard errors are reported in parentheses.

p-value

.959
.670
.927
.310
.484
.023
.068
.069
.020

Summary of the Study Aims Findings
Multivariable analyses did support much of the proposed hypotheses. For the primary
aim, we hypothesized that more symptoms are associated with poorer foot self-care practices,
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health perception and physical and mental QoL. This hypothesis was partially supported. Our
findings did support an association between DPN and foot self-care, but not in the direction that
we anticipated. As stated previously, DPN was associated with better foot self-care. There were
also significant associations between DPN, health perception, physical, and mental QoL as
proposed. Those with more DPN symptoms experienced poorer health perception, physical, and
mental QoL.
For the secondary aim, findings supported the hypothesis. DPN was associated with
HbA1c, comorbidity, physical activity and gender. The results indicated that people with worse
DPN symptoms had poor glycemic control, more comorbidity, were sedentary and males.
Conclusion of the Results Chapter
This study was descriptive to shed some light on the association of neuropathy symptoms,
biologic, environmental factors and quality of life. Through the use of descriptive and inferential
statistics, an examination of the relationship amongst the aforementioned variables has been
undertaken. The two study aims have been tested and supported. An interpretation of these
results as well as the implications of these results are addressed in the next chapter.

CHAPTER FIVE
DISCUSSION
Despite the fact that Diabetic Peripheral Neuropathy (DPN) is getting more attention
from researchers and clinicians around the world and in Saudi Arabia, certain aspects, including
its impact on patients’ lives, have not been examined sufficiently. The vast majority of research
in Saudi has been dedicated to the prevalence of DPN and the different approaches to detect and
diagnose the symptoms (AlOdhayani et al., 2017; Halawa et al., 2010; Mojaddidi et al., 2011).
Other studies focused on biomedical and physiological factors linked to the development of DPN
symptoms (Algeffari, 2018; AlQuliti, 2015; Wang et al., 2014). There has been no published
evidence that examined the impact of the symptoms on patients’ health, including the different
aspects that represent Quality of Life (QoL). In addition, there has never been a research
endeavor that was guided by a comprehensive theoretical framework.
This dissertation study attempted to bridge that gap as it pertains to the Saudi diabetic
population by using the revised Wilson and Cleary Health-related Quality of Life (HRQoL)
model (Ferrans et al., 2005; Wilson & Cleary, 1995). This model delineates the different factors
and influences that affect the individual’s QoL. By focusing on the health-related factors, the
model still acknowledges the individual and environmental forces that affect every dimension of
QoL in addition to biologic functions, symptom status, functional status, and health perceptions.
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This chapter addresses the study results, their relevance to clinical practice, and future
research. It also evaluates the study by addressing its strengths and weaknesses and means to
delimit them. This study aimed to find association between neuropathy symptoms and QoL in
the setting of type 2 diabetes mellitus (T2DM) in Saudi Arabia. It also aimed to examine the
factors associated with these symptoms. Based on the review of the literature and supported by
the revised Wilson and Cleary’s HRQoL (Ferrans et al., 2005), it was hypothesized that those
with symptomatic DPN would have poorer functioning, physical, and emotional QoL, and
negative health perceptions. It was also hypothesized that select factors would be associated with
more DPN symptoms.
Characteristics of the Individual
Description of the Sample
The majority of participants 67.5% (n = 81), were Native people (who always resided on
the Arabian Peninsula and have no other ethnic background). The average age was 54 years,
70% (n = 84) were married, 70.6% (n = 84) were unemployed/retired, 40.2% (n = 47) had T2DM
> 15 years, and about 70% (n = 83) had never smoked. As mentioned in Chapter 3, people who
are above the age of 50 make up 30% of the general population and the majority of the people,
70%, are below 35 years. The percentage of people aged > 65 is only 2.6% (General Authority
for Statistics, 2016) in Saudi Arabia yet the sample age range of 30 to 74 is consistent with the
demographic of the growing T2DM population with DPN. T2DM is becoming more prevalent
among young adults between the ages of 18 and 35 years (AlJohani et al., 2015). This current
sample’s age is similar to the evidence found in Saudi-based studies on people with T2DM and
DPN. Saudi studies reported an average age of patients of 58 & 39 years, respectively (Algeffari,
2018; AlOdhayani et al., 2017). The wide age range of 30-74 in the current study provide an
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additional unique contribution of our study. The proportion of individuals who were
unemployed or retired is also similar to previously published studies. A Saudi-based study found
that 52.4% of individuals with T2DM were unemployed (AlGhamdi et al., 2018).
Gender was almost evenly represented as 54% of the sample was male and 46% was
female. Further, the sample was homogenous in terms of race, marital, and employment status as
nearly two-thirds of the sample, about 67%, were Native people and were mostly married. These
characteristics also reflect the demographics of the Saudi population (General Authority for
Statistics, 2017).
Forty-nine percent (n = 59) of the participants had an income of less than 5,000 Saudi
riyals per month or 60,000 Saudi riyals (about $16,000) annually. The median income of the
Saudi family is between $25,000 and $40,000 annually. The gross national income in Saudi in
2018 was $55,840 compared to $63,690 in the U.S. (World Bank, 2020). Thus, the majority of
the patients benefiting from the free health services provided by Ministry of Health (MoH) are
low-income people. A Saudi study, in a different region from this study, reported much lower
family income and found that 47% of the participants made less than 30,000 Saudi riyals
($9,600) annually (Wang et al., 2014). This difference in reported income speaks to the wide
variations of income in Saudi. However, it is important to note that female patients, specifically
the housewives, frequently clarified that they do not have any income as their male family
member is the source of income in the household. Thus these results might be biased by the fact
that some unemployed women may have selected no income due to the fact that in Saudi some
people consider the income per the individual not the household as a whole. Further, although
no information of the location of residence was collected in this study, most patients reported
living in rural areas about 35 miles away from the city.
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In terms of education, 39.2% (n=47) were educated at the level of grade 6 or less, while
28.3% (n=34) had intermediate or high school; 25% (n = 30) had some college degree. This span
in education level may have affected the patients’ comprehension of the questionnaires and their
responses.
An important characteristic of the sample was that 31.7% (n = 38), had a formal
diagnosis of DPN as reported by participants that stated their physicians told them they exhibited
symptoms of DPN. Of those, 16.6% (n = 20) were prescribed neuropathy-specific medications
such as pregabalin and gabapentin. Another portion of the patients, 34.1% (n = 41), received
only vitamin B complex to help improve nerve function. The remaining 48.3% (n = 58)
participants did not receive any form of relief for their neuropathy symptoms and were not aware
of the condition. Thus there is such a large portion of the sample (48.3%) without symptom relief
and only one fourth (16.6%, n = 20) of sample who were formally diagnosed were treated
appropriately. This highlights an important issue related to the awareness and recognition of
DPN symptoms and it suggests that despite the high prevalence of symptoms, proper
identification and treatment are still lagging.
Overall, the study characteristics are comparable to other Saudi-based diabetes-related
studies. For instance, a study on the risk factors of diabetic foot ulcers had a sample of 598
patients with T2DM who were 38% females, aged 50 years, 39% illiterate, and of which 44%
had annual income of less than $16,000 (Hu et al., 2014). Collecting and reporting the racial and
ethnic characteristics of the participants is not customary in the Saudi literature. Only one study
of a Saudi-based population reported race/ethnicity of the sample. These categories were Middle
Eastern, Asian, and Black (Halawa et al., 2010). The ethnicity Middle Eastern, reported in the
above study, is inclusive of Native, North African, and Middle Eastern races, which were
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reported in this current study. This study used race, and the Halawa et al. (2010) study used the
term ethnicity to describe the racial/ethnic background as there are no clear guidelines for
describing race in Saudi.
Biologic Functions
HbA1c
The average HbA1c level of the sample was 8.89%. The sample had poor glycemic
control based on the criteria of the American Diabetes Association (ADA). For a diabetic, nonpregnant individual, the HbA1c levels should be kept < 7% (ADA, 2019). Although the HbA1c
levels in this dissertation study were higher than most studies, generally, glycemic control is one
of the most challenging goals that people with T2DM in Saudi strive to attain (Al-Rubeaan et al.,
2015). Thus, this current study’s level of HbA1c was reflective of persons who had diabetes for a
long period of time (> 15 years) and consequently had complications. In a non-Saudi study, 86
persons with T2DM with a comparable age range of 53.29 ± 7 years, and gender reported that
the HbA1c level was higher for those with DPN, 7.9% ± 2.19% compared to 6.6% ± 0.98% for
those without DPN (Hussain et al., 2014). Similarly, another non-Saudi study reported an
average HbA1c level of 8.8% in patients with DPN (Bansal et al., 2014). High HbA1c values,
however, are often found among the Saudi diabetic population. One study reported that patients
with symptomatic DPN had on average an HbA1c level of 10.06% ± 1.91% compared with those
who are asymptomatic, 8.58% ± 1.41% (Mojaddidi et al., 2011). In addition, another Saudi study
of persons with T2DM (n = 54,670) reported that 15% had a HbA1c level greater than 8% (AlRubeaan et al., 2015).
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Dyslipidemia
Dyslipidemia is one of the most commonly associated conditions with T2DM. In this
current study, dyslipidemia was considered if the participant had a prescribed lipid-lowering
medication. As discussed in Chapter 4, about 63% (n = 73) of the sample received lipid-lowering
treatments. However, it should be acknowledged that the evidence suggests that these
medications can be prescribed even with the absence of the diagnosis of dyslipidemia. According
to the American College of Cardiology, dyslipidemia is considered with either elevated
triglycerides or low HDL levels (American College of Cardiology, 2019). However, the
American Diabetes Association (ADA) guidelines recommend prescribing statins for T2DM
patients with or without a history of cardiovascular risk factors and irrespective of dyslipidemia
diagnosis. Specifically, the ADA recommends that all T2DM patients (unless exclusion criteria
apply) should be treated with varying doses of statins (ADA, 2019). This was based on the
evidence that in T2DM, statins may play a role in reducing the all-cause mortality and major
vascular events. In this current study, all patients who received treatment were prescribed a type
of statins as most Saudi guidelines are consistent with most of the ADA’s recommendations.
In the current study, a variation in the levels of the lipids between participants was found.
There was an abnormal lipid profile across the board between those treated for dyslipidemia and
those who were not. Those who received statins had lower LDL levels (2.3 ± 1.1 mmol/L, or
88.94 ± 42.54 mg/dL) compared to those who did not (2.8 ± 0.81 mmol/L, or 108.28 ±31.32
mg/dL) (p =.033). There were also significant differences in mean HDL between those who
received statins (1.1 ± 0.28 mmol/L, or 42.54 ± 10.82 mg/dL) and those who did not (0.99 ± 0.23
mmol/L, or 38.28 ± 8.89 mg/dL) (p = .002).
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Evidence of the prevalence of dyslipidemia among T2DM patients is significant. In one
cross-sectional study from Korea (n = 37,375), around 24% (n = 8,902) of persons with T2DM
had dyslipidemia (i.e., elevated triglycerides or low HDL) (Yang et al., 2015). Another crosssectional study (n = 600) found that based on the lipids profile, 58% of those with T2DM and
aged 60.6 years had dyslipidemia (Mejias, & Ramphul, 2018). Most reviewed evidence
determined dyslipidemia based on the levels of the lipids profile. However, one study (n =
2,006) did report that there was a difference between the prevalence of dyslipidemia between
DPN patients (n = 8) and non-DPN patients (n = 44) (Bansal et al., 2014). The overall prevalence
of dyslipidemia in those with DPN in Bansal et al.’s study was low (2.6%) compared with the
current study (62.9%).
Hypertension
The observed prevalence of hypertension was 52% (n = 59) in the current study.
Hypertension was ascertained by data in the medical records, which is based on a formal
diagnosis by the treating practitioners. One Saudi-based study of T2DM patients (n = 233)
reported that only 7.8% (n = 19) of the Saudi DPN patients had hypertension (Algeffari, 2018)
while another Saudi study reported higher numbers with up to 56% of DM patients also having
hypertension (AlJabri, Bokhari, & AlJabri, 2018). Other studies reported lower prevalence of
hypertension among individuals with T2DM. For instance, a study with a Taiwanese individuals
found that 41% of those with T2DM have hypertension concurrently (Yang et al., 2015).
Comorbidity
The prevalence of other comorbidities among the participants in the current study was as
follows: 50% had obesity (BMI > 30), 40% had degenerative joint diseases, 28.3% had visual
impairment, and 20.8% had upper gastrointestinal diseases. These comorbidities are common in
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T2DM as well as depression, nephropathy, cardiovascular diseases, and peripheral arterial
diseases (Rumora et al., 2018). Other studies reported higher prevalence of comorbidities in
individuals with T2DM and DPN. For example, Yang et al. (2015) found 10 comorbidities with a
sample of individuals with T2DM (n = 37,375). Also, a Saudi-based study found that individuals
with T2DM and DPN have about seven comorbidities, including hypertension, retinopathy,
nephropathy, and stroke (AlQuliti, 2015).
Symptom Status
Participants in the current study reported multiple DPN symptoms. About 80% of
subjects reported the presence of at least one symptom of DPN. As discussed in Chapter 2, DPN
symptoms can take the form of neuropathic pain or sensory or motor dysfunction. In the current
study, 90% of participants reported numbness most frequently. Numbness has been largely
reported in the literature, which suggests that it is one of most common symptoms of DPN. One
cross-sectional study examined the risk of developing DPN in patients with T2DM (n = 1,003)
and the Michigan Neuropathy Screening Instrument (MNSI) (the same instrument used to
measure DPN in this study) was used. They reported that numbness was reported by 81% of the
participants (Khawaja et al. 2018). In the current study, both the MNSI and the Self-ReportLeeds Assessment of Neuropathy Signs and Symptoms (S-LANSS) had numbness as the most
reported symptom (MNSI 90%) & (S-LANSS 80%). Another study from India (n = 208) which
also used the MNSI, reported that 72% of participants stated a feeling of weakness most of the
time (D’Souza et al., 2015). In the current study, 75.6% of our participants also reported
generalized weakness which ranked third in the symptoms list for DPN in our study.
Another Saudi-based study also concluded similarly that DPN symptoms numbness,
tingling, and pain (measured using the self-report Douleur Neuropathique 4) (DN4) were
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prevalent in at least half of the sample (n = 1,305) (Halawa et al., 2011). Thus two important
conclusions can be made with regard to our results. First, DPN among the population of Saudi
Arabia can be symptomatic. Second, despite the fact that MNSI reliability in our sample was at
.65, the findings were consistent with previously reported studies. It is important to note,
however, that the high prevalence reported in the current study was due to the recruitment of
those with confirmed or experienced symptoms of DPN, unlike other studies that included
people with or without DPN.
Of concern is that the participants in the current study reported severe symptoms of DPN.
Almost fifty-six percent (n = 67) of the participants had more than seven symptoms (a score of ≥
7 indicates severe DPN when assessed by the MNSI). In addition, about one third of the sample
had more than 10 symptoms (n = 34). Thus, in the current study, the ability to study DPN was
possible with evidence indicating that more than half of the sample had severe DPN.
Additionally, of interest is that even though the DPN measures of S-LANSS and the MNSI had
low reliability estimates, they both correlated with pain appropriately such that higher DPN
scores, measured with the S-LANSS and MNSI 1, were associated with more pain (r = .433, p <
.001 and r = .402, p < .001, respectively).
Characteristics of the Environment
Social Support
The participants completed the Medical Outcome Study-Social Support Survey (MOSSSS) to measure their perceived social support. The results showed that the sample had an
adequate social support as the overall perceived social support index was 70.70 ± 27.28, with a
range of 0-100 (higher scores indicate better social support). These data are comparable to the
results found in the published literature. Sherbourne and Stewart (1991), had a sample of mostly
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women (n = 2987), of whom 69% had chronic diseases (DM, hypertension, depression, and
coronary heart diseases). They reported a total MOS-SSS score of 70.1 ± 24.2. Overall (except
for informational support), this current study found higher perceived social support with regard
to the four subscales. For instance, in tangible support our sample had a score of 73 ± 30.26
compared with 69.8 ± 28.5 reported by Sherbourne & Stewart (1991). This is expected since
about 70% of the sample were married. For informational type support, our sample had a mean
of 64.5 ± 31.82 while the original study had a mean of 69.6 ± 25.5. This indicated that patients in
the current sample may have had either limited social network or less perceived benefit from
their existing social network. Perhaps patients did not get the help needed to address some of
their concern or received limited recommendations which may have contributed to their lower
scores.
The reliability estimates of the MOS-SSS in the current study (.95) was consistent with
that previously published (.97). In the current study, however, there was some concern about the
understanding of certain questions. Patients constantly inquired about the difference in meaning
between items 2 and 3. Item 2 reads, “How often someone gives you information to help you
understand a situation?” Item 3 reads, “How often someone gives you good advice about a
crisis”. Although the scale is properly translated and culturally adapted, previously, the two
statements in Arabic can understandably be misinterpreted. Patients needed help understanding
the differences between what constitutes a “situation” versus a “crisis”. There were also
questions about items 16, “someone to have a good time with” and 18, “someone to do
something enjoyable with.” To most patients, having a good time and doing something enjoyable
meant the same thing. The investigator had to provide examples to explain the difference
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between the two. Whether these questions asked by participants impacted the study findings is
unknown, but are important to consider in future research with this population.
Chronic Illness Resources
The support that T2DM patients need to manage their symptoms, maintain their health,
and prevent further complications from occurring expands beyond social support. They often
need accurate medical information; assistance in maintaining a healthful lifestyle; and support
and advocacy from family, friends, and the community at large. This was measured by the
Chronic Illness Resources Survey (CIRS). Participants in this current study had a mean chronic
illness resources score of 2.41 ± 0.68 (score range 1-5) with higher scores suggesting better
resources. The current study results were compared to the published means of the CIRS (preintervention scores) in persons with T2DM (n = 279) aged 60 years old, of whom 93% were
White and with an average comorbidity of 3 conditions (Glasgow et al., 2005). Our patients had
a negligibly lower total CIRS scores, 2.41 ± 0.68 compared with 2.71 ± 0.6 of the Glasgow et al.
(2005) sample. However, generally, the participants in both studies reported equal illness
resources. The lowest mean for our population was the mean of organizational support, 1.5 ±
0.76 versus 1.71 ± 0.8. For our population of Saudis with T2DM, most of support in the items in
this subscale had extremely limited availability. For instance, the community and organizations
did not offer low-cost meetings that supported managing diabetes. Thus, the lower scores may be
due to these factors. Also, the country has limited resources for public indoor exercise facilities
(Bajamal et al., 2017).
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Functional Status
Foot Self-Care
Patients’ level of functioning was represented by the frequency of performing foot selfcare. Foot care was measured by the Summary of Diabetes Self-Care Activities (SDSCA) footcare subscale. The sample had a mean of 4.74 ± 1.32. That is a frequency of performing foot care
67.71 ± 14.28% days/week. Meaning that patients performed foot self-care for the majority of
the time/week which indicate a good practice. Other studies had reported lower values compared
with this study. The developers of the SDSCA published a review of seven studies that used the
scale between 1992 and 2000. The means of each subscale were computed across all studies. The
sample was composed of adult individuals who had had DM for a duration of 6.3 to 13.0 years
(Toobert et al., 2000). The percentages of days/week for foot care were also examined. For foot
care practices, the published mean day/week was 47.1 ± 21.4%, which suggests poorer foot-care
practices compared with this current study, which had a mean of 67.7%. The mean foot care
subscale for participants in this study was also higher than that published for another Saudi
population of 49.85 ± 33.85% (AlJohani et al., 2015). Thus, participants in this current study
were performing foot care activities more frequently compared with other published studies. Our
sample composed of only symptomatic DPN patients and we found association of DPN and foot
care which suggested that more symptoms were associated with more foot care. It is important to
note that most of our sample had positive foot care exams indicating neuropathy and this may
explain the good foot self-care practices we found.
Additionally, considering the culture of Islam, our patients probably performed well in
foot self-care partly because of the daily prayers. Muslims perform prayers five times day and
part of getting ready to do so involves washing certain part of the body including face, lower
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arms, and feet. Thus, it is most likely that they wash their feet more frequently than other
populations. Yet, this frequency of feet washing might have impacted the skin condition of the
feet and perhaps contributed to dryness since participants expressed that they do not apply
moisturizer afterwards. The foot exams findings indicated that 72.2% had abnormal appearance
of feet. Of which, 36.1% (n = 30) had dry, cracked and callused feet. This might have played a
role in worsening foot ulcers. These issues will be further discussed as nursing implications.
Finally, the current results compared with those of the larger study of SDSCA across
different languages and populations were similar, even though the Cronbach alpha of the footcare subscale in our sample was low at .50, providing some support that the current study
findings are valid.
Health Perception and Quality-of-Life Indicators
The SF-12v2 was used to measure the QoL indicators for this study. The participants had,
expectedly, lower PCS values compared to MCS, which shows that the impact of DPN is greater
on the physical health compared with the mental health (see Table 28).
We compared the MCS and PCS scores of the current study with another study of Saudi
patients with T2DM (n = 216) who had diabetes for a mean of 8.6 years, and half were female
and had a mean age of 50 years (Al-Shehri, Taha, Bahnassy, & Salah, 2008). They aimed to
assess the effect of T2DM on HRQoL by comparing T2DM patients against another 216 healthy
people from Saudi. They reported that the sample’s PCS mean score was 41.3 ± 8.9 compared to
47.5 ± 9.5 of the healthy control group. The patients’ MCS mean was 47.8 ± 9.1 compared with
51.5 ± 9.4 of the controls. Thus, the results of the AlShehri et al. (2008) sample is comparable to
ours for these QoL scores. In addition, their sample had similar complications (72%), however
unfortunately, DPN was not reported among them. This may suggest that this level of
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impairment in the QoL among Saudis can be in part a result of having T2DM and its other longterm complications along with DPN. To better account for the effect of DPN a comparative
design with T2DM patients without DPN is needed.
Table 28. Comparison of the SF-12v2 Scores Between this Study and Another Saudi Study
Current Study

Al-Shehri et al. (2008)

PCS

40.21 (9.75)

41.3 (8.9)

MCS

47.29 (11.35)

47.5 (9.5)

As for the SF-12v2 reliability estimation, the measures’ two composite scores showed
high stability as the Cronbach alpha for PCS and MCS was .81. It is important to note that
through personal communication with the SF-12v2 scientist at Optum Corporation and also as
validated in the User’s manual for the SF-12v2 Health Survey, assessing the internal consistency
by the means of Cronbach alpha was not recommended nor endorsed. This is mainly because
subscales have one or two items and, thus, this would reflect poor correlation between items.
However, for the lack of a better indicator and considering many published peer-reviewed papers
using this method of testing reliability, the authors of this report, based on a statistician’s
recommendations, opted to use the internal consistency to determine the reliability of the SF12v2. Additionally, a published study on a large group of diabetic individuals (n = 2,214)
asserted the reliability of the SF-12v2 via assessing the Cronbach alpha. It reported sufficient
internal consistency with MCS and PCS alphas of .83 and .85, respectively (Kathe, Hayes,
Bhndari, & Payakachat, 2018). This finding is comparable to the finding of this reported study
(.81 for both).
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Discussion of Bivariate Association Among Variables
DPN Symptoms
The MNSI correlated negatively with MCS (r = -.238, p = .009), PCS (r = -.303, p =
.001), and the general health perception domain (r = -.322, p < .001). These correlations, suggest
a low-to-moderate negative association between DPN symptoms and the QoL domains in that as
MNSI scores increase, patients’ health perceptions, physical and mental health would decrease,
leading to poorer health perceptions, and worse physical and mental health. These correlations
were reflected also in the multivariable models, except for MNSI and PCS. More is discussed
about this in the primary aim section.
The DPN measures S-LANSS and MSNI were correlated (r = .473, p < .001), suggesting
that the two measures were related so that if subjects scored high on one measure they also
scored high on the other scale, adding more credibility to the DPN findings. Other studies have
reported either the relationship of DPN using the S-LANSS or the relationship of DPN using the
MNSI. Saudi studies most commonly used the MNSI (Algeffari, 2018; Halawa et al., 2010;
Mojaddidi et al., 2011). Only one Arabic, non-Saudi study used the S-LANSS (Garoushi et al.,
2017). However, no study has examined these two different measures at the same time which
makes this study the first to combine these measures of DPN. It worth noting that S-LANSS
although correlated significantly with the MNSI in the bivariate assessment which suggests both
measures are measuring the concept of DPN, S-LANSS did not show significant association with
other variables in the study such as QoL indicators, biologic, and individual factors.
Mental QoL
Social support correlated with mental QoL (r = .414, p = .021) so that more social
support was associated with better mental health suggesting that with better social support
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mental health improves (Zhong et al., 2016). Other Saudi investigators reported similarly that
lack of social support was associated with worse depressive symptoms in middle aged Saudis
(Albalawi, Faraj, Alanazi, & Albalawi, 2019). Also, the bivariate correlation of the current study
found an association of mental QoL with comorbidities (FCI) which included obesity, arthritis,
visual impairment, lower back pain, and peripheral vascular disease (r = -.219, p = .016). This
indicated that more comorbidity was associated with poorer mental health. This was also found
to be consistent with the multivariable model discussed next. Previous research has supported
this finding in T2DM individuals living in Saudi (AlHayek, et al., 2014; Bahjiri, Jambi,
Alraddadi, Ferns, & Tuomilehto, 2016; Wang et al., 2014). That evidence has indicated that
diabetic patients were disproportionately at increased risk of certain mood disorders such as
depression (Penckofer et al., 2017). Long-term complications, cardiovascular disease,
hypertension, and increased hospitalization were some of the precipitating factors (Papanas &
Ziegler, 2015).
Physical QoL
Physical QoL correlated, expectedly, negatively with age (r = -.198, p = .032), indicating
that poorer physical health was associated with increasing age which would be consistent with
the normal aging in the setting of T2DM (Papanas & Ziegler, 2015). A Saudi-based study,
however, did not find the physical QoL to be associated with age (AlHayek et al., 2014). They
assessed factors associated with QoL among people with T2DM (n = 238), aged 56.4 years, of
which 63% were males. The SF-36 was used to assess physical and mental QoL among
participants in that study. They concluded that gender, economic status, and DM complications
are risk factors for poorer physical health.
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Physical QoL also correlated with illness resources (r = .217, p = .018), suggesting that
more illness resources were associated with better physical health. When patients receive more
education and information about caring for their diabetes, their improved physical health
reflected better disease control (i.e., better self-care, lower HbA1c, and less pain and fatigue).
These current study results are supported in the literature in persons with T2DM (Glasgow et al.,
2005; Zhong et al., 2016).
Physical QoL also correlated with social support (r = -.188, p = .041) in this current
study. The results showed that more social support was associated with poorer physical health.
Considering that these associations are not causational, it cannot be suggested that more social
support causes poorer health. However, it could be that people with poorer physical health
require more support from their social network. An alternative explanation is that people with
poorer physical health are less engaged in social activities due to their poor health
(Koetsenruijter et al., 2015).
The findings also showed that exercise correlated with physical QoL (r = .287, p = .001)
suggesting that more exercise is associated with physical benefits. Several non-Saudi studies
associated performing regular exercise with better physical health in the setting of diabetes and
peripheral neuropathy (Kluding et al., 2014; Riandini et al., 2017). Physical and physiological
benefits of exercise include enhancing insulin receptors, promoting weight loss and muscle tone,
and mitigating insulin resistance. Significant improvements were found in general fatigue,
physical fatigue, and peripheral blood flow with regular exercise (Kluding et al., 2014).
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Discussion of the Study Aims
Regression Analysis of Aim 1
Aim 1 sought to explore the impact of DPN symptoms on the patient’s functional status
(foot-care practices), general health perception, and the overall QoL (PCS and MCS scores). It
was hypothesized that individuals with more DPN symptoms would have had poorer functional
status (fewer foot care practices), a negative health perception, and lower physical and mental
health. Most these associations were supported by the study findings. Each will now be
addressed with the literature that supports or refutes these results.
The Impact of DPN Symptoms on Foot Care
The current study demonstrated that foot care was associated with neuropathy symptoms
(S-LANSS), p=.05. This suggests that as the patients were exhibiting more neuropathy
symptoms, it prompted them to perform more self-care behaviors. This seems to be both logical
considering the nature of onset of complications of T2DM. It is not unusual that patients start
committing themselves to better self-care when they experience the long-term, diseaseassociated complications (Koetsenruijter et al., 2015). There were no Saudi-based studies found
that discussed the association of neuropathy symptoms and foot self-care which makes this study
the first to do so. A study of the association of self-care behaviors and the presence of
complications concluded that within the first year of T2DM diagnosis, those with diabetes
related-complications performed foot self-care practices more frequently compared to with those
without complications (p < .001). Further, in the presence of complications T2DM patients
perceived their condition to be unpredictable and has more consequences (van Puffelen et al.,
2015). Additionally, evidence suggested that newly diagnosed patients who do not exhibit
complications may perceive their condition differently from those with longer illness duration.
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This optimistic perception about living with diabetes could be misleading on the ability to
control their condition. It is also not conducive to self-care management given the low emotional
impact they experienced and the limited consequences for daily life (Gherman et al., 2011).
The hypothesized relationship between DPN symptoms and foot self-care, however,
presented findings that were the opposite of those we had planned. We hypothesized that
patients with more symptoms would perform foot care less frequently due to symptoms. This
hypothesis was based on the assumption that neuropathy symptoms affect the physical and
emotional functions and, if compromised, this will also impact patients’ ability and willingness
to care for themselves and manage their diabetes. Foot care in this assumption was considered a
form of functioning and, as such, would be affected by the severity and the disability resulted
from the symptoms. Individual factors such as fatigue, visual impairments, pain, mental and
emotional decline in addition to physical disability would lead to decreased self-care activities in
individuals with T2DM (Devarajooh & Chinna, 2017; Sina et al., 2018).
Although this association could be bi-directional the majority of evidence on the
association of self-care and diabetes outcomes is often in the direction of self-care impacting the
conditions. Evidence to support the impact of diabetes complication on self-care is scarce. A
cross-sectional study explored the effect of sleep disturbance on DM patients’ ability to perform
self-care management with a convenience sample of 64 patients aged 60 years, 49% of whom
were male, 26.5% were White, and had a mean duration of DM of 11.2 years (Zhu et al., 2018).
They measured sleep problems with both subjective (Pittsburgh Sleep Quality Index) and
objective (ActiGraph) instruments. They concluded that sleep disturbance, diabetes distress, and
daytime sleepiness were significant predictors of self-care. Zhu et al. (2017) study showed that
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the frequency of self-care can be affected by factors related to the ability to function and
problems with sleep could affect the level of functioning.
Another study of a predominantly Black (86.6%) diabetic female patients (76%),
assessed the relationship between two other factors that involve self-care, pain and HbA1c
levels. The study looked to see if the degree of pain resulted in higher HbA1c levels and if selfcare mediated this association (Herbert et al., 2013). They concluded that moderate to severe
pain was directly associated with the glycemic control (HbA1c). Although self-care did not
significantly mediate the association between pain and HbA1c, those with pain were more likely
to eat fat more frequently, exercise less, and have more depressive symptoms when compared to
participants without pain (Herbert et al., 2013). Another study focused on barriers of self-care
among diabetes patients and was conducted in Denmark (Sina, Graffy, & Simmons, 2018). They
found that most patients reported the following barriers to self-care management: physical
(comorbidity and treatment side effects) psychological (priorities, health beliefs, lack of time,
and lack of motivation), system (lack of personal finance, accessibility to proper care, and lack of
close proximity to resources), and psychosocial barriers (lack of support, pressure from others,
and family demands) (Sina et al., 2018).
The Impact of DPN Symptoms on Health Perception, Physical and Mental QoL
The first aim of the study also addressed the association of neuropathy symptoms, health
perception, and physical and mental QoL. We hypothesized a negative relationship between
neuropathy symptoms, health perception and physical and mental QoL such that more
neuropathy symptoms were associated with negative health perceptions and worse physical and
mental QoL. Our findings supported this hypothesis. To our knowledge, this current study is the
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first to address the health perception and QoL of T2DM patients with DPN. Other Saudi-based
studies addressed QoL and health perception in T2DM only.
Health perception. A cross-sectional study is one of the few studies on health perception
among the Saudis had a sample of persons with T2DM (n = 383) of which 48.8% were males
and were aged 46 years old. About 43% of the sample reported concurrent comorbid conditions.
Participants responded to the Illness Perception Questionnaire which had 84 items and addressed
various aspects of living with diabetes which included questions on whether they think that their
diabetes was temporary or permanent, was a serious condition, its consequences, symptoms
control, and the role of treatment in curing the condition (AlGhamdi et al., 2018). The findings
indicated that in the Saudi population, a level of acceptance and optimism was expressed by
persons with T2DM. For instance, 65.3% believed that diabetes had a major impact on their
lives. Eighty percent believed that there was “a lot to do to control symptoms.” On the positive
outlook, 72% thought that they had the power to influence their condition. In contrast, in the
current study, health perception was assessed using a single item that simply asked participants
to rate their health from poor to excellent. This might have been a limitation. However, DPN was
the focus of this study and was not in the other study. Thus, the conclusions made from both
studies were different. In addition, the focus was more on the level of understanding the way
patients feel about their disease and the outcomes of having a chronic condition. Meanwhile, this
current study focused on how generally patients rate their health, including having pain, from a
scale of poor-to-excellent. A simple question of rating health sufficed the purpose of
understanding the overall health perception of current sample.
Physical and mental QoL. Literature on the impact of DPN on physical and mental
health supported the current study findings. In the current study, DPN was predictive of the
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individual’s health perception and QoL (PCS and MCS). The subjective assessment of DPN
using the MNSI 1 was predictive of the physical QoL. Meanwhile, the objective assessment of
DPN via the MNSI 2 was predictive of the mental QoL. The S-LANSS did not correlated with
neither physical nor mental QoL. Other studies have reported similar findings, however none of
them have explored these relationships in the Saudi population (Brod et al., 2015; Geelen et al.,
2017; Kim et al., 2015; Singh-Franco & Jacobs, 2017; Ziegler et al., 2020). Thus, this is an
important contribution of the current study.
Consistent with the current study, a study from Greece used the SF-12v2 and the MNSI
on a comparatively smaller sample of T2DM patients (n = 64) and concluded that neuropathy,
reduced activity, mental fatigue, and elevated glucose level were associated with poorer physical
functioning (Lyrakos et al., 2013). The results of the current study demonstrated that both
subjective (MNSI 1) and objective (MNSI 2) symptoms were associated with mental and
physical QoL and, therefore, the overall QoL. In addition, these researchers reported that
neuropathy symptoms were not significantly associated with mental HRQoL as measured by the
MCS of the SF-12v2. But they did find that depressive symptoms (Depression Anxiety Stress
Scale), coronary artery disease, and treatment for neuropathy were associated with worse mental
health. In addition, their sample had significantly lower HRQoL scores compared to the current
study: PCS and MCS scores were 34.4 ± 11.5 and 41 ± 13.9 compared to 40.21 ± 9.75 and 47.29
± 11.35 in our study, respectively. In their study, Greek persons had overall significantly lower
physical and mental health compared to the Saudi sample of DPN patients of this study.
Although HbA1c in the Greek sample was lower than our sample (7.1 0.8% vs. 8.8%), both
samples included persons that had lived with diabetes for a long time. However, the Greek
sample had higher BMI (31.8 ± 5.3 vs. 30.81), were older (66.6 ± 9.3 vs. 54.0 ± 9.4 years), and
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had a more comorbidities. Interestingly, our Saudi patients had much more severe DPN
symptoms compared with the Greek patients. The mean MNSI (questionnaire) for that Greek
sample was 2.4 ± 1.4 versus 7.6 ± 2.8 of the current study sample. Noting that although MNSI
has a physical exam part, the Greek study did not report using it for DPN assessment. Our study
had the advantage of assessing the symptoms not only subjectively, but objectively as well
(monofilament, tuning fork, and reflex hammer) using the MNSI’s two parts.
The current study findings were also consistent with a recent systematic review (n = 66
studies) that summarized the accumulated evidence on the influence of DPN on QoL in terms of
the direct physical effect of pain, economic factors, sleep, mental health, and treatment regimens.
In that review, DPN represented 71% (n = 47) of types of neuropathies (Girach et al., 2019). In
this review, QoL was measured by different questionnaires. The most common were the SF-36
and SF-12. A notable study in this review was a cross-sectional study that included 90% with
T2DM adults (n = 124 total sample) and examined patient’s perspectives of the impact of DPN
on QoL (Singh-Franco & Jacobs, 2017). The sample was 95% female, 53% Black, aged 57 years
and 49% who had a diagnosis of DPN. The authors adapted questions from the Painful Diabetic
Neuropathy Assessment tool. A total of thirty-one items were used to assess the impact of DPN.
QoL as it relates to the ability to perform daily activities, pain severity, and interference with
sleep was assessed with 13 items. They reported that those with DPN had lower QoL scores with
greater impact on daily activities, higher levels of pain, and more sleep interference compared
with non-DPN patients (Singh-Franco & Jacobs, 2017). In the current study, we found that
Saudis who have T2DM and DPN symptoms also had poor overall physical QoL and also poorer
domains: poor vitality, limitations with physical role, and physical functioning. For instance,
patients reported decreased ability to perform daily tasks, such as performing daily chores,
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climbing a flight of stairs, and limited ability to perform daily prayers (repetitive moves that
require physical mobility). However, the effect of symptoms on sleep was not examined in our
study due to overburdening the participants, but is a factor that would be worthy of study in
future work for the Saudi population. This is particularly true in light of research that indicates
that poor sleep has negative consequences on diabetes and contributes to greater complications
(Zhu et al., 2019).
Additionally, an interventional study conducted with a sample of 72 non-Saudi patients
with DPN who were aged 65 years. Thirty-nine percent were males and 84% had T2DM, with a
mean duration of diabetes of 12.7 years, and an average HbA1c of 7.8% (Agathos et al., 2018).
In that study, patients received 600 mg/day of alpha lipoic acid for 40 days for treatment of DPN
which was assessed using the Neuropathy Symptoms Score, Subjective Peripheral Neuropathy
Screening Questionnaire, and the DN4. QoL was as assessed with a number of tools including
the Brief Pain Inventory, Neuropathic Pain Symptom Inventory, Sheehan Disability Scale, and
the Patient Global Impression Improvement. Patients reported a reduction in pain severity,
interference, work and social life disability, and family life disability scores following
supplementation (Agathos et al., 2018). This interventional study supported our finding that
QoL is associated with DPN and also that improvement in neuropathy symptoms was associated
with improvement in QoL.
Another important supporting piece of evidence of the association of DPN and QoL came
from a comparative-design study conducted in Croatia that examined T2DM patients (n = 160),
aged 62.3 years, of whom 48% were females, and with a duration of diabetes of 17.5 years. DPN
patients were divided into two cohorts based on the presence or absence of pain: painful and nonpainful DPN (Dermanovic Doborota et al., 2014). Current pain as well as pain during the
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previous month was the inclusion criteria. The study used the S-LANSS, Visual Analogue Scale
to measure DPN and the SF-36 to assess QoL. The researchers concluded that painful DPN was
associated with lower physical and mental QoL. The S-LANSS, as per the developers, was
meant to determine whether or not the pain was neuropathic of origin (Bennett, 2001). The type
of questions describes the characteristics of pain resulting from impairments in the function of
nerve thus using it in this manner seemed noteworthy. Accordingly, the score of 12 or less
suggest that the experienced pain is not neuropathic in nature. Interestingly, Dermanovic
Doborota et al. (2014) used the S-LANSS to ascertain pain so that the cutoff score of 12 was
used to include patients in the painful group. Their study is important since they used other
multiple objective measures to assess DPN which included neurological assessments (muscle
strength, proprioception reflexes, monofilament, and vibration).
Furthermore, Dermanovic Doborota et al. (2013) found that the physical QoL of men was
higher than women. This is similar to what this study is concluding. In our study, women had
lower physical QoL scores compared to men. This can be possibly attributed to the level of
education, income, and marital status amongst other factors. In our sample, men had higher
education levels than women. The number of persons with ≥ 12 years of education was 35 for
men versus 10 for women. The number of women who have less than 6 years of education was
33 compared to 13 for men. Thus, the number of women with fewer years of education was
higher compared to men. Furthermore, the chi-square test showed a significant relationship
between gender and the level of education, p < .001. This difference in the level of education
could have caused men to have greater awareness and, thus, better self-care management
behaviors. Another explanation is related to the physical attributes of men and women. As
women are the primary child-bearing party, several physical consequences render them more
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vulnerable to lower back pain and impaired mobility (Kirchengast & Haslinger, 2008).
Additionally, women showed greater attitude towards care-giving compared to men indicating
that women performed more care giving than men (Muhwezi, Okello, & Turiho, 2010)
Regression Analysis of Aim 2
This aim sought to examine the complex associations delineated in the HRQoL model
(Ferrans et al., 2005). Within this theoretical relationship, the association of the biologic factors
(HbA1c, comorbidity, hypertension, level of physical activity, duration of DM, and
dyslipidemia) and individual factors (age and gender) with DPN symptoms and QoL was
examined. This current study hypothesized that poor glycemic control, hypertension, multiple
comorbidity, increased age, female gender, longer duration of diabetes, and less physical activity
were associated with more DPN symptoms. The analysis of this aim supported most of these
associations.
The Association of DPN Symptoms and Key Variables
Glycemic control. In this study, poor HbA1c control was associated with more
neuropathy symptoms. A similar study among the Middle Easterners with diabetes in Jordan
found biologic variables (including glucose levels) associated with DPN. However, HbA1c was
not one of them (Khawaja et al., 2018). Others (including Saudi-based) concluded that HbA1c
levels were associated with more neuropathy symptoms (Algeffari, 2018; AlQuliti, 2015;
Assuncao et al., 2020; Hussain et al., 2014; Mojaddidi et al., 2011). As mentioned in Chapter 2,
one Saudi-based study concluded that HbA1c level was not associated with neuropathy (Wang et
al., 2014). One possible reason for lack of significance is related to the presence of anemia
among that sample as discussed previously. Algeffari (2018) assessed a sample of T2DM Saudi
patients (n = 233) who were aged 56.9 years and 63% were females. They compared patients
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with DPN with non-DPN patients. DPN was measured by the MNSI questionnaire and physical
exam. Glycemic control was measured by the HbA1c. The odds of having DPN was 3 times
higher for those with HbA1c > 9% (Algeffari, 2018). In the Algeffari (2018) study, 48% of the
sample had an HbA1c of > 9% and 49.5% had a level HbA1c of 7-9%. In the current study, the
mean HbA1c was 8.89%. Thus, generally, both Saudi studies samples had a poor glycemic
control. Additionally, both samples had dyslipidemia and hypertension. However, our sample
had other comorbidities that Algeffari (2018) did not discuss. Another factor that might have
impacted the association of the level of HbA1c might be the type of DM treatment. In the current
sample, 41.4% were treated with oral hypoglycemic agents and 55.2% received injections
(insulin and other agents). In the other Saudi study, most patients (81.5%) received oral agent
alone to control their condition. This probably explains the higher levels of HbA1c among their
sample, since insulin is superior to oral agents in lowering glucose levels (ADA, 2019). Last,
there were more people who had had T2DM for > 5 years in Algeffari’s study (2018) than our
sample (27.2% versus 12.9%). Having more people with oral agents alone and with longer DM
duration may explain the poor glycemic control in that study.
Duration of T2DM. Contrary to most previous findings (Assuncao et al., 2020; Halawa
et al., 2010; Bansal et al., 2014; Hussain et al., 2014; Khawaja et al., 2018; Lyrakos et al., 2013;
Wang et al., 2014), our results indicated no association of longer duration of diabetes and
neuropathy symptoms. This lack of association was possibly related to the measurement of study
variables. In the current study, the duration of DM was a categorical variable (< 5 years, 5-10
years, 11-15 years, & >15 years). However, it had also been measured categorically in studies
that had the same conclusion (Assuncao et al., 2020; Wang et al., 2014). It was also a categorical
variable in studies that found no association (Khawaja et al., 2018; Wang et al., 2014). A Saudi-
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based study was conducted with a large sample size (n=1,039) of which 94% were T2DM
patients with a mean age of 51 years. Males were 53% of the sample, 60% were Middle
Easterner, 22% were Asians, and 8% were Black. The duration of DM was both continuous and
categorical scales. They concluded that there was an association of longer duration of DM and
worsening of DPN symptoms (Halawa et al., 2010).
It is interesting that in the univariable model of the current study the duration of DM was
associated with neuropathy symptoms using the MSNI 1 (p = .042). Yet, the multivariable model
showed no significance. Thus the lack of association in our study may be due to the association
among the other variables in the multivariable model. A study conducted in Bahrain (a
neighboring country) found the duration of DM to be associated with increased risk of DPN
(AlMahroos & AlRumi, 2007). DPN was assessed using the modified Neuropathy Symptom
Score and the Neuropathy Disability Score. The foot examination included sensation of pain,
touch, cold, reflexes, and vibration perception. The sample included a large sample (n = 1477) of
which 93% were T2DM. Other characteristics include 57% female, mean age of 57.3 years and a
mean duration of DM of 9.5 years. AlMahroos and AlRumi (2007) had several categorical
intervals for the duration of DM and a large sample size of each interval category compared to
the current sample. For instance, they had more patients (n = 34 and 53, respectively) in the
categories (1-5 years) and (16-20 years). The odds of having DPN increased with the increased
length of having DM >5 years (p<.001). Thus perhaps with a larger sample size in each DM
duration category we could have detected an association in our multivariable model.
Hypertension. We found no association between hypertension and DPN symptoms in the
current study. Evidence was inconclusive as several cross-sectional studies, including Saudibased studies, found no association between DPN and hypertension (Algeffari, 2018; Mojaddidi
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et al., 2011). Others (Wang et al., 2014; Yang et al., 2015) concluded an association of DPN with
hypertension. A retrospective analysis of a large population-based (n = 37,375) study of persons
with T2DM found an association of DPN and hypertension (Yang et al., 2015). However, their
sample was older persons (60 years) who were Taiwanese, consumed more alcohol, and had
more frequent and serious comorbidities compared to our sample. For example, 7.9% of their
patients had coronary artery disease, 2.9% had congestive heart failure, 4.1% had stroke, 2%
with cancer, and 9% with chronic hepatitis. In addition, hypertension was measured by assessing
the systolic and diastolic blood pressure providing increased accuracy. In our study, hypertension
was reported as present or absent. Due to feasibility factors we did not assess the blood pressure
which was not documented in the medical records. For all of these reasons, perhaps the
association that they reported was more accurate.
Among the Saudis, Wang and colleagues (2014) also concluded that hypertension
significantly increased DPN risk 1.79 times compared with normotensive patients, p = .027. This
Saudi study used foot examination tests like vibration perception, light touch perception,
monofilament, and pinprick sensation to assess DPN, similar to the current study. Hypertension
was also measured dichotomously. Unlike our study, however, Wang et al. (2014) had two
groups: DPN and non-DPN patients. A common theme in both studies that concluded association
is that they had included DPN and non-DPN cases for comparison. Due to time limitations, this
was not possible for the current study. Interestingly, however, Algeffari (2018) also conducted a
study with two groups (DPN and non-DPN) of Saudi T2DM patients (n = 233). They concluded
that hypertension did not increase the odds of DPN, p = .763. In their study, however, the
number of hypertensive patients was low for non-DPN (n = 3) and for DPN (n = 16) groups.
Perhaps the small number of hypertension cases obscured its association with DPN.
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Dyslipidemia. Consistent with some of the previous findings is our finding of the
association between DPN symptoms and dyslipidemia (Perez-Matos, Morales-Alvarez,
Mendivil, 2017; Rumora et al., 2017). Our data did not suggest that the presence of dyslipidemia
was linked to worse neuropathy symptoms. Other studies that measured dyslipidemia by the
laboratory values of lipids profiles found an association of DPN and dyslipidemia (Cho et al.,
2014; Jaiswal et al., 2017) and also some that included the variable indicating the presence or
absence of dyslipidemia (Jaiswal et al., 2017). In our study, we used a dichotomous variable,
namely dyslipidemia, based on the taking of lipid lowering medication instead of using the
individual components of the lipid profile (HDL, LDL, cholesterol, and triglycerides). This
decision was based on previous literature where the association of dyslipidemia and DPN has not
been consistent, as studies found one or more of the lipid components (HDL, LDL, triglycerides)
associated with DPN but not others. There were no studies that concluded that all the lipid types
were associated or not associated with DPN. Although the current study found an association
where those who receive treatment had lower foot exam scores and, thus, fewer neuropathy
symptoms; many providers prescribe lipid-lowering agents, especially statins, for diabetic
patients irrespective of dyslipidemia.
Physical activity. Our findings indicated that some exercising (not regularly) was
associated with fewer DPN symptoms. Consistent with other research examining cardiovascular
risk factors, the association between DPN symptoms and physical activity has been inconclusive.
Saudi studies did not include physical activity as a factor when studying DPN. Some previous
studies found DPN symptoms to be associated with the level of physical activity. One US based
study concluded that performing aerobic exercise for 16 weeks was associated with decreased
pain perception among T2DM patients with DPN (Yoo et al., 2015). The researchers conducted a
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pilot interventional study where 14 middle aged, sedentary participants underwent aerobic
exercise regimen. Patients performed exercise on cycle ergometers, treadmills and elliptical
trainers for 50 minutes three time a week for 16 weeks. Also, DPN and pain were measured
using the Brief Pain Inventory Short Form for Diabetic Peripheral Neuropathy. They developed
questionnaires for the frequency of symptoms, impact of DPN on sleep, general activity, mood,
and walking ability. Because of the observational measure of physical activity in that study, they
were able to detect the true impact of exercise on DPN.
Another three-arm interventional study came to a similar conclusion of the association of
DPN and physical activity. Different types of physical activity training levels were examined for
relief of DPN symptoms. In the study, 60 patients with T2DM and DPN, who were aged 54 years
old and had an average 11 years with their disease, were assigned randomly to three types of
treatment: ball training (using a training ball) (n = 20), Frenkele training (slow repetitious
movements to improve coordination) (n = 20), and a control group (no exercise) (n = 20).
Patients in the two treatment arms showed improved posture, balance, and reduced instability (all
of which is a result of DPN) compared to the no-exercise control group which these authors
attributed due to an improvement in DPN (Rojhani-Shirazi, Barzintaj, Salimfard, 2017).
Of the cross-sectional studies, Khawaja et al. (2018) had a sample of 1,003 DPN Middle
Eastern Jordanians. Physical activity was an ordinal variable (similar to this study) with regular,
not-regular, and no-exercise groups. Khawaja and colleagues’ findings were similar to our
findings that performing “exercise irregularly (30 minutes for 1-3 days/week)” was associated
with lower likelihood of developing neuropathy symptoms compared to those who were inactive.
In that same study, performing “regular activity” was not statistically significantly associated
with less neuropathy, p = .239. In our study, the significance of the slope of the association of
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neuropathy and “regular exercise” was also trending towards significance, p = .089. Also in our
sample, the association of neuropathy and performing exercise “not regularly” was significant, p
= .023. Thus, similar to Khawaja and colleagues’ study, we found that performing irregular
exercise and not regular exercise was associated with less DPN. It seems like the performance of
some physical activity may curb the progress of DPN.
This finding in which regular exercise was not significantly associated with DPN is
interesting as there are many confounders that may be attributable. First, our sample was smaller
in the regular exercise group (n = 22) compared to the irregular exercise group (n = 32).
Although the definition of physical activity was provided to our participants (30 minutes of
moderate physical activity daily), there are variations on what constitutes moderate physical
activity. For instance, when answering the questions, some individuals may have considered
strolling around the house (indoors as well as outdoors) a physical exercise while others
considered weight lifting at the gym. Therefore, to accurately measure physical activity using
reliable questionnaires and objective measures in the future will ensure better conclusions.
Age. In addition to these findings about exercise, our results indicated that age was not
associated with neuropathy (p = .069). The results showed trending toward significance. As the
patients aged, they experienced worse neuropathy symptoms. Evidence around the world on the
association of age with neuropathy has been consistently significant (Algeffari, 2018; AlQuliti,
2015; Assuncao et al., 2020; Bansal et al., 2014; D’Souza et al., 2015; Halawa et al., 2010;
Khawaja et al., 2018; Mojaddidi et al., 2011; Wang et al., 2014). Some studies suggested that for
each decade increase in age, the nerve fiber condition worsens leading up to more neuropathy
symptoms (Papanas & Ziegler, 2015). Although in our cross-sectional study we did not
meaningfully quantify the impact of age on neuropathy, our findings were trending to indicate
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that as patients advance in age they experience worse symptoms. Quantifying the impact of age
on DPN can possibly be attained by assessing the age of the person at which symptoms started
and possibly compare it to the severity of symptoms. Other advanced quantifying endeavors
requires physiologic testing which are not feasible in the interim.
Gender. Unlike age, the relationship of gender and neuropathy has not been as
consistent. Most evidence suggested either no association (Algeffari, 2018; Bansal et al., 2014;
Khawaja et al., 2018; Wang et al., 2014) or that males had worse neuropathy symptoms
compared to females (D'Souze et al., 2015; Gogia & Rao, 2017; Halawa et al., 2010). However,
a study from Korea concluded that women had higher odds of developing neuropathy compared
with men (Won et al., 2012). Yet a recent study from Portugal among a sample of persons with
T2DM failed to find an association of neuropathy and gender (Assuncao et al., 2020). Evidence
from Saudi was mixed with both an association (Halawa et al., 2010; Mojaddidi et al., 2011) and
the lack thereof (Algeffari, 2018; Wang et al., 2014).
In line with some findings, our data indicated that females had lower neuropathy scores
compared with males, suggesting that males have a higher tendency to have worse symptoms.
However, we theorized that females would have worse neuropathy symptoms compared to
males. This assumption was based on the previous studies where it was reported that females had
worse symptoms compared with males (Abbott, Malik, van Ross, & Bolton, 2011; Jambart et al.,
2011; Won et al., 2012) including a Saudi study (Halawa et al., 2010). This was also supported
by some evidence that females have greater pain sensitivity compared to males (Fillingim, King,
Ribeiro-Dasilva, Rahim-William, & Riley, 2009).
Our findings, however, only suggested an association of gender and DPN. Yet, it does not
indicate that one gender develops the symptoms earlier than the other. Studies have not been

155
focused on the onset of DPN symptoms making it challenging to study gender differences.
Nevertheless, a Saudi study also used the MNSI’s two parts, Diabetic Neuropathy Index, and
Diabetic Neuropathy Score to measure the prevalence of DPN symptoms (Mojaddidi et al.,
2011). They found that females had higher DPN scores compared with males. Females had a
mean of 2.88±4.18 higher than the males 1.77±4.30 (though not statistically significant). In
addition, electrophysiological tests were performed by blinded neurologists. The sample included
263 persons with diabetes of which 85% had T2DM. The mean duration of DM was 13.89 ± 8.7
years. The mean age was 51.8 years. That study had higher HbA1c levels compared to ours
(9.32% vs. 8.89%), more hypertensive patients (57.8% vs. 51.8%), relatively younger people
(51.8 years vs. 54.6 years), and a higher BMI (33.4 vs. 30.8).
Some evidence exists suggesting that the differences in DPN severity between males and
females can be attributed to the differences in height since height has also been independently
linked to worse neuropathy. Height was implicated for the length-dependent pattern of
neuropathy as a measure of nerve fiber length (Hébert et al., 2017). In a population study from
Mauritius it was found that each 5 centimeters increase in height was associated with 1.36 times
higher risk of DPN (p < .001). This study was run between 1987 to 1992. Vibration perception
threshold was used to determine the presence of DPN. The sample included 1178 participants, of
which n=847 had T2DM and 54% were males. The prevalence of DPN among the sample was
8.3%. DPN and non-DPN patients were compared. Other sample characteristics include a mean
height of 157.5 cm, average duration of DM of 5 years, and BMI of 26 (Shaw et al., 1998).
By contrast, an US-based study concluded no significant association of height and DPN
(Franklin, Shetterly, Cohen, Baxter, & Hamman, 1998). Franklin and colleagues conducted a
comparative design study as well with DPN (n = 77) and non-DPN individuals (n = 277). Sample
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characteristics included mean age of 60.1 years, 45.2% male, 62% Hispanic, and an average
height of 162.4 cm. DPN was also confirmed by history and physical examination. Among the
patients in our study, gender-based differences were notable. Males had statistically significantly
higher foot exam scores MNSI 2 (4.0 vs. 3.0, p = .048) compared to females, were taller (168.5
cm vs. 157.2 cm, p = .032), and weighed more (87.5 kg vs. 78.4 kg, p < .001). Interestingly, the
BMI was not significantly different between males and females, p = .252.
DPN is a complex human disease and has a magnitude of environmental factors that
render some patients susceptible but not others. There is also evidence that implicates genetic
risk factors independently, as well as the interactions between the biologic, environmental, and
genetic factors. The different genetic compositions of men and women and also differences
between races, ethnicities, and nationalities may play a role in differing conclusions (Rich,
2006). A team of genetics researchers in the UK conducted a population-based Genome-Wide
Association Study (GWAS) by analyzing data from previous projects (Meng et al., 2015). The
sample was divided into neuropathic and a control group. The researchers compared the means
of age and BMI between the cases and the controls. Gender differences were evaluated using chisquare. They excluded ethnically outlying, genetically related, and T1DM individuals. The total
analysis included n = 2491 males and n = 1729 females. The study found that the narrow-sense
heritability of neuropathic pain was 30% among males and 14.7% among females. Further, the
study found genetic variations in chromosomes 1 and 8 of the DPN group. Narrow-sense
heritability is the measurement of the amount of variation among individuals that is influenced
by genetic differences which are passed from parents to descendants. The findings suggest that
there is gender-specific influence on DPN in that males had higher heritability than females
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(Meng et al., 2015). They also concluded that gender-specific differences in DPN are complex
and might be influenced by the parent of origin, hormones, and chromosome.
Conclusion of Discussion of Aims
The findings of this study showed mild QoL impairment in a sample of T2DM Saudi
patients due to the presence of DPN symptoms. Physical and mental QoL were both affected by
neuropathy symptoms. Interestsingly, patients had poorer physical health compared to mental
health. Neuropathy symptoms were associated with glycemic control, gender, comorbidity, and
exercise. In conclusion, our study provided additional evidence for the association of neuropathy
and QoL which has not been addressed in previous Saudi studies. The findings of this study
demonstrate the importance of neuropathy screening; above all, it aimed at increasing the
awareness of the impact of neuropathy on QoL among Saudis. This study is the first to address
the problem of DPN, the common and debilitating chronic complications, and its impact on the
QoL among the population of Saudi.
Study Strengths and Limitations
Study Strengths
The findings of this study are significant as they highlighted the impact of DPN on
physical and mental QoL and on the overall QoL for persons with T2DM living in Saudi Arabia.
In addition, this study found that DPN symptoms impact the QoL of domains of physical and
mental QoL the most. However, the traditional individual and environmental factors such as
increased age, comorbidities, and social functions did impact the DPN symptoms. Thus, it is
likely that a more sophisticated level of modeling the data with the use of mediation, moderation
or structural equation models may allow these relationships to be better understood. Although the
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multivariable modeling controls for the covariates, the impact of these various relationships may
become more clear with different statistical approaches (Hulley et al, 2013).
Further, the strength of this cross-sectional study comes from the ability to collect data
on all of the hypothesized variables at one time, and this has ensured that there were minimal
missing data that would have been due to attrition. The amount of missing data was limited to
1.5-5%, which was ensured by reviewing the survey packets upon receiving them.
Although a stronger design would have been to include a control group of persons of the
same age and comorbid conditions, such factors as time and cost to the investigator were not
possible. This may have contributed to the lack of significance in some of the findings (Hulley et
al, 2013). For instance, in our sample we found duration of diabetes, hypertension, and regular
exercise were not associated with neuropathy. These findings are contrary to many correlational
and interventional studies that used a comparative healthy group which may suggest the benefit
of such design. Since a few Saudi-based studies with T2DM also found impairment in QoL,
comparing those with DPN with T2DM patients and without DPN would have increased the
validity of our findings.
Since the data were collected by a single investigator, the protocol was consistently
followed. Another strength of this study was that it ascertained DPN using detailed objective
assessment of foot examination. The objective assessment yielded significant results which are
more reliable compared to the self-report measures. The objective measure (MNSI 2) correlated
to physical QoL in a sample of individuals with T2DM in Saudi which make this study the one
and only to do so.
The most important strength of this reported study was several fold. It was the first study
in the Loyola University Marcella Niehoff School of Nursing to have collected data onsite in
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Saudi Arabia. This was an opportunity to set the foundation for future research to be conducted
in a country outside the United States that has diabetes as a major health issue. This is important
as nursing broadens the multicultural understanding of concepts as QoL. The opportunity to
work with the Loyola IRB as well as the Ministry of Health in Saudi Arabia was a factor that
needed consideration when working abroad. The investigator was able to navigate through the
process of obtaining approval from the centralized system of MoH which provided an additional
learning experience. Then, two other IRB applications were submitted to the regional Directorate
of Health and the hospital with which the diabetes center is affiliated. After obtaining those
approvals, the application to the Loyola University Health Science’s IRB was submitted.
Considering the nature of this research in terms of human subject protections our study was
exempt from the review in Loyola University as it carried minimal risk to humans. This strength
of the study will be further discussed in the nursing implication on research.
In addition, the learning about an international group of persons who are most affected by
T2DM is another major contribution of this study, since the practice of nursing has become
immensely influenced by the cultural context. This study provided a gateway into understanding
the impact of neuropathy on an ethnic group. There are many cultural variations that direct the
Saudis perception and practices of self-care management (Albarqawi, Snethen, AlGanns, &
Kelber, 2017). It is common that some individuals in Saudi self-treat and utilize unlicensed, nonmedical practitioners for various ailments (ElRefaei, Abduljawad, & Alghamdi, 2014) which
might be similar to some understudied groups living in the US. Further, although population
census in Saudi does not report statistics on the racial/ethnic make-up of the population, this
study collected such data. This element further strengthened this study’s impact. Addressing such
a high prevalent health issue by a student at Loyola University School of Nursing would
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contributed to cross-cultural research in the U.S. Since Loyola University is in the forefront of
social justice, equality and empowerment, this work is a proof of the potentials to work with
immigrants and marginalized minorities in the U.S.
Finally, in terms of the measurements, the biologic variables like HbA1c were reliable
because they were obtained from a certified and dependable laboratory of the Prince Abdul Aziz
Bin Majid Diabetes Center. This asserted the accuracy of the data. Also, the use of reliable
measures in this study (SF-12v2, CIRS, and MOS-SSS) would facilitate future comparison
efforts of our data against other populations.
Study Limitations
The limitations of this study should also be addressed. As the sampling approach was
non-probability convenience sampling, this could have led to selection bias. This type of bias
arises because only patients experiencing neuropathy symptoms volunteered and participated in
the study. However, this study examined an important health problem by examining the
association of neuropathy and QoL. Also, the predictive ability of this cross-sectional
observational study, unfortunately is limited as such affirmation requires a comparative,
longitudinal or experimental design.
This study was powered to achieve the aims of this study, however, by increasing the
sample size by setting the parameters for the power to be increased, this may have been better as
some variables bordered on approaching statistical significance. The statistical power depends
on other factors which are the significance level, type II errors, effects size, and number of
independent variables. Additionally, increasing our sample size would have improved the
generalizability of the findings as it would include a wider range of the Saudi population.
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Further, a concern of the investigators was that the sample represented a large
understudied group of individuals who were of the lower income which represented an important
factor most likely contributing to the health problems in Saudi (Global Burden of Disease (GBD)
2017 Saudi Arabia Collaborators, 2020; Robert et al., 2017). It was noted that about one-half of
the sample were poor and some patients expressed lack of access to fresh produce as a hindrance
to improving their diet. Participants living in rural areas are at particular risk of limited access to
resources and healthcare services.
Further, a limitation of this study was the exclusion of non-Arabic speaking permanent
residents and immigrants living in Saudi. Although the sample included (n = 12, 10%) non-Saudi
patients, they spoke and read Arabic fluently. Others were not able to participate due to language
barriers. This had further limited the generalizability of the findings. Also, this study might have
a narrow operationalization of functional status when measured by the frequency of foot selfcare. However, it was important for this study to examine the association of foot self-care and
DPN considering the limited research globally and in Saudi.
Finally, a limitation of this study was the recruitment of participants from one clinic
versus multiple sites. The sample perhaps would be enriched by participants from a variety of
access to healthcare resources.
Instruments reliability. In reviewing the tools, the reading levels of the tools ranged
from 5th to 6th grade. These readability estimates, however, were calculated for the English
versions of the measures. Thus with translations and adaptations of the measures, they may not
be 5th and 6th grade level in the Arabic versions. In fact, at the onset of the study it became
evident that it was necessary to have each participant read the questions to the investigator to
determine their ability to read, and this became an enrollment criteria used for participation. In
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addition, as evidenced with some of the reliability estimates, there is room for improvement. It
was expected that such variation in participants’ educational level would have impacted their
responses to the questions. It is interesting, however, that for instance, the SF-12v2, the MOSSSS, and the CIRS although were verbose and frequent questions were raised about the meaning
of some questions, this did not seem to have affected the reliability of those measures. The SF12v2, the MOS-SSS, and the CIRS all had acceptable internal consistency of .81, .95, and .76,
respectively. A concerning question on the SF-12v2 which reads, “Does your health limit you
in…moderate activities such as moving a table, pushing a vacuum, bowling, or playing golf?” A
particular patient raised worries of the way participants may have interpreted the questions. This
is because of their understanding of the answers presented; yes, limited a lot, yes, limited a little,
and no, not limited at all. This participant, although had high school level of education, read the
answers in a way that made them miss the double negative of no, not limited at all. Thereafter,
this was the criterion question with which participants were asked to read and respond to in order
to be enrolled in the study.
Meanwhile, the questions on the DPN measures, the MNSI and the S-LANSS were
generally easy to understand. Participants did not have many questions about them, yet there
was poor internal consistency for these measures. This poor reliability might be related to the
nature of the tools as both have dichotomous questions and are composed of multiple
characteristics of DPN and thus items were not related (Waltz et al., 2017). Interestingly the
MNSI has mixed reliability estimates in the literature. Overall, it had mixed reports of
psychometric assessment in the English version. However, in other languages like the Portuguese
it had better estimates (Barbosa, Saavedra, Severo, Maier, & Carvalho, 2017). The Arabic
version of the MNSI had an acceptable interclass correlation coefficient of .87 (Mohammed et
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al., 2019), which is a better indicator of internal consistency compared to Cronbach alpha.
However, limited resources made providing the test twice to the participants not feasible.
Additionally, studies on the MNSI used other estimates for the accuracy and precisions
considering the diagnostic usage of the measure. For instance, sensitivity, specificity, negative
and positive predictive values are methods commonly used in dichotomously scored items
(Waltz et al., 2017). However, due to limited resources, lack of objective measures to compare
the findings these tests were not performed. Further, interestingly, the MNSI had mixed
evidence with some studies reporting low sensitivity (38 -72%) and specificity (79-99%)
depending on the cutoff scores used (Moghtaderi, Bakhshipour, & Rashidi, 2006; Oliveira et al.,
2016). This poor sensitivity and specificity is said to be due to a high published cut-off point of >
7.0. Also, notable is the difference between the sensitivity and specificity discrimination of the
two parts, questionnaire versus examination. As the examination has higher values that suggest
better and accurate diagnosis. Herman et al. (2012) recommended that this cut-off point be
reduced to >4.0 for better detecting DPN. Yet, the MNSI is the most widely used measure of
DPN, including among the Saudis. Thus we opted to use it for this current study and it produced
results consistent with other measures and with the literature from different populations.
Another limitation that has to be acknowledged is that self-report measures were used to
collect the data. Patients’ responses might have been influenced by the individual, cultural, and
emotional status of the person completing the surveys. Although social desirability may not fully
apply to this type of survey, as there were no personal or sensitive questions involved, there is
the possibility that patients may not have accurately reported their symptoms of the related
impact. Of concern, however, was perhaps the lack of privacy for the participants which may
have impacted the ability of the participants to be able to concentrate or feel free to ask questions
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due to others in the environment. As will be discussed next, patients are often accompanied by
their spouses and adult children which may also impact on the responses that they provide.
Nursing Implications
Nursing and Research in Saudi Arabia
There are a few reasons that this research study on persons with DPN is directly
impacting the discipline of nursing and other healthcare providers equally. This study is one of
the few nurse-led accomplishments among the Saudi community. The unique aspect and the
focus on the patients’ experience with living with chronic conditions in general and diabetesrelated complications in specific has not been a goal for nurses in Saudi. The hope is that this
study inspires other nurses and provides them with future opportunity to take part in research
designing, data collection, and analysis. The lead investigator of this endeavor was a female
which shows that gender was not a hindrance to perform research among Saudis. The sample
included both males and females equally and interaction with both has been equally positive. The
gender of the investigator has not shown to affect the way participants perceived them neither on
their openness to get foot exams performed.
A unique perspective of nursing profession is the interest in grounding phenomena on
human behavior and psychological and behavioral theories. As Saudi nurses are venturing in the
world of knowledge generation and dissemination, the hope is that we can develop multiprofessional team to provide a wider cast at studying the different health phenomena that are
unique to the Saudi culture. Since there are not many nurse researchers this study showed that
Saudi nurses can be on the forefront of conceptualizing, designing, and articulating a research
study.
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Diabetes Education
Saudi nurse diabetic educators are actively engaged in the plan of care. Typically,
patients meet the diabetes educator when they are newly diagnosed, prescribed diabetes
controlling injection, or if they have persistent poor glycemic control (Alshareef et al., 2018).
Patients meet the educator monthly, quarterly, or more frequently depending on their educational
needs. The diabetic educators provide teaching on diabetes symptoms, glycemic control, physical
activity, and injection taking. Teaching about dietary consumption is often provided by the
dietitians. Foot self-care education is shared between the physicians and wound nurses
(AlMustafa, 2013). However, our results showed some degree of lack of recognition of DPN
symptoms by patients. It also suggested that DPN is not adequately recognized, discussed, and
assessed by the providers. Thus, these findings should be disseminated and shared on a broader
level with physicians, diabetic educators and patients alike. It is also the hope that additional
roles can be created where nurses can provide foot screening and teaching patients to reinforce
foot self-care practices.
Another alarming finding is the poor glycemic control. The average HbA1c in this study
was 8.89% which was higher than most reported evidence from outside of Saudi. Other Saudi
studies have also reported similar levels. This highlights the importance of promoting patient
education to perhaps increase the awareness that poor glycemic control is linked to the
debilitating DM complications (ADA, 2019).
Foot Self-care Management
In this reported study, foot care practices showed that patients were performing good foot
care practices amongst the other self-care activities. However, our sample had significant
symptoms, chronic pain, and foot infections. Further, our data suggested that patients often
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initiate and adhere to self-care after experiencing neuropathy symptoms. This highlights the issue
of self-care practices, one of the focal issues with patients with chronic illnesses (Barlow,
Wright, Sheasby, Turner, & Hainsworth, 2002). Thus, some creative interventions, with simple
understandable language, are needed that target patients in the early stages of the disease to help
raise awareness to prevent the incidence of DPN. Furthermore, as discussed above, practicing
Muslims wash certain parts of their body including the feet prior to performing the five daily
prayers. Although this shows a good practice, washing the feet multiple times a day without
proper drying and moisturizing can be further damaging to the feet. This damage can result from
excessive dryness (ADA, 2019; Institute for Preventative Foot Health, 2012). Another issue with
daily washing is related to foot ulcers. As reported earlier in Chapter 4, about 10% of the sample
had active foot ulcers and during foot exams patients with foot ulcers showed concerns of
improper foot self-care with regards to washing the foot with the presence of ulcers. This
practice shows the need for comprehensive education on diabetic foot care which adds additional
cultural implications of this study findings.
Diabetes Risk Factors
Additionally, our findings indicated that BMI was higher among younger individuals
corresponding to previous research (AlNozha et al., 2015). Considering that the majority of the
Saudi population is <35 years, and that T2DM is becoming more prevalent among the youth, this
finding is alarming. The trajectory of such statistics is worrying as youth with obesity and weight
issues can progress to prediabetes and then diabetes (AlHazzaa, Abahussain, Alsobayel,
Qahwaji, & Musaiger, 2011). The combination of obesity, smoking and other metabolic
conditions is forming a real threat to the public health of the Saudi population (GBD 2017 Saudi
Arabia Collaborators, 2020).
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Additionally, the current lifestyle of the Saudis provides further environment that
worsens their physical QoL. Overwhelming evidence indicated the gross inactivity among the
Saudi children, youth and adults. AlHazzaa (2018) compiled a review on the evidence of factors
associated with physical activity in Saudis, however, the evidence was limited about the rural
areas in Saudi. They reported that physical inactivity among Saudis ranged from 26% to 85%.
Some of the hindrances to exercising reported included extreme weather, lack of social support,
limited exercise facilities, cultural barriers, and crowded traffic (AlHazzaa, 2018). Other
variations are caused by the span of ages, regional, cultural, and educational variability existed
between the Saudis. Although Saudi Arabia is seen as homogenous country that is composed
mostly of Native people it still has varying degrees of cultural beliefs that in turn impact the
lifestyles and health choices of the people (Saudi Arabian Cultural Mission-Australia, 2020).
Gender related influences were also significant among the Saudis as only about 25% of
female adolescent meet the recommendation of 60 minutes of exercise per day (AlHazzaa et al.,
2011). A Saudi study reported that female adolescents in particular had low physical activity
rates. Some of the factors associated with inactivity among them were self-efficacy, enjoyment
of physical activity, and social support (Bajamal et al., 2017). Thus, based on the previous
knowledge about the people of Saudi, future nursing research and education should build on and
further advance this knowledge. The focus should be on women of adolescence and adult age as
they are particularly at risk for metabolic syndromes (AlHazzaa et al., 2011).
Research data indicated that poor diet habits are identified as risk factors for poor
glycemic control among the Saudis (AlNozha et al., 2007; AlQwaidhi, Pearce, Critchley,
Sobngwi, & O’flaherty, 2014). In our study, patients also performed poorly in their diet self-care
practices at 3.6 days/week (52% days of the week). This evidence should alert nurses in clinical
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settings to screen those individuals at risk more carefully and educate them accordingly. For
instance, being aware that diabetes and obesity are part of the family medical history of a
younger patient should be an impetus for the nurse to have different strategies for prevention and
early detection. Also, the lifestyle practice by patients is an important history to obtain. Foods
like crème cheese spreads are a common light food for breakfast and snacks for Saudis. In this
current study patients noted that they mostly eat these sandwiches for dinner thinking that they
are a healthy food choice. Other similar misconceptions about food were also noted previously.
A research team found that half of their Saudi T2DM sample had misconceptions about what
carbohydrate is and the recommended daily serving. Other patients had difficulty refraining from
or limiting intake of honey and dates thinking that they would never be harmful as they are seen
as holy and sacred foods (Alsaeedi, Elzubair, AlDawood, & Bahnasi, 2002). The study also
found that there were contrasting perceptions as to the dietary allowance of those two foods.
Most patients thought they should not be consumed at all. Others thought that they were
harmless regardless of the quantity.
Cultural Determinants
This study, as mentioned earlier, examined the frequency of performing diabetes self-care
practices. Although not a main purpose of this study, the findings suggested that, among the selfcare subscales, the frequency with which participants performed exercise was lower than many
of the published non-Saudi evidence (Toobert et al., 2000). This should call for substantial and
creative efforts from nurses to provide education and reinforce knowledge to ensure safe and
effective exercise routines tailored to the demographic, cultural, and environmental
characteristics of the Saudi population. For instance, since the temperature is high almost yearround, negotiating an alternate indoor simple exercise routine instead of outdoor walking can
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help motivate patients more. Although indoor fitness centers and gyms are increasing in
popularity including a sex-specific sites, the cost of those memberships make such a basic
practice a luxury (AlNozha et al. 2011; AlHazzaa, 2018). Thus, this may not be available to
people of limited financial resources. However, indoor exercise should not be limited to forprofit fitness facilities. With some creativity nurses can recommend simple hassle-free routines
that patient can do in the comfort of their homes. For instance, to increase the level of physical
activity by being aware of alternatives keep them active such as taking the stairs instead of
elevators, or walking instead of driving to go the masjid (house of worship). Taking their walks
inside of an indoor shopping mall can also be an achievable alternative.
It is not uncommon that the family is involved in the care of the diabetic patient in Saudi.
Research on the unique social and cultural system supports that observation as well (Jazieh et al.,
2018). This is almost always the case with people over the age of 50 years and when illiterate.
Involving the daughter or the son of the patient’s care plan is widely practiced in Saudi Arabia.
This prompted studies to explore models in which the family as a whole is centered in the care
and decision making (Jazieh et al., 2018). Certain individual characteristics such as age,
education, medical condition, and cultural issues allow for a shared decision-making process
about their family member’s health. Thus, nurses have an understanding of this element and
often provide education to the caregiver/family member. In light of these results, now nurses can
actively discuss daily foot self-care with the caregiver. They can be involved in the assessment of
their family member’s foot, lotion application, and inspecting of inside shoes.
Some Saudi-based evidence suggested that patients for reasons of education and trust
would prefer the traditional physician centered model where physicians lead the decision making
process (Qidwai, et al., 2013). However, patients should be empowered and educated to make
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informed decision about their health. The practice of actively involving the patient in their own
care is still growing in the Saudi health system (Ministry of Health, 2016). Actively engaging
patients in the decision making process would improve their commitment to self-care
management (Bezreh, Laws, Taubin, Rifkin, & Wilson, 2012; Young, Azam, Meurer, Hill, &
Cui, 2016). Together, the patient and the provider should adjust and modify the management
plan to better address the patient’s QoL concerns.
Implications on Diabetes Care
The expenses of healthcare associated with DM and its complications are among the most
significant healthcare expenses around the world (CDC, 2018; ADA, 2019; Sadosky et al.,
2015). As an essential part of the workforce of the healthcare system, Saudi nurses are concerned
with reducing the costs while maintaining optimal care. Decreasing the costs of DPN management
can be attained by early detection through careful screening and following evidence-based
guidelines. Using the Saudi National Diabetes Registry database of 62,681 persons, Al-Rubeaan
et al. (2015) conducted a large retrospective cohort study and reported that almost all (95%) of
those with DM have T2DM. Around 37% of them have diabetic foot ulcers; almost all of them
had undergone lower limb amputations. Simple measures like inquiring about pain or decrease of
sensation as a part of vital signs assessment can be a key to detecting early signs of neuropathy.
The incidence of complications associated with DPN, such as foot ulcers, would be enormously
reduced and so would the costs of care. Currently, the practice of DM care in Saudi indicates that
patients receive the basic chronic illness care, including laboratory work ups quarterly, at their
primary care physician’s office at the primary care centers. Patients are referred to the diabetes
center to receive further care and strict glycemic control if their HbA1c > 9%. Also, patients
receive annual ophthalmologic assessment and exam along with kidney function assessment.
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These standards of care are the general practice followed by physicians and were developed by
the MoH and are in line with the ADA’s guidelines (Alshareef, 2013). However, most of these
guidelines are followed, the care provision concerning foot care and exams seems to be a
challenging goal to attain (AlMutairi, 2015). Unfortunately, there was no evidence found on the
frequency of foot care assessment in the Saudi literature.
The study also examined, though indirectly, the patient’s perceptions about
communication with the healthcare providers. Communication with the provider is one of the
challenges and hindrances in providing optimal diabetes care in Saudi (AlMalki et al., 2011). In
most Saudi clinical settings, diabetes care, in terms of diagnosing and treatment is provided by
physicians. Nurses provide vital signs assessment including glucose checking, wound changing,
and diabetes education. Diabetes educators receive additional training and certifications beyond
their nursing license. As healthcare providers, nurses are directly involved with DM patients, and
having real data to support the importance of establishing and maintaining a trusting relationship
between provider and patients should enrich their knowledge. It should also promote further
efforts at providing optimal education for patients.
Nursing and Health Disparities
This study’s limitation of excluding illiterate people raised an issue of health disparity.
Literacy is also a pressing issue for nurses who provide education to DM patients. The number of
illiterate adults (no formal education) in Saudi is 1,105,338 excluding those under 10 years old;
of which 398, 322 are older adults. This is about 3.8% of the population (General Authority for
Statistics, 2017). Literacy is directly linked to knowledge retention and, thus, application and
outcome. Providing education and training to individuals with low health literacy is inevitably
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challenging to nurses in Saudi. This is also another application for family-centered care. The
family member can assume responsibility of care for the beloved one.
Another excluded group from this study was non-Arab immigrants and permanent
residents. According to the General Authority for Statistics (2017) there were about 11 million
people, about one-third of the population in Saudi with various forms of immigration status who
may not have access to healthcare resources. There is thus a lot of unknown health issues that
affect the health and QoL of individuals in Saudi. This problem impacts the overall health and
QoL of the entire country. A recent example is the Saudi national response during the pandemic
of Corona Virus Disease-2019 (COVID-19) (Reuters, 2020). As stated earlier, the access to free
healthcare is, mostly, limited to Saudi individuals. Thus, many of non-Saudis were not able to be
tested or treated. This in turn has led to potential health crisis due to the rapid widespread of
infection as those individuals were either unaware of the infection or have limited access to
healthcare resources due to financial restraints. The country was only able to curb this crisis by a
royal decree that allowed everybody including the undocumented to be treated free of charge
(Alarabiya Network, 2020). Such situation might extend to many non-communicable diseases in
Saudi. Similarly, the lack of access to diabetes resources may disproportionately affect those
who are non-citizens which creates some ethical concerns and limit the overall benefits in quality
of care.
Recommendations for Future Research
This reported study contributed to the existing body of research in Saudi by explaining the
symptoms of DPN for persons living with T2DM in Saudi. It is significant that this endeavor
helped establish a research basis for the unique cultural and environmental attributes of the region.
For the Saudi population, the study of factors associated with DPN in relation to healthcare
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resources provided an understanding of the role of the environment in the development and
progress of neuropathy. Peripheral neuropathy is a developing area of research in Saudi and in the
Middle East. There are plenty of questions to be answered about how DPN develops and ways to
prevent it. This study contributed to explaining the symptoms of DPN for persons living in Saudi.
It was the first step in creating evidence using approved and culturally adapted measures. Future
research could focus on the specific aspects of physical impact of neuropathy. For instance, using
multiple measures to assess specific functional attributes is warranted. In this current study,
functioning was measured by the frequency of self-care practices. Future studies would use
instruments that were developed to measure the different components of functionality such as
walking, single-leg stance, and gait measures. Reduced functional status has been attributed to
reduction in QoL among DPN individuals. Studies found significant results with some population
of T2DM and DPN. For instance, a non-Saudi study used a detailed measurement system to assess
functional status. The biological approaches included assessing muscle strength with a
dynamometer, the range of motion with an inclinometer, functional capability with tests like the
timed up and go and sit-to-stand. Also, the average body velocity and balance confidence were
assessed (Riandini et al., 2017). Replicating such a study on the population of T2DM in Saudi
would be a remarkable endeavor.
In addition, in future studies efforts should be focused on exploring the impact of DPN on
sleep disorders. Among the population of Saudi there is some evidence to suggest sleep problems.
Darraj and colleagues (2018) assessed the risk factors of poor quality of sleep among T2DM
people and found that it was a prevalent issue with 55% exhibiting symptoms of sleep problems. It
was associated with being female, illiterate, having DM >10 years, and having diabetes
complications. Another study also studied the pattern of sleep among the Saudis. A team of
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researcher found that among 1, 369 middle aged Saudis, about 61% reported sleeping disturbance,
18% of whom claiming they have slowed or stopped breathing during sleep (AlTannir et al., 2018).
Future interventional studies could include the impact of physiological and psychological
therapy approaches, such as the impact of prescribed physical activity routine on pain perception
and QoL. Given the younger population of T2DM Saudi patients, utilizing technology in
interventions would create an exciting opportunity for participation.
To provide an enhanced understanding of living with DPN, some qualitative research is
also warranted considering the lack of such methodology in the literature of DPN among Saudis
with T2DM. There have been no studies examining the understanding of diabetes and its
complications among the population of Saudi. Qualitative research is needed to provide deep
understanding of the experience of having the diagnosis of DPN. Qualitative data would provide
strong evidence and strength to the description of DPN without which the progress to
interventional design is deficient.
Other research plans involve studying the perceptions and the attitudes of the practitioners
caring for DM patients as understanding the challenges, resources, and approaches of tackling the
epidemic of DM from the perspective of healthcare personnel is key for improved outcomes.
Again, both qualitative and descriptive quantitative methods are valuable in providing profound
understanding of healthcare capacities and limitations. As discussed earlier, the detection and
diagnosis of DPN is variable and information is needed on the beliefs and practices of health
providers on the frequency of foot care examination and DPN development. It is the hope that such
study will increase awareness and enable the scientific community to quantify and measure the
variation in DPN management among the Saudis.
As discussed above, in strengths and limitations, the investigator of this study had a first-
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hand experience with IRB application both nationally and internationally. Such experience
would provide basis for future research collaboration with Marcella Niehoff School of Nursing
as nurses are continuing to build knowledge jointly across the globe. Such endeavor would
recognize the need for nurses to respond to cross-cultural influences on health phenomena and
other global health needs. The cultural influence explored in this study may shed some light to
some of the issues some Muslim, Arab minorities living in the US.
Additionally, field observation notes during foot exams indicated that some patients were
not adhering to the footwear recommendations and thus were wearing sandals. Those, however,
were patients without foot problems. This observation was also previously reported (AlAyed et
al., 2019). Those patients are at increased risk of developing foot problems later in their life. It
was also noted that patients with foot problems and diabetic foot were adhering to the
recommendations of footwear. Most of them wore therapeutic diabetic shoes. The best practice
for footwear for diabetic patients is to wear well-fitting shoes with round-toes that is closed from
all sides (ADA, 2019). Open footwear like sandals, ill-fitting shoes, and squared-toes are some of
the inappropriate footwear for diabetic individuals (van Netten et al., 2020). This observation
further proofs the previous research that the presence of complications improves the patients’
self-care practices, discussed earlier. This, however, was not assessed by any instrument.
Unfortunately, the SDSCA that was used to measure foot self-care practices does not include
questions on footwear. Future research projects should plan to measure this important risk factor
of DPN among Saudis, especially that the risk of dryness and callus development increase with
wearing sandals (ADA, 2019; AlAyed et al., 2019).
Another research project involves the psychometric testing of the newly translated CIRS.
The CIRS has been widely used in the English language. However, to our knowledge, this study
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was the first to use the CIRS in Arabic. For the process of translation, the Back-translation
approach was used (Waltz et al., 2017). It refers to the use of two translators working
independently translating the measure from the primary to the target language. In our study, we
used double translators with two persons translating the CIRS from English to Arabic and two
different translators to translate it back into English. One of the four translators was a bilingual
with English being their first language. The other three translators were Arabic speaking bilinguals.
Three of the translators were competent in the Saudi culture. For future research we would field
test the measure for clarity and appropriateness. This would provide a great opportunity to utilize
such a key measure to be used in research involving the Arabic speaking individuals.
Finally, as discussed in limitations and strengths section, in this current study we excluded
those who cannot read and write at the level of 6th grade. Thus future research efforts would utilize
designs that allow for interview basis of data collections, since many of excluded individuals in
this current study were women and above the age of 45 years. Focusing on the low income, poorly
educated Saudis would ensure better understanding of this important group of people. Overall, it is
evident that there is an abundance of research that can be conducted in persons with T2DM in
Saudi Arabia and the promise for nurses to lead these endeavors is possible.
This study hopes to impark a scholarly discourse and research endeavors on the factors
associated with diabetic peripheral neuropathy among the population of people with diabetes in
Saudi. This study was the first that explored the association of neuropathy and quality of life
among T2DM individuals in Saudi Arabia. This current study, also, was the first study that
examined the impact of DPN on QoL using an objective measure. It was also the first to explore
the association of foot care and neuropathy.
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Study Information Sheet
Study Title: Factors Associated with Diabetic Peripheral Neuropathy Symptoms and Quality of
Life Among Saudis with Type 2 Diabetes.
The purpose of this study is to see if there is a link between neuropathy symptoms, biological,
individual, and environmental factors, and quality of life in adults with type 2 diabetes.
You are invited to participate in the study if:
• You have type 2 diabetes
• You are experiencing pain, tingling, or numbness in your lower legs and feet
• You are between the age of 18 and 80 years
• You are not pregnant
• You are on diabetes treatment (insulin and oral agents)
• Your most recent A1c is obtained within 6 months
• You can read and write in Arabic or English at the level of 6th Grade
If you agree to be in the study,
You will be asked to complete a booklet of questionnaires. The questions ask about the
symptoms, demographics, resources available, social support, and quality of life. It takes
approximately 30 minutes to finish the survey.
• You will undergo a brief physical examination including assessment of your feet
• The total time expected for this data collection is about 40 minutes.
If you are interested in taking a part in this study, please contact Awatef Ibraheem on her cell
phone.
•
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ﺻﻔﺤﺔ ﻣﻌﻠﻮﻣﺎت اﻟﺪراﺳﺔ
ﻋﻨﻮان اﻟﺪراﺳﺔ :اﻟﻌﻮاﻣﻞ اﻟﻤﺆﺛﺮة ﻋﻠﻰ اﻋﺮاض اﻋﺘﻼل اﻻﻋﺼﺎب اﻟﻄﺮﻓﯿﺔ ﻟﻤﺮﺿﻲ اﻟﺴﻜﺮ ﻓﻲ اﻟﺴﻌﻮدﯾﺔ وﻗﯿﺎس ﺟﻮدة اﻟﺤﯿﺎة.
اﻟﮭﺪف ﻣﻦ ھﺬه اﻟﺪراﺳﺔ ھﻮ ﻋﻤﻞ ﺑﺤﺚ ﻟﺘﺤﺪﯾﺪ اﻟﻌﻮاﻣﻞ اﻟﺒﯿﺌﯿﺔ ،اﻟﻔﺮدﯾﺔ ،واﻻﺟﺘﻤﺎﻋﯿﺔ واﻟﺘﻲ ﺗﺆﺛﺮ ﻋﻠﻰ ﺗﻄﻮر ﻣﺮض اﻋﺘﻼل
اﻻﻋﺼﺎب اﻟﻄﺮﻓﯿﺔ ﻟﺪى ﻣﺮﺿﻰ اﻟﺴﻜﺮي ﻣﻦ اﻟﻨﻮع اﻟﺜﺎﻧﻲ ﻓﻲ اﻟﺴﻌﻮدﯾﺔ .ﻛﺬﻟﻚ ﺗﮭﺪف ھﺬه اﻟﺪراﺳﺔ اﻟﻰ ﻗﯿﺎس ﻣﺴﺘﻮى ﺟﻮدة ﻧﻮﻋﯿﺔ
اﻟﺤﯿﺎة ﻟﺪى ھﺆﻻء اﻟﻤﺮﺿﻰ.
ﺑﺈﻣﻜﺎﻧﻚ اﻟﻤﺸﺎرك ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اذا:
• رﺟﻞ او اﻣﺮأة
• ﻟﺪﯾﻚ ﺳﻜﺮي ﻣﻦ اﻟﻨﻮع اﻟﺜﺎﻧﻲ
• ﻗﺪ ﺗﻢ ﺗﺸﺨﯿﺼﻚ أو اﻻﺷﺘﺒﺎه ﺑﻮﺟﻮد اﻋﺘﻼل اﻻﻋﺼﺎب اﻟﻄﺮﻓﯿﺔ ،او ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﺗﻨﻤﯿﻞ ،ﺧﺪر ،اواﻟﺸﻌﻮر ﺑﻮﺧﺰ ﻛﺎﻹﺑﺮ
ﻓﻲ أﺳﻔﻞ اﻟﺴﺎﻗﯿﻦ واﻟﻘﺪﻣﯿﻦ
• ﻋﻤﺮك ﺑﯿﻦ  ٨٠ ١٨ﺳﻨﺔ
• ﺗﺘﻌﺎﻟﺞ ﺑﺎﻷﻧﺴﻮﻟﯿﻦ او اﻟﺤﺒﻮب
• اﺧﺮ ﻗﺮاءة ﻟﻨﺴﺒﺔ اﻟﺴﻜﺮ اﻟﺘﺮاﻛﻤﻲ ﻣﺎ ﺑﯿﻦ  ٦ ٣أﺷﮭﺮ
• إذا ﻛﻨﺖ ﺗﻜﺘﺐ وﺗﻘﺮا ﺑﺎﻟﻌﺮﺑﻲ او اﻻﻧﺠﻠﯿﺰي
إذا واﻓﻘﺖ ﻋﻠﻰ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ ﻓﺄﻧﻚ:
• ﺳﻮف ﺗﻘﻮم ﺑﺘﻌﺒﺌﺔ اﺳﺘﺒﯿﺎﻧﺎت ﻣﺘﻌﻠﻘﺔ ﺑﺨﺼﻮص اﻻﻋﺮاض اﻟﺘﻲ ﺗﻌﺘﺮﯾﻚ وﻛﺬﻟﻚ أﺳﺌﻠﺔ ﺗﺘﻌﻠﻖ ﺑﺒﯿﺎﻧﺎﺗﻚ اﻟﺸﺨﺼﯿﺔ
واﻻﺟﺘﻤﺎﻋﯿﺔ ،واﻟﺒﯿﺌﯿﺔ .ﺗﺴﺘﻐﺮق اﻹﺟﺎﺑﺔ ﻋﻠﻰ ھﺬه اﻷﺳﺌﻠﺔ ﻣﺪة  ٣٠دﻗﯿﻘﺔ.
• ﺳﻮف ﺗﺨﻀﻊ ﻟﻔﺤﺺ ﻣﺒﺴﻂ ﻟﻠﻜﺸﻒ ﻋﻦ ﻗﺪﻣﯿﻚ وﻋﻤﻞ اﺧﺘﺒﺎر اﻹﺣﺴﺎس ﻓﻲ اﻟﻘﺪﻣﯿﻦ.
• ﯾﺴﺘﻐﺮق اﻛﻤﺎل اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ ﻣﺪة  ٤٠دﻗﯿﻘﺔ.
إذا ﻛﻨﺖ ﺗﺮﻏﺐ ﺑﺎﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ ﺗﻔﻀﻞ ﺑﺎﻟﺘﻮاﺻﻞ ﻣﻊ اﻟﺒﺎﺣﺜﺔ ﻣﻦ ﺧﻼل رﻗﻢ ﺟﻮاﻟﮭﺎ ،اﻟﺒﺮﯾﺪ اﻻﻟﻜﺘﺮوﻧﻲ ،او ﺑﺘﻮاﺟﺪك
ﻓﻲ ﻣﺮﻛﺰ اﻟﺴﻜﺮ
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Informed Consent Form
You are invited to participate in a research study:

Introduction
You are being asked to participate in this study because you have type 2 diabetes mellitus and
developed a complication known as diabetic peripheral neuropathy. To briefly describe this
condition, it develops as a result of longstanding elevated blood glucose level and other
underlying changes. The symptoms of this condition that you might be exhibiting varies a lot
between individuals but usually are prickling, deep aching, sharp like electrical shock and
burning pain.
Purpose of the research
The purpose of this study is to determine if there is a significant association between blood sugar
control, age, duration of diabetes, diabetic neuropathy symptoms, functioning status, and your
quality of life.
Participant selection
This study invites all people with:
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The diagnosis of type 2 diabetes or adult onset diabetes
Have a confirmed neuropathy diagnosis or experiencing some of the symptoms
(prickling, deep aching pain, sharp pain like electrical shock, or burning sensation)
• Between the age of 18 and 80 years
• Not pregnant
• On diabetes management medications such as insulin and oral agents
• The most recent hemoglobin A1c in the record is within 6 months
• Read and write in Arabic or English at the level of 6th Grade
Voluntary Participation
Your participation in this research is entirely voluntary. It is your choice whether to participate or
not. In case you chose to not participate, all the services you receive at this clinic will continue
and nothing will change. You will still be offered the treatment that is routinely offered in this
clinic for your case. You may also change your mind later and stop participating even if you
agreed earlier.
Procedures and Protocol
If you agree to participate in this study, you will be asked to meet with the investigator for one
time. This meeting serves two purposes. First, the investigator will explain the study to you and
will obtain your consent to participate. The second purpose of the meeting is to provide you with
the survey booklet for you to complete and to perform a physical check-up of your feet. The
assessment involves touching your feet with cotton and a plastic object to check sensation. This
application should not make you feel any pain.
For the surveys, you will be asked to complete questionnaires about your condition and quality
of life and will approximately take around 30 minutes to complete. All the questions are asking
about your own point of view. The first three questionnaires are about the condition you have
and referred to as diabetic peripheral neuropathy. You will respond to three different surveys
about your symptoms.
The second questionnaire is about your perception of your level of energy, limitations, and
satisfaction with health and your general well-being. This questionnaire is composed of 12
questions about several aspects of your daily life. Some questions involve how happy you are
with your general health, physical, and work-related life.
The third set of questions is about the resources that are available for you to help you manage
your condition. You will be asked to answer questions on the resources that you need to manage
your diabetes. You should consider your own perception when answering the questions. The
fourth set of questions is to assess your social support. For example, it asks about emotional
support and support on information needed for diabetes management.
The fifth questionnaire includes questions about your ability and regularity of managing the
needs of your diabetes. You will be asked to answer questions on how regular you are checking
your glucose level, taking medications, eating healthy, keeping food records, and exercising.
There will also be questions about your background and health history: questions on age, gender,
education level, income level, and employment. Also, there are questions about your current
medical problems and medications you are taking.
•
•
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Risks
There is relatively no risk of participating in the study. There is a possibility that your shared
information gets exposed at any time during data collection or transporting. However, the
researcher will do her best to keep your confidentiality.
Benefits
There may not be any benefit for you but your participation is likely to help us find the answer to
the research question. The potential benefits of the study are to advance and improve diabetes
care.
Reimbursements
Taking part in the study will not cost you anything. If you agree to participate in the study you
will be handed a tote bag that contains a mug and an educational flyer about diabetes and nerve
damage as an appreciation of your time.
Confidentiality
Your participation in this research study is highly honorable and so every information you share
with the researcher will be treated as such. All the information you provide will be kept
confidential. All the medical information accessed by the researcher will be treated similarly.
The investigator will protect the screen during data collection and will not share the temporary
access provided to her with anybody. All survey forms will be stored in a safe place in the
investigator’s own home office. Once data collection is finished, the investigator will transport
the filled consent forms and survey packets back to the U.S. to be stored at the university’s
facilities. Filled forms will also be scanned and stored electronically.
Right to Refuse or Withdraw
You do not have to take part in this research if you do not wish to do so. You may also stop
participating in the research at any time you choose. It is your choice, and all your rights will still
be respected.
Questions and Complaints
If you have a question about the study or would like to withdraw, please contact the
researcher, Awatef Ibraheem at her email or cell phone number. Acknowledgment of
participation in the research: special for the use of participants ....
I understand that I will be free to withdraw at any time. I understand that my information
will be treated in strict confidence by the researcher and will not disclose my identity when
publishing any results for this study.
The name: ................................................ .....................
Signature: ................................................ .................Date: ...............................................
..................
¨ I am informed that I can keep a copy of this form for myself
¨ I agree to participate in this research study
¨ I do not agree to participate in this research study
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اﻟﻤﻮاﻓﻘﺔ اﻟﻤﺴﺘﻨﯿﺮة ﻋﻠﻰ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ﺑﺤﺚ ﻋﻠﻤﻲ
أﻧﺖ ﻣﺪﻋﻮ )ة( ﻟﻠﻤﺸﺎرﻛﺔ ﺑﺒﺤﺚ ﻋﻠﻤﻲ

ﻣﻘﺪﻣﺔ
ھﺬه اﻟﺪراﺳﺔ ھﻲ ﺑﻌﻨﻮان " اﻟﻌﻮاﻣﻞ اﻟﻤﺆﺛﺮة ﻋﻠﻰ اﻋﺮاض اﻻﻋﺘﻼل اﻟﻌﺼﺒﻲ وﺟﻮدة اﻟﺤﯿﺎة اﻟﻤﻌﯿﺸﯿﺔ ﻟﺪى ﻣﺮﺿﻰ اﻟﺴﻜﺮي ﻓﻲ
اﻟﺴﻌﻮدﯾﺔ" .واﻟﻐﺮض ﻣﻦ ﻧﻤﻮذج اﻟﻤﻮاﻓﻘﺔ اﻟﻤﺴﺒﻘﺔ ھﺬه ھﻮ إﻋﻄﺎﺋﻚ اﻟﻤﻌﻠﻮﻣﺎت اﻟﺘﻲ ﺳﺘﺴﺎﻋﺪك ﻋﻠﻰ أن ﺗﻘﺮر أن ﺗﻜﻮن ﻓﻲ ھﺬه
اﻟﺪراﺳﺔ أم ﻻ .ﻓﻼ ﺗﺘﺮدد ﻓﻲ طﺮح أي أﺳﺌﻠﺔ ﻟﺪﯾﻚ وأﻧﺖ ﺗﻘﺮأ ھﺬا اﻟﻨﻤﻮذج .ﻟﯿﺲ ﻣﻦ اﻟﻀﺮوري أن ﺗﻘﺮر اﻟﯿﻮم ﻣﺸﺎرﻛﺘﻚ ﻣﻦ
ﻋﺪﻣﮭﺎ .ﻓﻘﺒﻞ أن ﺗﺘﺨﺬ اﻟﻘﺮار ،ﯾﻤﻜﻨﻚ اﻟﺘﺤﺪث ﻋﻦ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ إﻟﻰ أي ﺷﺨﺺ ﻣﻮﺛﻮق ﻟﺪﯾﻚ.
إذا واﺟﮭﺘﻚ ﺻﻌﻮﺑﺔ ﻓﻲ ﻓﮭﻢ ﺑﻌﺾ اﻟﻜﻠﻤﺎت ،أرﺟﻮ ﻣﻨﻚ أن ﺗﻄﻠﺐ ﻣﻨﻲ اﻟﺘﻮﻗﻒ ﻷﺷﺮح ﻟﻚ ﺗﻠﻚ اﻟﻜﻠﻤﺎت .ﻟﻄﻔﺎً ،اﻧﺘﺒﮫ ﻟﻜﻞ اﻟﺘﻔﺎﺻﯿﻞ
وﻻ ﺗﺘﺮدد ﻓﻲ طﺮح أي ﺳﺆال ﻋﻠﻲ .أﻧﺖ ﻟﺴﺖ ﻣﺠﺒﺮا ﻋﻠﻰ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ،ﻛﻤﺎ ﯾﻤﻜﻨﻚ اﻻﻧﺴﺤﺎب ﻓﻲ أي
ﻟﺤﻈﺔ ﺧﻼل اﻟﻤﺸﺎرﻛﺔ .وإذا ﻛﺎﻧﺖ ﻟﺪﯾﻚ أي أﺳﺌﻠﺔ ﻻﺣﻘﺎً ،ﻓﺒﺈﻣﻜﺎﻧﻚ طﺮﺣﮭﺎ ﻋﻠﻲ .ﻋﻨﺪ اﻹﺟﺎﺑﺔ ﻋﻠﻰ ﺟﻤﯿﻊ أﺳﺌﻠﺘﻚ ،ﯾﻤﻜﻨﻚ أن ﺗﻘﺮر
إذا ﻛﻨﺖ ﺗﺮﯾﺪ أن ﺗﺸﺎرك ﻓﻲ اﻟﺪراﺳﺔ أم ﻻ.
اﻟﻐﺮض ﻣﻦ اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ
ﺳﺒﺐ ﻗﯿﺎﻣﻨﺎ ﺑﮭﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ھﻮ وﺻﻒ طﺒﯿﻌﺔ اﻋﺮاض ﻣﺮض اﻋﺘﻼل اﻻﻋﺼﺎب اﻟﺬي ﻗﺪ ﯾﻮاﺟﮫ اﻟﻤﺮﺿﻰ واﻟﺬي ﯾﻨﺘﺞ ﻋﻦ
ارﺗﻔﺎع ﻣﻌﺪل اﻟﺴﻜﺮ ﻓﻲ اﻟﺪم .أﯾﻀﺎ اﻟﻐﺮض ﻣﻦ اﻟﺪراﺳﺔ ھﻮ دراﺳﺔ ﻣﺎ إذا ﻛﺎن ھﻨﺎك ﻋﻼﻗﺔ ﺑﯿﻦ ھﺬه اﻻﻋﺮاض وﻋﺪد ﻣﻦ اﻟﻌﻮاﻣﻞ
اﻟﻤﺆﺛﺮة ﻣﺜﻞ ﻣﻌﺪل اﻟﺴﻜﺮ ،اﻟﻌﻤﺮ ،اﻟﺠﻨﺲ ،اﻟﺪﻋﻢ اﻻﺟﺘﻤﺎﻋﻲ ،واﻟﻤﻮارد اﻟﻤﺘﻮﻓﺮة ﻟﻠﻌﻨﺎﯾﺔ ﺑﺎﻟﻤﺮض .وأﺧﯿﺮا ،اﻟﮭﺪف ﻣﻦ ھﺬه
اﻟﺪراﺳﺔ ھﻮ ﻟﺪراﺳﺔ ﻣﺎ إذا ﻛﺎﻧﺖ ھﺬه اﻻﻋﺮاض ﺗﺆﺛﺮ ﻋﻠﻰ ﺟﻮدة اﻟﻤﻌﯿﺸﺔ ﻟﺪﯾﻜﻢ .أﻣﻮر ﻣﺜﻞ إﺣﺴﺎس ﺑﺎﻟﺘﻌﺐ ،اﻷﻟﻢ اﻟﻤﺴﺘﻤﺮ ،ﻋﺪم
اﻟﻘﺪرة ﻋﻠﻰ اﻟﻘﯿﺎم ﺑﺎﻷﻋﻤﺎل اﻟﺮوﺗﯿﻨﯿﺔ وﻣﺎ اﻟﻰ ذﻟﻚ.
اﺧﺘﯿﺎر اﻟﻤﺸﺎرﻛﯿﻦ
ﺗﮭﺪف ھﺬه اﻟﺪراﺳﺔ اﻟﻰ اﺳﺘﻘﻄﺎب اﻷﻓﺮاد ﻣﻦ اﻟﺠﻨﺴﯿﻦ اﻟﺬﯾﻦ :ﯾﻌﺎﻧﻮن ﻣﻦ ﻣﺮض اﻟﺴﻜﺮ ﻣﻦ اﻟﻨﻮع اﻟﺜﺎﻧﻲ ،ﻟﺪﯾﮭﻢ اﻋﺮاض ﻣﺜﻞ )أﻟﻢ
ﺑﺎﻟﻘﺪﻣﯿﻦ ،وﺧﺰ ،دﺑﺎﺑﯿﺲ ﻓﻲ اﻟﻘﺪم ،ﺗﻨﻤﯿﻞ ،وﻓﻘﺪان اﻹﺣﺴﺎس ﻓﻲ ﺑﻌﺾ اﻷﺣﯿﺎن( ،او ﺳﺒﻖ ﺗﺸﺨﯿﺼﮭﻢ ﻣﻦ ﻗﺒﻞ اﻟﻄﺒﯿﺐ ﺑﻤﺮض
اﻋﺘﻼل اﻻﻋﺼﺎب اﻟﻄﺮﻓﯿﺔ ،أﻋﻤﺎرھﻢ ﻣﺎ ﺑﯿﻦ  ٨٠ ١٨ﺳﻨﺔ ،اﻟﻨﺴﺎء ﻣﻦ ﻟﯿﺴﺖ ﺣﺎﻣﻞ ،ﻣﻤﻦ ﯾﺘﻌﺎﻟﺠﻮن اﻣﺎ ﺑﺎﻷﻧﺴﻮﻟﯿﻦ او ادوﯾﺔ
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اﻟﺴﻜﺮ ﻋﻦ طﺮﯾﻖ اﻟﻔﻢ ،ﻻ ﯾﻌﺎﻧﻮن ﻣﻦ اﻣﺮاض ﺷﺪﯾﺪة ﻛﺎﻟﺴﺮطﺎن واﻟﻔﺸﻞ اﻟﻜﻠﻮي ،اﺧﺮ ﻗﺮاءة ﻟﻨﺴﺒﺔ اﻟﺴﻜﺮ اﻟﺘﺮاﻛﻤﻲ ھﻲ ﻣﺎ
ﺑﯿﻦ  ٦ ٣أﺷﮭﺮ.
اﻟﻤﺸﺎرﻛﺔ ﺗﻄﻮﻋﯿﺔ
ﻣﺸﺎرﻛﺘﻚ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ﺗﻄﻮﻋﯿﺔ ﺑﺤﺘﺔ .اﻷﻣﺮ ﻋﺎﺋﺪ إﻟﯿﻚ ﺳﻮاء رﻏﺒﺖ ﺑﺎﻟﻤﺸﺎرﻛﺔ أم ﻟﻢ ﺗﺮﻏﺐ .ﺑﻐﺾ اﻟﻨﻈﺮ ﻋﻦ
ﻣﺸﺎرﻛﺘﻚ ﻣﻦ ﻋﺪﻣﮭﺎ ،ﻟﻦ ﺗﻨﻘﻄﻊ ﻋﻨﻚ أي ﺧﺪﻣﺔ ﻣﻦ اﻟﺨﺪﻣﺎت اﻟﻤﻘﺪﻣﺔ ﻟﻚ ﻓﻲ ھﺬه اﻟﻌﯿﺎدة وﻟﻦ ﯾﺘﻐﯿﺮ أي ﺷﻲء .إذا ﻓﻀﻠﺖ ﻋﺪم
اﻟﻤﺸﺎرﻛﺔ ﻓﻲ اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ،ﺳﯿﺘﻢ ﺗﻘﺪﯾﻢ اﻟﺨﺪﻣﺎت اﻟﻌﻼﺟﯿﺔ ﻟﻚ ﻛﻤﺎ ھﻮ اﻟﻤﻌﻤﻮل ﻟﻤﺜﻞ ﺣﺎﻟﺘﻚ ﻓﻲ ھﺬه اﻟﻌﯿﺎدة/اﻟﻤﺴﺘﺸﻔﻰ .ﻛﻤﺎ
ﯾﻤﻜﻨﻚ اﻟﺮﺟﻮع ﻋﻦ ﻗﺮار اﻟﻤﺸﺎرﻛﺔ واﻟﺘﻮﻗﻒ ﺣﺘﻰ ﺑﻌﺪ اﻟﺒﺪء ﻓﯿﮭﺎ.
اﻹﺟﺮاءات اﻟﻤﺘﺒﻌﺔ
إذا واﻓﻘﺖ ﻋﻠﻰ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ،ﻓﺎن اﻟﻤﻄﻠﻮب ﻣﻨﻚ ھﻮ ان ﺗﻘﺎﺑﻞ اﻟﺒﺎﺣﺜﺔ ﻟﻤﺮة واﺣﺪة ﻓﻘﻂ .اﻟﻐﺮض ﻣﻦ ھﺬا
اﻟﻠﻘﺎء ھﻮ ﻛﺎﻟﺘﺎﻟﻲ :أوﻻ ﺣﺘﻰ ﯾﺘﻢ ﺷﺮح اﻟﺪراﺳﺔ ﻟﻚ ﺑﺸﻜﻞ واﻓﻲ وﺣﺘﻰ ﺗﻘﻮم ﺑﻄﺮح اﻷﺳﺌﻠﺔ اﻟﺘﻲ ﺗﺮﯾﺪ وﯾﺘﻢ اﻹﺟﺎﺑﺔ ﻋﻠﯿﮭﺎ .ﺛﺎﻧﯿﺎ ،ﺑﻌﺪ
اﻟﺤﺼﻮل ﻋﻠﻰ اﻟﻤﻮاﻓﻘﺔ اﻟﺨﻄﯿﺔ ﺑﺎﻟﻤﺸﺎرﻛﺔ ﻓﻲ اﻟﺒﺤﺚ ﺳﯿﺘﻢ ﺗﻘﺪﯾﻢ اﻻﺳﺘﺒﺎﻧﺎت ﻟﻜﻢ ﻟﻺﺟﺎﺑﺔ ﻋﻠﯿﮭﺎ .وأﯾﻀﺎ ﺳﯿﺘﻢ ھﻤﻞ ﻓﺤﺺ ﻣﺨﺘﺼﺮ
ﻟﻠﻘﺪﻣﯿﻦ.
ﺳﺘﻘﻮم اﻟﺒﺎﺣﺜﺔ ﺑﻔﺤﺺ اﻟﻘﺪﻣﯿﻦ وذﻟﻚ ﺑﺎﻟﻨﻈﺮ اﻟﯿﮭﻤﺎ .أﯾﻀﺎ ﺳﯿﺘﻢ اﺳﺘﺨﺪام أدوات ﻟﻘﯿﺎس اﻹﺣﺴﺎس واﻻﻟﻢ .ﺳﻮف ﻟﻦ ﺗﻘﻮم ﺑﺎﻹﺣﺴﺎس
ﺑﺎي اﻟﻢ ﻧﺘﯿﺠﺔ ھﺬا اﻟﻔﺤﺺ .ﺳﺘﻤﺮر اﻟﺒﺎﺣﺜﺔ ﺧﯿﻂ ﺑﻼﺳﺘﯿﻜﻲ ،ﻗﻄﻦ ﻋﻠﻰ ﺟﻠﺪ اﻟﻘﺪﻣﯿﻦ ﻟﻘﯿﺎس اﻹﺣﺴﺎس ﻓﯿﮭﻤﺎ .ﻛﺬﻟﻚ ﺳﻨﻘﻮم ﺑﻮﺧﺰ
اﻟﻘﺪﻣﯿﻦ ﺑﺄداة ﺣﺎدة وﻟﻜﻦ ﻟﻦ ﺗﺸﻌﺮ ﺑﺄﻟﻢ اذ اﻧﮫ ﻟﻦ ﯾﻜﻮن ھﻨﺎك اﺧﺘﺮاق ﻟﻠﺠﻠﺪ.
ﺑﺎﻟﻨﺴﺒﺔ ﻟﻼﺳﺘﺒﯿﺎﻧﺎت ﺳﺘﻘﻮم ﺑﺎﻹﺟﺎﺑﺔ ﻋﻠﻰ ﻋﺪد  ٨اﺳﺘﺒﯿﺎﻧﺎت .ھﻨﺎك ﺛﻼﺛﺔ ﻣﻦ ھﺬه اﻻﺳﺘﺒﺎﻧﺎت ﺗﺘﻌﻠﻖ ﺑﺎﻷﻋﺮاض اﻟﺘﻲ ﻗﺪ ﺗﺸﻜﻮ ﻣﻨﮭﺎ
وھﻲ اﻋﺘﻼل اﻟﻌﺼﺎب اﻟﻄﺮﻓﯿﺔ .ﻛﻞ واﺣﺪ ﻣﻨﮭﺎ ﻟﮫ ﻏﺮض ﻣﺨﺘﻠﻒ وﯾﺴﺎل ﻋﻦ أوﺟﮫ ﻣﺘﻌﺪدة ﻣﻦ اﻻﻋﺮاض.
اﻻﺳﺘﺒﯿﺎن اﻟﺮاﺑﻊ ھﻮ ﺑﺨﺼﻮص ادراﻛﻚ ووﻋﯿﻚ ﺑﻤﻘﺪرﺗﻚ اﻟﺤﯿﻮﯾﺔ ،ﻣﺴﺘﻮى اﻟﻄﺎﻗﺔ ،اﻟﻘﯿﻮد اﻟﺘﻲ ﺗﺸﻌﺮ ﺑﮭﺎ ﻧﺘﯿﺠﺔ اﻋﺘﻼل
اﻻﻋﺼﺎب .ﻛﺬﻟﻚ ﯾﻘﻮم اﻻﺳﺘﺒﯿﺎن ﺑﺎﻟﺴﺆال ﻋﻦ ﻣﺪى رﺿﺎك ﻋﻦ ﺟﻮدة اﻟﺤﯿﺎة ﻓﯿﻤﺎ ﯾﺘﻌﻠﻖ ﺑﺎﻟﻤﺸﻜﻠﺔ اﻟﺼﺤﯿﺔ اﻟﺘﻲ ﻟﺪﯾﻚ.
اﻻﺳﺘﺒﯿﺎن اﻟﺨﺎﻣﺲ ﯾﺘﻨﺎول أﺳﺌﻠﺔ ﺗﺘﻌﻠﻖ ﺑﺎﻟﻤﻮارد اﻟﺼﺤﯿﺔ اﻟﻤﺘﺎﺣﺔ ﻟﻚ .ﻛﺬﻟﻚ ھﻨﺎك أﺳﺌﻠﺔ ﺧﺎﺻﺔ ﺑﻄﺮﯾﻘﺔ اﺳﺘﺨﺪاﻣﻚ ﻟﻠﻤﻮارد
اﻷﺧﺮى ﻛﺎﻷھﻞ ،اﻟﻌﻤﻞ ،اﻟﻤﺆﺳﺴﺎت اﻟﻤﺠﺘﻤﻌﯿﺔ.
اﻻﺳﺘﺒﯿﺎن اﻟﺴﺎدس ﯾﺸﺘﻤﻞ ﻋﻠﻰ ﻣﺴﺘﻮى اﻟﺪﻋﻢ اﻻﺟﺘﻤﺎﻋﻲ اﻟﺬي ﺗﺘﻠﻘﺎه واﻟﺬي ﻟﮫ ﻋﺪة ﺻﻮر .ھﻨﺎك أﺳﺌﻠﺔ ﻋﻦ ﺗﻮﻓﺮ اﻟﺪﻋﻢ اﻟﻌﺎطﻔﻲ،
اﻟﺪﻋﻢ اﻟﺤﺴﻲ واﻟﻤﻠﻤﻮس.
اﻻﺳﺘﺒﯿﺎن اﻟﺴﺎﺑﻊ ﯾﺘﻌﻠﻖ ﺑﻨﻤﻂ اﻟﺮﻋﺎﯾﺔ اﻟﺸﺨﺼﯿﺔ اﻟﺘﻲ ﺗﻘﻮم ﺑﮭﺎ ﻟﻠﻌﻨﺎﯾﺔ ﺑﺎﻟﺴﻜﺮي .ھﺬا اﻻﺳﺘﺒﯿﺎن ﯾﺸﻤﻞ طﺮﯾﻘﺔ وﻋﺪد اﻟﻤﺮات اﻟﺘﻲ
ﺗﻘﻮم ﻓﯿﮭﺎ ﺑﻘﯿﺎس اﻟﺴﻜﺮ ،اﻟﺤﻤﯿﺔ اﻟﻐﺬاﺋﯿﺔ ،اﻟﻘﯿﺎم ﺑﺎﻟﺘﻤﺎرﯾﻦ اﻟﺮﯾﺎﺿﯿﺔ وﻣﺎ اﻟﻰ ذﻟﻚ.
اﻻﺳﺘﺒﯿﺎن اﻷﺧﯿﺮ ھﻮ ﻟﺠﻤﻊ ﺑﯿﺎﻧﺎت ﻋﺎﻣﺔ ﻋﻨﻚ .ﺗﺸﻤﻞ أﻣﻮر ﻣﺜﻞ اﻟﻌﻤﺮ ،اﻟﺠﻨﺲ ،اﻟﻤﺆھﻞ اﻟﺘﻌﻠﯿﻤﻲ ،اﻟﻮظﯿﻔﺔ ،واﻻﻣﺮاض اﻟﺘﻲ
ﺗﻌﺎﻧﻲ ﻣﻨﮭﺎ.
ﻛﺬﻟﻚ ﺳﯿﺘﻢ اﻟﻮﺻﻮل اﻟﻰ ﺳﺠﻠﻜﻢ اﻟﻄﺒﻲ ﻟﻠﺤﺼﻮل ﻋﻠﻰ ﻣﻌﻠﻮﻣﺎﺗﻜﻢ اﻟﻄﺒﯿﺔ اﻟﺘﻲ ﺗﺘﻌﻠﻖ ﺑﺎﻟﻐﺮض ﻣﻦ اﻟﺒﺤﺚ.
ﺑﺎﺧﺘﺼﺎر ﺳﯿﻄﻠﺐ ﻣﻨﻚ اﻟﺒﺎﺣﺚ اﻟﻘﯿﺎم ﺑﻤﺎ ﯾﻠﻲ:
• ﻗﺮاءة ﻧﻤﻮذج اﻟﻤﻮاﻓﻘﺔ اﻟﻤﺴﺒﻘﺔ وﻣﻨﺎﻗﺸﺘﮫ وﺗﻮﻗﯿﻌﮫ.
• ﺗﻌﺒﺌﺔ اﺳﺘﺒﯿﺎن ﺣﻮل ﻣﻌﻠﻮﻣﺎﺗﻚ اﻟﺸﺨﺼﯿﺔ ﻣﺜﻞ اﻟﻌﻤﺮ ،واﻟﺠﻨﺲ ،اﻟﺤﺎﻟﺔ اﻻﺟﺘﻤﺎﻋﯿﺔ ،اﻟﺪﺧﻞ ،وﻣﺴﺘﻮى اﻟﺘﻌﻠﯿﻢ.
• ﺗﻌﺒﺌﺔ  ٨اﺳﺘﺒﺎﻧﺎت ﺣﻮل أﻋﺮاض اﻋﺘﻼل اﻻﻋﺼﺎب ،اﻟﺪﻋﻢ اﻻﺟﺘﻤﺎﻋﻲ ،ﻣﺪى اﻟﺮﺿﻰ ﻋﻦ اﻟﻤﻌﯿﺸﺔ ﻣﻊ اﻻﻋﺮاض،
طﺒﯿﻌﺔ ﻣﻤﺎرﺳﺔ اﻟﻌﻨﺎﯾﺔ اﻟﺸﺨﺼﯿﺔ ﺑﺎﻟﻘﺪﻣﯿﻦ ،واﺳﺘﺨﺪام اﻟﻤﻮارد اﻟﻤﺘﻮﻓﺮة ﻟﻤﺮﺿﻰ اﻟﺴﻜﺮ وﻏﯿﺮ ذﻟﻚ .ﺗﺴﺘﻐﺮق اﻹﺟﺎﺑﺔ
ﻋﻠﻰ ﺟﻤﯿﻊ اﻻﺳﺘﺒﺎﻧﺎت ﻣﺪة ﻻ ﺗﺘﺠﺎوز  ٣٠دﻗﯿﻘﺔ.
• اﻟﺨﻀﻮع ﻟﻔﺤﺺ ﺳﺮﯾﻊ ﻟﻠﻘﺪﻣﯿﻦ وذﻟﻚ ﻣﻦ ﺧﻼل اﻟﻨﻈﺮ واﺟﺮاء اﺧﺘﺒﺎر اﻟﻤﻮﻧﻮﻓﯿﻠﻤﻨﺖ ﺑﺎﻟﻀﻐﻂ ﻋﻠﻰ اﻟﻘﺪﻣﯿﻦ .أﯾﻀﺎ
اﺧﺘﺒﺎر اﻟﻤﻄﺮﻗﺔ واﻻھﺘﺰازات ﻟﻔﺤﺺ اﻟﻌﻤﻠﯿﺎت اﻟﻌﺼﺒﯿﺔ ﻓﻲ اﻷطﺮاف اﻟﺴﻔﻠﯿﺔ.
• ﺳﯿﺘﻢ ﻣﺮاﺟﻌﺔ ﻣﻠﻔﻚ اﻟﻄﺒﻲ ﻣﻦ ﻗﺒﻞ اﻟﺒﺎﺣﺚ ﻟﻠﺤﺼﻮل ﻋﻠﻰ ﻣﻌﻠﻮﻣﺎت ﺗﺘﻌﻠﻖ ﺑﺎﻷدوﯾﺔ ،اﻻﻣﺮاض اﻟﻤﺰﻣﻨﺔ اﻷﺧﺮى ،وﻧﺘﺎﺋﺞ
اﻟﺘﺤﺎﻟﯿﻞ اﻟﻤﺨﺒﺮﯾﺔ.
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اﻟﻤﺨﺎطﺮ
ﻟﯿﺲ ھﻨﺎك ﻣﺨﺎطﺮ ﻣﺤﺘﻤﻠﺔ ﻧﺘﯿﺠﺔ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ .ھﻨﺎك اﺣﺘﻤﺎل ﻓﻘﺪان اﻟﺒﯿﺎﻧﺎت او ﺗﻌﺮﺿﮭﺎ ﻟﻠﻀﯿﺎع .وﻟﻜﻦ اﻟﺒﺎﺣﺜﺔ
ﺳﻮف ﺗﺴﻌﻰ ﺟﺎھﺪة اﻟﻰ اﻟﻤﺤﺎﻓﻈﺔ ﻋﻠﻰ ﺳﺮﯾﺔ اﻟﻤﻌﻠﻮﻣﺎت وﻟﻦ ﯾﺘﻢ ﻣﺸﺎرﻛﺘﮭﺎ اﻻ ﻣﻊ ﺟﺎﻣﻌﺔ ﻟﻮﯾﻮﻻ ﺑﺸﯿﻜﺎﻏﻮ ووزارة اﻟﺼﺤﺔ
ﺑﺎﻟﺴﻌﻮدﯾﺔ )ﻓﻲ ﺣﺎل طﻠﺒﺖ(.
اﻟﻤﻨﺎﻓﻊ
ﻣﺸﺎرﻛﺘﻚ ﻗﺪ ﻻ ﺗﺤﻘﻖ ﻟﻚ أي ﻣﻨﻔﻌﺔ ،وﻟﻜﻨﮭﺎ ﺳﺘﺴﮭﻢ ﻋﻠﻰ اﻷرﺟﺢ ﻓﻲ اﻹﺟﺎﺑﺔ ﻋﻦ ﺳﺆال اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ .وﻋﻠﻰ أﯾﺔ ﺣﺎل ،ﻓﺎﻟﻤﻨﻔﻌﺔ
اﻟﻤﺮﺟﻮة ﻣﻦ اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ھﻲ ﺗﻌﺰﯾﺰ وﺗﺤﺴﯿﻦ ﻣﺴﺘﻮى رﻋﺎﯾﺔ اﻟﺴﻜﺮي واﻟﻤﻀﺎﻋﻔﺎت اﻟﻤﺘﻌﻠﻘﺔ ﺑﮫ .ﻛﻤﺎ أن ﻧﺘﺎﺋﺞ اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ
ﻗﺪ ﺗﺴﺎﻋﺪ ﻓﻲ رﻓﻊ اﻟﻮﻋﻲ ﻋﻦ اﻋﺮاض اﻻﻋﺘﻼل اﻟﻌﺼﺒﻲ وﻣﺪى ﺗﺄﺛﺮ ﺟﻮدة اﻟﺤﯿﺎة ﻧﺘﯿﺠﺔ ھﺬه اﻻﻋﺮاض.
اﻟﺘﻌﻮﯾﻀﺎت
ﻟﻦ ﺗﻜﻠﻔﻚ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ أي ﺷﻲء .ﻓﺈذا ﻗﺮرت اﻟﻤﺸﺎرﻛﺔ ،ﺳﯿﺘﻢ ﻣﻨﺤﻚ ﺣﻘﯿﺒﺔ ﯾﺪ وﺑﺪاﺧﻠﮭﺎ ﻣﻌﻠﻮﻣﺎت ﻋﻦ اﻻﻋﺮاض
اﻟﺘﻲ ﺗﻮاﺟﮭﻚ.
ﺳﺮﯾﺔ اﻟﺒﯿﺎﻧﺎت
ﺳﯿﺘﻢ اﻻﺣﺘﻔﺎظ ﺑﺴﺮﯾﺔ اﻟﺒﯿﺎﻧﺎت اﻟﺘﻲ ﯾﺘﻢ ﺟﻤﻌﮭﺎ ﻷﻏﺮاض ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ .أﻣﺎ ﻣﻌﻠﻮﻣﺎﺗﻚ اﻟﺸﺨﺼﯿﺔ
)ﻣﺜﻞ اﺳﻤﻚ ورﻗﻢ ﺳﺠﻠﻚ اﻟﻄﺒﻲ( اﻟﺘﻲ ﯾﺘﻢ ﺟﻤﻌﮭﺎ ﺧﻼل اﻟﺪراﺳﺔ ،ﻓﺴﯿﺘﻢ إﺑﻌﺎدھﺎ وﻻ ﯾﺮاھﺎ أﺣﺪ ﻏﯿﺮ اﻟﺒﺎﺣﺜﯿﻦ .وﺳﯿﺘﻢ اﻟﺘﻌﺮف ﻋﻠﻰ
ﻛﻞ ﻣﻌﻠﻮﻣﺔ ﺷﺨﺼﯿﺔ ﻟﻚ ﻋﻦ طﺮﯾﻖ رﻗﻢ ﻣﻌﯿﻦ وﻟﯿﺲ ﻋﻦ طﺮﯾﻖ اﺳﻤﻚ .ﻟﻦ ﯾﻌﺮف أﺣﺪ ﻣﺎ ھﻮ رﻗﻤﻚ ﻏﯿﺮ اﻟﺒﺎﺣﺜﯿﻦ وﺳﻨﺤﺘﻔﻆ ﺑﺘﻠﻚ
اﻟﺒﯿﺎﻧﺎت ﻣﻐﻠﻘﺔ ﺑﻘﻔﻞ وﻣﻔﺘﺎح ،وﻟﻦ ﯾﺘﻢ ﻣﺸﺎرﻛﺘﮭﺎ أو إﻋﻄﺎءھﺎ أﺣﺪا ﻏﯿﺮ أﻋﻀﺎء ﻓﺮﯾﻖ اﻟﺒﺤﺚ وﻣﺠﺎﻟﺲ اﻟﺠﺎﻣﻌﺔ ﻟﻠﻤﺮاﺟﻌﺔ
واﻟﻤﺴﺆوﻟﺔ ﻋﻦ ﺣﻤﺎﯾﺔ اﻟﻤﺸﺎرﻛﯿﻦ ﻣﻦ اﻟﺒﺸﺮ ﻓﻲ ﺟﺎﻣﻌﺔ ﻟﻮﯾﻮﻻ ﺑﺸﯿﻜﺎﻏﻮ وﻓﻲ وزارة اﻟﺼﺤﺔ اﻟﺴﻌﻮدﯾﺔ .أﯾﻀﺎ ﺳﯿﺘﻢ ﺣﻔﻆ اﻟﺒﯿﺎﻧﺎت
اﻟﻜﺘﺮوﻧﯿﺎ )ﻟﺴﮭﻮﻟﺔ اﻟﻮﺻﻮل اﻟﯿﮭﺎ( وﯾﺴﺘﻢ ﺣﻤﺎﯾﺔ ھﺬه اﻟﺒﯿﺎﻧﺎت ﻋﻦ طﺮﯾﻖ ﻋﺪد ﻣﻦ اﻟﻮﺳﺎﺋﻞ ﻛﺎﻟﻤﻌﯿﺎر اﻹزدواﺟﻲ ﻟﻠﻮﺻﻮل.
ﺣﻖ اﻟﺮﻓﺾ أو اﻻﻧﺴﺤﺎب
ﻟﺴﺖ ﻣﺠﺒﺮا ﻋﻠﻰ اﻟﻤﺸﺎرﻛﺔ ﻓﻲ ھﺬه اﻟﺪراﺳﺔ اﻟﺒﺤﺜﯿﺔ ﻣﺎ ﻟﻢ ﺗﻜﻦ ﺗﺮﻏﺐ ﺑﺬﻟﻚ ،ﻛﻤﺎ ﯾﻤﻜﻨﻚ اﻟﺘﻮﻗﻒ ﻋﻦ ﻣﺸﺎرﻛﺘﻚ ﻓﻲ أي ﻟﺤﻈﺔ.
اﻷﻣﺮ ﻋﺎﺋﺪ ﻛﻠﯿﺎ إﻟﯿﻚ وﺳﯿﺘﻢ اﺣﺘﺮام ﻛﺎﻓﺔ ﺣﻘﻮﻗﻚ .اﻧﺴﺤﺎﺑﻚ او ﻋﺪم ﻣﺸﺎرﻛﺘﻚ ﻟﻦ ﯾﺆﺛﺮ ﺑﺎي ﺷﻜﻞ ﻛﺎن ﻋﻠﻰ ﺣﻘﻮﻗﻚ ﻛﻤﺮﯾﺾ او
ﻋﻠﻰ ﻣﺴﺘﻮى او اﺣﻘﯿﺔ اﻟﺤﺼﻮل ﻋﻠﻰ اﻟﺮﻋﺎﯾﺔ اﻟﺼﺤﻲ.
اﻷﺳﺌﻠﺔ واﻟﺸﻜﺎوى
ﻟﻄﺮح أﺳﺌﻠﺔ ﺣﻮل ﺣﻘﻮﻗﻚ ﻛﻤﺸﺎرك ﻓﻲ اﻷﺑﺤﺎث أو اﻟﺸﻜﺎوى :اﺗﺼﻞ ﺑﻮزارة اﻟﺼﺤﺔ /ﻣﺪﯾﺮﯾﺔ اﻟﺸﺆون اﻟﺼﺤﯿﺔ– اﻟﻤﺪﯾﻨﺔ
اﻟﻤﻨﻮرة
ﻟﻼﺳﺘﻔﺴﺎرات اﻟﻤﺘﻌﻠﻘﺔ ﺑﺎﻟﺒﺤﺚ او ﻓﻲ ﺣﺎل اﻟﺮﻏﺒﺔ ﻓﻲ اﻻﻧﺴﺤﺎب ،اﻟﺮﺟﺎء اﻟﺘﻮاﺻﻞ ﻣﻊ اﻟﺒﺎﺣﺜﺔ ﻋﻮاطﻒ إﺑﺮاھﯿﻢ

APPENDIX C
SELF-REPORT MEASURES (ARABIC AND ENGLISH)
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Study ID#:

General Health and Demographic Survey

Please fill out the information below. All the information will remain confidential.
1. Age……

Date of birth………

2. Gender:

Female

Male

Prefer not to answer

3. Race (Saudi from):
Native people

East Asian (e. g., Malaysia and Indonesia)

North African (Egypt and Morocco)
Middle Eastern

African (Black)

South Asian (India and Pakistan)

Prefer not to answer

Non-Saudi

More than one race, describe

Other, describe…….

4. Marital condition:
Married

Divorced

Single

Widow

Separated

Prefer not to answer
5. Monthly income (Saudi Riyal):
None

Less than 5,000

More than 15,000

5,000-10,000

10,000-15,000

Prefer not to answer

6. Level of education:
Can read and write Arabic
6th grade
College degree

9th grade

Can read and write English
12th grade

Higher education

Less than 6th grade

Associate degree

Prefer not to answer
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7. Employment status:
Do you work currently?
(If yes):

Yes

No

Government

Private

Prefer not to answer
Retired

Self-employed

8. You have diabetes for (which best applies):
Less than 6 months
5-10 years

Less than 1 year

Less than 5 years

11-15 years

More than 15 years

9. Do you have family history of diabetes (type 1 or 2)?

No

Yes

(If yes, who) mother, father, sibling, or child
10. Diabetes Medications:
1.…….
4..……

2….……

3………….

5. ……

11. Are you taking any neuropathy medications?
(If yes, please list all)
1.…….

2….……

No

Yes

3………….

12. List all the medications you are currently taking (including the over-the-counter
medications)
1.

…….

2….……

3………….
4..……

5. ……

6………..

7………

8…………

9. ………

10………..
13. Are you a smoker?
Never smoked

Currently smokes

Former (smoked in the past but

not now)
If current or former smoker, how many pack(s) per day?
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…………………………………
14. How much do you exercise? (at least 30 minutes)
4-7 days a week

1-3 days a week

15. Do you have a history of fall(s)?

Yes

I do not exercise
No

(if yes, how many times in the past 3 months)?............................
16. The circumstances of the fall(s):
Fainted

Confusion

Tripped
Poor balance

Legs gave away (knee buckling)
Foot problems (bunions and

hammertoes)
17. Have you ever fallen down because you lost sensation in your feet?

Yes

No

if yes, how times ……...
18. Have you ever lost sensation while driving?

Yes

No

if yes, how times ……
19. Do you have a fear of falling as a result of your symptoms?

Yes

No

if yes, how times ……...
20. Have you ever been diagnosed for the symptoms of neuropathy?

Yes

No
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اﻟﺼﺤﺔ اﻟﻌﺎﻣﺔ واﻟﻤﻌﻠﻮﻣﺎت اﻷوﻟﯿﺔ
ھﺬا اﻻﺳﺘﺒﯿﺎن ھﻮ ﺑﺨﺼﻮص ﺗﺠﻤﯿﻊ ﺑﯿﺎﻧﺎت ﻋﻦ اﻟﺤﺎﻟﺔ اﻟﺼﺤﯿﺔ واﻻﺟﺘﻤﺎﻋﯿﺔ اﻟﻌﺎﻣﺔ .اﻟﺮﺟﺎء ﺗﻌﺒﺌﺔ ھﺬه اﻻﺳﺘﻤﺎرة ﻋﻠﻤﺎ ﺑﺎن ﺟﻤﯿﻊ
اﻟﻤﻌﻠﻮﻣﺎت ﺳﺘﻜﻮن ﺳﺮﯾﺔ:
ﺗﺎرﯾﺦ اﻟﻤﯿﻼد...... :

 .1اﻟﻌﻤﺮ.......
 .2اﻟﺠﻨﺲ:

اﻧﺜﻰ

 .3اﻷﺻﻞ اﻟﻌﺮﻗﻲ )ﺳﻌﻮدي ﻣﻦ(:
اﻟﺴﻜﺎن اﻷﺻﻠﯿﯿﻦ

ذﻛﺮ

أﻓﻀﻞ ﻋﺪم اﻹﺟﺎﺑﺔ

ﺷﻤﺎل اﻓﺮﯾﻘﯿﺎ ) ﻣﺼﺮ ،ﺗﻮﻧﺲ،

ﺷﺮق اﺳﯿﻮي ) ﻣﺜﻞ ﻣﺎﻟﯿﺰﯾﺎ واﻧﺪوﻧﯿﺴﯿﺎ(

اﻟﻤﻐﺮب(
اﻟﻤﺸﺮق اﻟﻌﺮﺑﻲ )ﺳﻮرﯾﺎ ،اﻟﻌﺮاق ،ﻓﻠﺴﻄﯿﻦ(

أﺻﻞ اﻓﺮﯾﻘﻲ )اﺳﻮد(

ﺟﻨﻮب اﺳﯿﺎ )ﺑﻼد اﻟﮭﻨﺪ

وﺑﺎﻛﺴﺘﺎن(
ﻏﯿﺮ ﺳﻌﻮدي

أﻓﻀﻞ ﻋﺪم اﻟﺠﻮاب

أﺧﺮى

ﻣﺘﻌﺪد اﻻﺻﻞ اﻟﻌﺮﻗﻲ ،اﺷﺮح.........
 .4اﻟﺤﺎﻟﺔ اﻻﺟﺘﻤﺎﻋﯿﺔ:
ﻣﺘﺰوج)ة(
أﻓﻀﻞ ﻋﺪم اﻹﺟﺎﺑﺔ

ﻣﻄﻠﻖ)ة(

ﻋﺎزب)ة(

ﻣﻨﻔﺼﻞ )ﻏﯿﺮ ﻣﻄﻠﻖ(

أرﻣﻞ)ة(

 .5اﻟﺤﺎﻟﺔ اﻟﻤﺎدﯾﺔ )اﻟﺪﺧﻞ اﻟﺸﮭﺮي ﺑﺎﻟﺮﯾﺎل(:
اﻗﻞ ﻣﻦ ٥٠٠٠
ﻻ ﯾﻮﺟﺪ
أﻓﻀﻞ ﻋﺪم اﻻﺟﺎﺑﺔ

١٠٠٠٠ ٥٠٠٠

١٥٠٠٠ ١٠٠٠٠

أﻛﺜﺮ ﻣﻦ ١٥٠٠٠

 .6اﻟﺤﺎﻟﺔ اﻟﺘﻌﻠﯿﻤﯿﺔ:
ﯾﻘﺮا وﯾﻜﺘﺐ ﻋﺮﺑﻲ
ﺟﺎﻣﻌﯿﺔ ﻣﺘﻮﺳﻄﺔ

اﻗﻞ ﻣﻦ ﺳﺎدس اﺑﺘﺪاﺋﻲ
ﺟﺎﻣﻌﻲ

اﺑﺘﺪاﺋﻲ

ﻣﺎﺟﺴﺘﯿﺮ او دﻛﺘﻮراه

اﻻﺟﺎﺑﺔ
 .7ھﻞ ﺗﻌﻤﻞ ﺣﺎﻟﯿﺎ؟
ﻧﻌﻢ

ﻻ

أﻓﻀﻞ ﻋﺪم اﻻﺟﺎﺑﺔ

ﻣﺘﻮﺳﻂ
ﯾﻘﺮأ وﯾﻜﺘﺐ اﻧﺠﻠﯿﺰي

ﺛﺎﻧﻮي
أﻓﻀﻞ ﻋﺪم
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)ﻓﻲ ﺣﺎل اﻹﺟﺎﺑﺔ ﺑﻨﻌﻢ(:

ﺷﺮﻛﺔ ﺧﺎﺻﺔ

وظﯿﻔﺔ ﺣﻜﻮﻣﯿﺔ

ﻣﺘﺴﺒﺐ

ﻣﺘﻘﺎﻋﺪ

 .8اﻧﺖ ﻣﺮﯾﺾ ﺳﻜﺮ ﻣﻨﺬ:
اﻗﻞ ﻣﻦ  ٦ﺷﮭﻮر
 ١٥ ١١ﺳﻨﺔ

اﻗﻞ ﻣﻦ ﺳﻨﺔ

 ١٠ ٥ﺳﻨﻮات

اﻗﻞ ﻣﻦ  ٥ﺳﻨﻮات

أﻛﺜﺮ ﻣﻦ  ١٥ﺳﻨﺔ )ﻛﻢ ﺑﺎﻟﺘﺤﺪﯾﺪ(؟.........

 .9ھﻞ ﻟﺪﯾﻚ ﻗﺮﯾﺐ ﻣﺼﺎب ﺑﺎﻟﺴﻜﺮي )اﻟﻨﻮع اﻻول او اﻟﺜﺎﻧﻲ(؟
طﻔﻞ............

ﻧﻌﻢ )ﻣﻦ(؟أم ،اب ،اخ،

ﻻ

 .10أدوﯾﺔ اﻟﺴﻜﺮي اﻟﻤﻮﺻﻮﻓﺔ ﻣﻦ ﻗﺒﻞ اﻟﻄﺒﯿﺐ:
.............. .

...................٢

....................٤

.......................٣

............................٥

 ١١ھﻞ ﺗﻠﻘﯿﺖ ﻋﻼﺟﺎ ً ﻷﻋﺮاض اﻟﺘﻠﻒ اﻟﻌﺼﺒﻲ؟
...............١

......................٦
ﻻ

ﻧﻌﻢ

إذا ﻛﺎﻧﺖ اﻻﺟﺎﺑﺔ ﺑﻨﻌﻢ ،ﻣﺎھﻲ؟
.................٣

..............٢

اذﻛﺮ)ي(أي ادوﯾﺔ أﺧﺮى ﺗﺘﻌﺎطﺎھﺎ ﺣﺎﻟﯿﺎ ً ﻟﻢ ﯾﺘﻢ ذﻛﺮھﺎ ﻣﺴﺒﻘﺎ ً )ﺗﺸﻤﻞ اﻟﻤﻮﺻﻮﻓﺔ وﻏﯿﺮ اﻟﻤﻮﺻﻮﻓﺔ(
................. .

...................٢

.............٥

.................٦

........................٩
 .11ھﻞ اﻧﺖ ﻣﺪﺧﻦ؟

...................٣
.......................٧

...................٤
...................٨

..........................١٠
ﻻ اﺑﺪا

ﺳﺎﺑﻘﺎ وﻟﯿﺲ ﺣﺎﻟﯿﺎ

ﺣﺎﻟﯿﺎ

ﻓﻲ ﺣﺎل اﻹﺟﺎﺑﺔ ﺑﻨﻌﻢ :ﻛﻢ ﻋﺪد اﻟﺴﺠﺎﺋﺮ ﯾﻮﻣﯿﺎ؟ .......
 .12اﻟﻨﺸﺎط اﻟﺒﺪﻧﻲ ھﻞ ﺗﻤﺎرس اﻟﺮﯾﺎﺿﺔ؟ )ﺑﻤﻌﺪل ﺛﻼﺛﻮن دﻗﯿﻘﺔ ﯾﻮﻣﯿﺎ(:
 ٧ ٤أﯾﺎم ﻓﻲ اﻷﺳﺒﻮع

 ٣ ١ﯾﻮم ﻓﻲ اﻷﺳﺒﻮع

 .13ھﻞ ﻟﺪﯾﻚ ﺗﺎرﯾﺦ ﺳﻘﻮط ﺣﺪﯾﺜﺎ )ﺧﻼل اﻟﺜﻼث ﺷﮭﻮر اﻟﻤﺎﺿﯿﺔ(؟

ﻻ اﻣﺎرس اﻟﺮﯾﺎﺿﺔ
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ﻻ

ﻧﻌﻢ

)ﻓﻲ ﺣﺎل اﻹﺟﺎﺑﺔ ﺑﻨﻌﻢ( ﻛﻢ ﻣﺮة ﺧﻼل اﻟﺜﻼث اﻟﺸﮭﺮ اﻟﻤﺎﺿﯿﺔ؟.........

اﻟﻈﺮوف اﻟﻤﺮﺗﺒﻄﺔ ﺑﺎﻟﺴﻘﻮط:
ﺗﻌﺜﺮت

اﻟﺴﺎﻗﯿﻦ ﺧﺎرت

ﻧﺘﯿﺠﺔ اﻏﻤﺎء

اﺧﺘﻼل اﻟﺘﻮازن

دوﺧﺔ

اﻟﻘﺪﻣﯿﻦ )ﻓﻲ اﻷﺻﺎﺑﻊ او اﻟﻤﻔﺎﺻﻞ(
ت( ﻧﺘﯿﺠﺔ اﻋﺮاض اﻻﻋﺘﻼل اﻟﻄﺮﻓﻲ اﻟﻌﺼﺒﻲ؟
ھﻞ ﺳﺒﻖ وان ﺳﻘﻄﺖ) ِ

ﻻ

ﻧﻌﻢ

إذا ﻛﺎﻧﺖ اﻹﺟﺎﺑﺔ ﺑﻨﻌﻢ ،ﻛﻢ ﻣﺮة؟ ........................
ھﻞ ﺳﺒﻖ وان ﺷﺨﺼﺖ ﻧﺘﯿﺠﺔ اﻋﺮاض اﻻﻋﺘﻼل اﻟﻌﺼﺒﻲ اﻟﻄﺮﻓﻲ؟

ﻧﻌﻢ

ﻻ

ﻣﺸﻜﻠﺔ ﻓﻲ
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ELECTRONIC MEDICAL RECORD VARIABLES
ID#……………………

Name ……………………

Date of birth……….

Date……………………

Age…….

Current medical history:
Duration of diabetes …………… month / years.
Dyslipidemia Yes

No

Cardiovascular disease: Yes

Hypertension: Yes

Nephropathy: Yes
No

Retinopathy: Yes

Oral agents (OHA): Yes
No
(If yes) list:……………………
Insulin: Yes
No
Combination therapy: Insulin+ (OHA)

No
No
No

(If yes) list:

Anthropometric measurement (Last reading): Weight ……..kg
Waist circumference……cm
History of tobacco use: Yes
No:
How many packs/day______________

Height…….cm
Blood pressure………mmHg
(if yes): Current smoker:

Laboratory measurement (Last reading):HbA1c ........................ %
Fasting blood glucose (FBG) …… mg/dI
Random glucose level (RBG) ............ mg/dI
Vitamin B12 …………..pg/ml
Total Glycerides ........................ mg/dI
S.HDL ........................ mg/dI
S.LDL........................ mg/dI
Total cholesterol ..................... mg/dI
Vitamin D...........ng/dl
List of current medications:
1…….
4..……
7………
10……….

2….……
5. ……
8…………

3………….
6………..
9. ………
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MICHIGAN NEUROPATHY SCREENING INSTRUMENT
A. History (To be completed by the person with diabetes)
Please take a few minutes to answer the following questions about the feeling in your legs and
feet. Check yes or no based on how you usually feel. Thank you .
Are you legs and/or feet numb?

Yes

No

Do you ever have any burning pain in your legs and/or feet?

Yes

No

Are your feet too sensitive to touch?

Yes

No

Do you get muscle cramps in your legs and/or feet?

Yes

No

Do you ever have any prickling feelings in your legs or feet?

Yes

No

Does it hurt when the bed covers touch your skin?

Yes

No

When you get into the tub or shower, are you able to tell the hot water from the cold water?
Yes No
Have you ever had an open sore on your foot?
Has your doctor ever told you that you have diabetic neuropathy?
Do you feel weak all over most of the time?

Yes
Yes
Yes

No
No
No

Are your symptoms worse at night?

Yes

No

Do your legs hurt when you walk?

Yes

No

Are you able to sense your feet when you walk?

Yes

No

Is the skin on your feet so dry that it cracks open?
Have you ever had an amputation?
MNSI, © University of Michigan, 2000

Yes
Yes

No
No
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MICHIGAN NEUROPATHY SCREENING INSTRUMENT
اﺳﺘﺒﯿﺎن ﻣﯿﺘﺸﻐﺎن ﻟﻔﺤﺺ اﻋﺘﻼل اﻟﻄﺮاف اﻟﻌﺼﺒﯿﺔ
 -Aاﻟﺘﺎرﯾﺦ )ﺗﺴﺘﻜﻤﻞ ﻣﻦ ﻗﺒﻞ ﺷﺨﺺ ﯾﻌﺎﻧﻲ ﻣﻦ ﻣﺮض اﻟﺴﻜﺮي(
ﯾﺮﺟﻰ أﺧﺬ ﺑﻌﺾ اﻟﺪﻗﺎﺋﻖ ﻟﻺﺟﺎﺑﺔ ﻋﻠﻰ اﻷﺳﺌﻠﺔ اﻟﺘﺎﻟﯿﺔ ﺣﻮل اﻟﺴﺎﻗﯿﻦ واﻟﻘﺪﻣﯿﻦ ،اﻹﺟﺎﺑﺔ ﺑﻨﻌﻢ أم ﻻ ﻋﻠﻰ أﺳﺎس اﻟﻜﯿﻔﯿﺔ اﻟﺘﻲ ﻋﺎدة ﻣﺎ
ﺗﺸﻌﺮ ﺑﮫ .ﺷﻜﺮا ﻟﻚ.
 (1ھﻞ ﺗﺸﻌﺮ ﺑﺨﺪر ﻓﻲ رﺟﻠﯿﻚ أو ﻗﺪﻣﯿﻚ ؟

ﻧﻌﻢ

ﻻ

 (2ھﻞ ﺗﺸﻌﺮ ﺑﺄﻟﻢ ﺣﺎرق ) ﯾﺤﺮق ( رﺟﻠﯿﻚ أو ﻗﺪﻣﯿﻚ ؟

ﻧﻌﻢ

ﻻ

 (3ھﻞ ﻗﺪﻣﯿﻚ ﺣﺴﺎﺳﺘﺎن ﻷي ﺷﺊ ﻋﻨﺪ اﻟﻠﻤﺲ ؟

ﻧﻌﻢ

ﻻ

 (4ھﻞ ﺗﺸﻌﺮ ﺑﺘﺸﻨﺠﺎت ﻋﻀﻠﯿﺔ ﻓﻲ رﺟﻠﯿﻚ أو ﻗﺪﻣﯿﻚ ؟

ﻧﻌﻢ

ﻻ

 (5ھﻞ ﺗﺸﻌﺮ ﺑﻮﺧﺰ ﻓﻲ ﻗﺪﻣﯿﻚ أو رﺟﻠﯿﻚ ؟

ﻧﻌﻢ

ﻻ

 (6ھﻞ ﺗﺸﻌﺮ ﺑﺎﻷﻟﻢ ﻋﻨﺪﻣﺎ ﺗﻼﻣﺲ أﻏﻄﯿﺔ اﻟﺴﺮﯾﺮ ﺟﻠﺪك ) ﺟﺴﻤﻚ ( ؟
 (7ھﻞ ﺗﺴﺘﻄﯿﻊ أن ﺗﻔﺮق ﺑﯿﻦ اﻟﻤﺎء اﻟﺪاﻓﺊ واﻟﺒﺎرد ﻋﻨﺪ اﻻﺳﺘﺤﻤﺎم ؟

ﻧﻌﻢ
ﻧﻌﻢ

ﻻ
ﻻ

 (8ھﻞ أﺻﺒﺖ ﯾﻮﻣﺎ ﺑﺘﻘﺮﺣﺎت ﻣﻔﺘﻮﺣﺔ ﻓﻲ ﻗﺪﻣﯿﻚ ؟

ﻧﻌﻢ

ﻻ

 (9ھﻞ أﺧﺒﺮك اﻟﻄﺒﯿﺐ ﯾﻮﻣﺎ ﻣﻦ أﻧﻚ ﺗﻌﺎﻧﻲ ﻣﻦ اﻻﻋﺘﻼل اﻟﻌﺼﺒﻲ اﻟﺴﻜﺮي ؟

ﻧﻌﻢ

ﻻ

ﻧﻌﻢ

ﻻ

 (11ھﻞ ﺗﺰداد أﻋﺮاض اﻟﻤﺮض أﻛﺜﺮ ﻓﻲ اﻟﻠﯿﻞ ؟

ﻧﻌﻢ

ﻻ

 (12ھﻞ ﺗﺆﻟﻤﻚ رﺟﻠﯿﻚ ﻋﻨﺪ اﻟﻤﺸﻲ ؟

ﻧﻌﻢ

ﻻ

 (13ھﻞ ﺗﺸﻌﺮ ﺑﻘﺪﻣﯿﻚ ﻋﻨﺪ اﻟﻤﺸﻲ ؟

ﻧﻌﻢ

ﻻ

 (14ھﻞ ﺟﻠﺪ ﻗﺪﻣﯿﻚ ﺟﺎف ﻟﺪرﺟﺔ أن ﺗﺼﺎب ﺑﺘﺸﻘﻘﺎت ﻣﻔﺘﻮﺣﺔ ﻓﯿﮭﻤﺎ ؟

ﻧﻌﻢ

ﻻ

 (10ھﻞ ﺗﺸﻌﺮ ﺑﺎﻟﻀﻌﻒ اﻟﻌﺎم ﻓﻲ ﺟﺴﺪك ﻣﻌﻈﻢ اﻷﯾﺎم ؟

 (15ھﻞ ﺧﻀﻌﺖ ﯾﻮﻣﺎ إﻟﻰ ﻋﻤﻠﯿﺔ ﺑﺘﺮ ﻓﻲ إﺣﺪى أطﺮاﻓﻚ ؟
اﻟﻤﺠﻤﻮع.........................:

ﻧﻌﻢ

ﻻ
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MICHIGAN NEUROPATHY SCREENING INSTRUMENT
B. Physical Assessment (To be completed by health professional)
1.

Appearance of Feet
Right
a. Normal
0 Yes
1 No
b. If no, check all that apply:
Deformities
Dry skin, callus
Infection
Fissure
Other
Specify:
Right
Absent
Present
2. Ulceration
0
1
Present Reinforcement
3. Ankle Reflexes
0
0.5
4.
5.

Present
0

Vibration
Perception at
Great toe
Monofilament

Left
a. Normal
0 Yes
1 No
b. If no, check all that apply:
Deformities
Dry skin, callus
Infection
Fissure
Other
Specify:
Left
Absent
Present
0
1
Absent Present Reinforcement Absent
1
0
0.5
1

Decreased
0.5

Absent
1

Present

Normal Reduced
1
0.5

Absent
0

Normal
1
Total Score

MNSI, © University of Michigan, 2000

Decreased
0
0.5
Reduced
0.5

Absent
1
Absent
0
/10 Points

208

209

210

211

212

213

214

215

216
اﺳﺘﺒﯿﺎن ﺗﺄﺛﯿﺮ اﻻﻋﺘﻼل اﻟﻤﺸﺘﺮك ﻋﻠﻰ اﻟﻮظﯿﻔﺔ
Functional Comorbidity Scale (FCI)

The FCI is a measure of the effect of
comorbidity on physical functioning.
Choose all conditions that apply:
□ Arthritis (Rheumatoid and
Osteoarthritis
Osteoporosis)
□ Asthma
□ Chronic Obstructive Pulmonary
Disease, □ Acute Respiratory Distress
Syndrome, or emphysema
□ Angina
□ Congestive heart failure
□ Heart attack (myocardial infarct)
□ Neurological disease (multiple
sclerosis or Parkinson’s’)
□ Stroke or transient ischemic attack
□ Peripheral vascular disease
□ Diabetes (type 1 and 2)
□ Upper gastrointestinal disease (ulcer,
hernia, reflux)
□ Depression
□ Anxiety or Panic Disorders
□ Visual impairment (cataracts,
glaucoma, macular degeneration)
□ Hearing impairment (very hard of
hearing, even with hearing aids)
□ Degenerative disc disease (back
disease, spinal stenosis, or severe
chronic back pain)
□ Obesity and or BMI >30

Total score:

ھﻮ ﻣﻌﯿﺎر ﻟﻤﻘﯿﺎس ﻣﺪى ﺗﺄﺛﯿﺮ ﺗﻌﺪد اﻻﻣﺮاض ﻋﻠﻰ
.اﻟﻮظﯿﻔﯿﺔ اﻟﺒﺪﻧﯿﺔ
:اﺧﺘﺮ ﺟﻤﯿﻊ ﻣﺎ ﯾﻨﺎﺳﺐ ﺣﺴﺐ اﻟﺘﺎرﯾﺦ اﻟﻤﺮﺿﻲ
، اﻟﻌﻈﻤﻲ،□ اﻟﺘﮭﺎب اﻟﻤﻔﺎﺻﻞ )اﻟﺮوﻣﺎﺗﺰﻣﻲ
(وھﺸﺎﺷﺔ اﻟﻌﻈﺎم
□ اﻟﺮﺑﻮ اﻟﺸﻌﺒﻲ
 ﻣﺘﻼزﻣﺔ اﻟﻀﺎﺋﻘﺔ،□ ﻣﺮض اﻻﻧﺴﺪاد اﻟﺮﺋﻮي اﻟﺰﻣﻦ
 وأﻧﺘﻔﺎخ اﻟﺮﺋﺔ،اﻟﺘﻨﻔﺴﯿﺔ اﻟﺤﺎدة
□ اﻟﺬﺑﺤﺔ اﻟﺼﺪرﯾﺔ
□ ﻓﺸﻞ اﻟﻘﻠﺐ اﻻﺣﺘﻘﺎﻧﻲ
اﻷزﻣﺔ او اﻟﻨﻮﺑﺔ اﻟﻘﻠﺒﯿﺔ
 اﻟﺸﻠﻞ،□ اﻻﻣﺮاض اﻟﻌﺼﺒﯿﺔ )اﻟﺘﺼﻠﺐ اﻟﻤﺘﻌﺪد
(اﻟﺮﻋﺎش
□ اﻟﺴﻜﺘﺔ اﻟﺪﻣﺎﻏﯿﺔ او ھﺠﻮم ﻧﻘﺺ اﻟﺘﺮوﯾﺔ اﻟﻌﺎﺑﺮة
□ اﻣﺮاض اﻻوﻋﯿﺔ اﻟﺪﻣﻮﯾﺔ اﻟﻄﺮﻓﯿﺔ
(اﻟﺴﻜﺮي )اﻷول واﻟﺜﺎﻧﻲ
،□ اﻣﺮاض اﻟﺠﮭﺎز اﻟﮭﻀﻤﻲ اﻟﻌﻠﻮي )اﻟﻘﺮﺣﺔ
( ارﺗﺪاد اﻟﺤﻤﺾ،اﻟﻔﺘﺎق
□ اﻻﻛﺘﺌﺎب
□ اﻟﻘﻠﻖ واﺿﻄﺮاب ﻧﻮﺑﺎت اﻟﮭﻠﻊ
 اﻟﻤﺎء،□ ﻣﺸﺎﻛﻞ ﺑﺼﺮﯾﺔ )اﻋﺘﺎم ﻋﺪﺳﺔ اﻟﻌﯿﻦ
( اﻟﻀﻤﻮر اﻟﺒﻘﻌﻲ،اﻷزرق
□ ﻣﺸﺎﻛﻞ ﺳﻤﻌﯿﺔ )ﺿﻌﻒ اﻟﺴﻤﻊ اﻟﺤﺎد ﺣﺘﻰ ﻣﻊ
(وﺟﻮد ﻣﺴﺎﻋﺪات ﻟﻠﺴﻤﻊ
 ﺗﻀﯿﻖ اﻟﻌﻤﻮد،□ داء اﻟﻘﺮص اﻟﺘﻨﻜﺴﻲ )اﻻم اﻟﻈﮭﺮ
( اﻟﻢ ﺷﺪﯾﺪ ﻣﺰﻣﻦ ﻓﻲ اﻟﻈﮭﺮ،اﻟﻔﻘﺮي
(٣٠ < □ اﻟﺒﺪاﻧﺔ )ﻣﺆﺷﺮ ﻛﺘﻠﺔ اﻟﺠﺴﻢ
:اﻟﻤﺠﻤﻮع
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Table G1. Saudi-based cross-sectional studies on risk factors of DPN and QoL
Author (s)
AlAboudi et al. (2016)
Algeffari (2018)

Sample
n=75, T2DM, males =77%,
duration of DM=12.6±8.4
yrs., no demographic data.
n=233, T1DM n= 9, age=
56.9 yrs., no demographic
data.

Aljohani et al. (2015)

n=210, T2DM=66%,
aged=39 yrs., females=50%,
no demographic data.

Alhariri et al. (2017)

n=229, males=54%,
T2DM=74%, aged=51 yrs.
n=283, T2DM, age=56 yrs.,
males=63%, no demographic
data.
n=350, males=64%, T2DM,
aged=58 years, no
demographic data.
n=198, T2DM, males=37%,
aged=52 yrs., duration of
DM=10. 5 yrs. (no further
demographic data).

Alhayek et al. (2013)
Alodhayani et al. (2017)
ALQuilti (2015)

Mojaddidi et al. (2011)

n=263, T1DM=39,
T2DM=224.

Halawa et al. (2010)

n=1039, T2DM=94%,
aged=52 yrs., males=53%,
Middle Eastern=60%, Asian=
22%, Black= 8%.

Hu et al. (2014)

n=598, females=38%,
aged=50 yrs., illiterate=39%,
low income=44%.

Variable (s) Studied
DV: QoL
Knowledge about DM,
attitudes.
DV; painful DPN
IVs: HbA1c, FBG,
comorbidity, compliance,
age, gender, BP, BMI,
smoking, & duration of DM.
Diabetes self-care knowledge
and practices, medication,
glucose monitoring, diet,
exercise, & foot-care
practices.
Knowledge about foot ulcers
and practices of foot-care.
DV: QoL
IV: age, gender, HbA1c,
BMI, DM complications.
Knowledge and practices of
foot-care.
DV: painful DPN
IVs: age, gender, HTN,
smoking, years DM,
macrovascular and
microvascular complications,
glycaemia, & insulin use.
DV: DPN
IV: age, duration of DM,
smoking, HbA1c, & gender.
DV: painful DPN
IV: age, gender, BMI,
duration of DM, smoking, &
race.
DV: foot ulcers
IV: age, gender, BMI, income
status, HTN, biomarkers, &
duration of DM.
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Author (s)
Sidawi & Alhariri (2012)

Sample
n=30, T2DM, males=100%,
aged=45 years, had DM=12
yrs.
n=552, T2DM, age=53.2 yrs.,
males=62%.

Variable (s) Studied
Neighborhood context, built
environment & DM
outcomes.
Wang et al. (2014)
DV: DPN
IV: age, gender, HbA1c,
BMI, lipid profile, HTN,
education level, inflammatory
markers.
*DV: dependent variable, IV: independent variable, T2DM: type 2 diabetes mellitus, HTN:
hypertension, BMI: body mass index, HbA1c: glycosylated hemoglobin, QoL: quality of life,
DPN: diabetic peripheral neuropathy.
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Table G2. Non-experimental studies on risk factors of DPN and QoL (Other countries)
Author (s)
Bansal et al. (2014)

Aim
Prevalence, compare
groups, risk factors;
se-x specific
differences

Cho et al. (2014)

Impact of insulin
resistance on DPN
The prevalence of
DPN symptoms and
severity assessment
Assess prevalence,
risk factors

Dyck et al. (1993)
Jaiswal et al (2017)

Javed et al. (2014)

Assess gender-based
differences

Khawaja et al. (2018)

Prevalence and
predictors of DPN

Lyrakos et al. (2013)

Assess QoL of
Greeks, predictors

Pei et al. (2106)

Assess the effect of
regular exercise on
DPN

Qureshi et al. (2017)

Predictors of severity
of DPN symptoms
Examine differences
in QoL between

Riandhini et al.
(2017)

Sample
Variable (s) Studied
n=1637, T2DM, age 52 DV: DPN
yrs.
IVs: demographics,
years w DM,
cardiovascular risk
factors, alcohol, &
macrovascular.
n=86, T2DM adult
DV: DPN
males and females
IV: insulin resistance.
n=64,573, T2DM=663, DV: DPN
males= aged=47 yrs.,
White=99%.
n=1995, T1DM,
Demographics, DM
T2DM=543, males=
duration, smoking,
955, aged=20.5 yrs.
HTN, obesity,
HbA1c, lipids.
n=125, T1DM=10%
and T2DM, n= 57
males, n=68 females
(equal sample size
assumed)
n=1003, T2DM,
aged=57 yrs. Female=
52%.

DV: DPN
IV: gender, age,
duration of DM,
duration of DPN.

DV: DPN
IVs: demographics,
HbA1c, BMI, statin
therapy, physical
activity, medication,
smoking,
comorbidity.
n=53, T2DM,
DV: QoL
aged=66.6 yrs.
IVs: DPN, age,
males=13, females=40 comorbidity, &
HbA1c=7.1.
depression.
n=122, T2DM,
DV: DPN
females=29%, aged=60 IV: Exercise
yrs., had DPN for=22
frequency.
months.
n= 800, T2DM=80%.
DV: DPN
IVs:
n=160, T2DM, (n=80, DV: QoL
DPN), (n=80 nonIV: DPN
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Author (s)
Spring (2018)

Aim
patients with and
without DPN
Examine health
perception and
neighborhood
condition

Veresiu et al. (2015)

Screen undiagnosed
DPN Romanian
people w/ Norfolk
QoL

Xu et al. (2014)

Examine relationship
between DPN and
Glycemic variability

Sample
DPN).

Variable (s) Studied

n=3, 240, aged=56
yrs., males=48%,
homeowner=83%,
Race: White=76%,
Black=18, <1 chronic
conditions.
n= 21,261,
T1DM=10%,
T2DM=90%,
males=9,503,
women=10,086 (no
further details).
n=90, T2DM,
aged=59.2 yrs.
female=50%.

Self-rated health &
neighborhood
condition
(demographic,
census, facilities).
DV: QoL
IV: DPN symptoms
severity

DV: DPN
IVs: glycemic
variability, BMI,
HbA1c, blood
glucose standard
deviation.
Yang et al. (2015)
Examine
n=37,375, T2DM,
DV: DPN
cardiovascular risk
males=49%, aged=60
IVs, HbA1c,
factors impact on
yrs., mean duration of
cardiovascular risk
DPN
DM=5.8 yrs., multiple factors (lipids, HTN,
comorbidities.
hypoglycemia).
*DV: dependent variable, IV: independent variable, T2DM: type 2 diabetes mellitus, HTN:
hypertension, BMI: body mass index, HbA1c: glycosylated hemoglobin, QoL: quality of life,
DPN: diabetic peripheral neuropathy.
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Table G3. Experimental and systematic review studies on risk factors of DPN and QoL
Author(s)
Boyd et al.
(2011)

Design
Randomized
trial

Aim (s)
Compare effect of
two drugs
(Topeiramate vs.
Ruboxistaurin)

Sample
n=54, T2DM;
Age=35–75
Women=11,
Men= 33;
HbA1c=7.0%.
n=38 studies,
total n==33,152,
T2DM.
males=50%.
N= 24 research
articles
T2DM adults.

Clair et al. (2015) Systematic
review

Review evidence
on smoking and
DPN

Hébert et al.
(2017)

Topical review

Review of risk
factors of
neuropathic pain.

Hussain et al.
(2014)

Quasiexperimental,
comparative
design

Assess influence
of DM duration
on DPN.

n=86, T2DM,
women= 26,
men=38,
age=53.29±7 yrs.

Papanas &
Ziegler (2015)

Topical review

Review of risk
factors and
comorbidities of
DPN.

n=159, T2DM w
DPN

Yoo et al. (2015)

Interventional

Effect of exercise
on painful DPN
symptoms.

Variables
DV: QoL
IV: DPN

DV: DPN
IVs: cigarette
smoking
DV: DPN
IVs:
demographic,
clinical, lifestyle,
& genetics
DV: DPN
IVs: HbA1c, age,
DM duration,
height, weight,
lipids, gender.
DV: DPN
IVs: Clinical,
individual
factors,
depression,
cognitive
dysfunction,
HTN, & PVD.
DV: painful DPN
IVs: regular
exercise

n=14, T2DM, w
painful DPN,
age=57 yrs.,
females=
*DV: dependent variable, IV: independent variable, T2DM: type 2 diabetes mellitus, HTN:
hypertension, BMI: body mass index, HbA1c: glycosylated hemoglobin, QoL: quality of life,
DPN: diabetic peripheral neuropathy, PVD: peripheral vascular disease.
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Table G4. Supplemental Literature Review
Author (s)
Design
Aim
Agathos et al.
(2018)

AlGamdi et al.
(2018)

Assuncao et
al., 2020

Ausili et al.
(2017)

Girach et al.
(2019)
Kathe et al.
(2018)

Markle-Reid
et al. (2018)

RCT

Effect of alpha
lipoic acid
treatment on
symptoms

Sample

(n=72,
T2DM=84%,
aged=65 yrs.,
males=39%, &
duration of
DM=13 yrs.)
Observational Patients
(n=383, T2DM,
perception about males=48.8%,
DM
aged=46 yrs.,
median DM
duration=6 yrs.)
Observational Demographic and (n=359, T2DM,
clinical factors
DPN,
associated with
males=54.8%, &
DPN
aged >65
yrs.=70%)
Observational Description of
(n=302, T2DM,
self-care, clinical males=53.6%,
factors and QoL
aged=68 yrs.,
duration of
DM=10 yrs.,
with DM
complications)
Systematic
Review on DPN
(n=60,
review
& QoL
DPN=71.2%)
Observational Assessment of
SF-12 reliability
and validity

Interventional Impact of
community
program
intervention on
QoL
RCT: Randomized controlled trials.

Variable (s) Studied
DV: DPN symptoms
& QoL
IV: supplementation
of alpha lipoic acid
DV: Illness
perception
IV: T2DM
DV: DPN symptoms
IVs: HbA1c, gender,
age, & duration of
DM
DV: self-care, QoL
IV: HbA1c,
comorbidity,
smoking, gender,
age, & BMI.

DV: QoL
IV: peripheral
neuropathy
(n=2214, aged
Internal consistency,
58.2 yrs., T2DM, test-retest reliability,
duration of
construct, criterion,
DM=9 yrs.,
& concurrent
females=51%,
validity.
White=61%,
Black=15%, &
Hispanic=16%)
(n=159, T2DM, DV: QoL
aged=74 yrs.,
IV: self-management
females=45%,
intervention
with
comorbidity)
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Table G4. Supplemental Literature Review
Mejias &
Ramphul (2018)

Observational

Prevalence and
risk factors of
peripheral artery
diseases

Singh-Franco &
Jacobs (2017)

Observational

Patient
perspective on
DPN

van LaakeGeelen (2019)

Systematic
review

Review on
combination of
physical and
psychological
therapy of DPN

Venkataraman
et al. (2019)

RCT

Effect of
structured
strength on QoL

Zeigler et al.
(2018)

Observational

Prevalence &
risk factors of
DPN

(n=600, T2DM,
males=50%,
aged=60.6 yrs.,
Hispanic=80%,
Black=12%)

DV: PAD
IVs: DPN, foot
ulcers, nontraumatic
amputation,
race, smoking,
hypertension, &
hyperlipidemia
(n=124, T1DM, DV: QoL
T2DM, DPN,
IV: DPN,
aged=57.2 yrs.,
Duration of DM,
females=58.9%, number of DPN
Black=53.2, &
symptoms,
White=25.8%)
activity of daily
living, & DPN
treatment
(n=8 randomized DV: QoL
control trials,
IVs: Physical
T1DM, T2DM,
activity, &
participants
psychological
aged>18 yrs.,
therapy
DPN)
(n=143, aged=62 DVs: QoL,
yrs.,
functional
females=56%,
mobility, muscle
South
strength, &
Asian=77%,
range of motion
duration of
IVs: strength and
DM=15.3 yrs.,
balance training
& DPN)
(n=1850,
DV: DPN
T2DM=51%, no IVs: peripheral
DM=42%,
arterial disease,
males=44.7%,
gender, age, &
aged=65.7 yrs.). BMI
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Table H1. Instruments, Costs, and Access
Instrument
Michigan
Neuropathy
Symptoms
Inventory
Leeds
Assessment
of
Neuropathy
Signs and
Symptoms
Numeric Pain
Rating Scale
Chronic
Illness
Resources
Survey
MOS-Social
Support
Survey
SF-12v2

Permission
needed
No

Website

Yesobtained

Personal
No validation
communication
with authors

Acceptable
reliability
and validity

Free

No

Yes, British
Pain Society
Yes

No validation

Yes

Free

Translated
No validation

Acceptable
reliability
and validity

Free

Yes

RAND

Yes

Free

Yesobtained

Optum

Yes

ORI.org

Yes

Amazon

NA

Acceptable
reliability
and validity
Acceptable
reliability
and validity
Acceptable
reliability
and validity
Yes

Yesobtained

Summary of
YesDM
obtained
Activities
Monofilament NA

University of
Michigan

Arabic
Psychometric Cost
version/validated Evidence
No validation
Acceptable
Free
reliability
and validity

Free for
students
$$
$$
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Table H2. Comparison of MNSI, S-LANSS and Numerical Pain Rating Scale of DPN
S-LANSS
MNSI
Pain Rating scale
# items

5 questions; 2 exam
items
Symptoms/Variables Dysesthesia
Autonomic
Evoked
Paroxysmal
Thermal
Allodynia
Tender/numb

2 part

Yes
Cotton and pin-prick

Arabic validity

Yes

15 questions; 3 exam
items
Numbness
Burning
Sensitivity
Cramps
Prickling
Hypersensitivity
Hot cold feeling
Open sore
Nocturnal nature
Yes
Appearance
Ulceration
Reflexes
SWMT
Vibration

6 questions

Yes

No

Current pain
Severity
Last week
Severity
Treatment helped
Mood disability

NA
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Table H3. Reliability Estimates of the Study Tools as Reported in the Literature
Tool
Michigan Neuropathy Symptoms Inventory
Short-Leeds Assessment of Neuropathy Signs and Symptoms
Pain Rating Scale
Chronic Illness Resources Survey
MOS-Social Support Survey-Arabic
SF-12v2-Arabic
Summary of Diabetes Self-care Activities-Arabic
Monofilament (SWMT)*
Functional Comorbidity Index
*Interclass correlation coefficient

Cronbach
Alpha
.91
.76
.95-.96
.82
.78
.79-.80
.76
.92
.91
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Table I1. Univariable Coefficients of Aim 1
Coefficients

p-value

S-LANSS
MNSI 1
MNSI 2
Age
Gender (female)
CIRS
MOS-SSS
Health perception

0.057
0.052
0.025
0.007
-0.002
0.350
0.009

.006
.231
.605
.580
.993
.045
.041

S-LANSS
MNSI 1
MNSI 2
Foot care
Age
Gender (female)
CIRS
MOS-SSS
PCS

-0.809
-3.122
-1.231
4.599
-0.140
-1.181
10.349
0.225

.025
.001
.212
.018
.609
.818
.005
.025

S-LANSS
MNSI 1
MNSI 2
Foot care
Age
Gender (female)
CIRS
MOS-SSS
MCS

-0.394
-1.032
-1.045
0.366
-0.200
-2.164
4.724
-0.013

.007
.001
.003
.598
.036
.229
.000
.711

S-LANSS
MNSI 1
MNSI 2
Foot care
Age
Gender (female)
CIRS
MOS-SSS

-0.171
-0.942
0.177
0.587
0.005
-3.548
0.718
0.176

.327
.009
.665
.466
.967
.089
.640
.000

Foot care
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Table I2. Univariable Coefficients of Aim 2
Coefficients

p-value

HbA1c
FCI
Hypertension
Duration of DM
Exercise
Regular
Not-regular
Treated Dyslipidemia
Age
Gender (Female)
MNSI 1

-0.027
0.898
0.976
-0.117

.935
.016
.392
.820

-0.737
-2.176
1.431
0.011
-0.472

.612
.085
.217
.851
.677

HbA1c
FCI
Hypertension
Duration of DM
Exercise
Regular
Not-regular
Treated Dyslipidemia
Age
Gender (Female)
MNSI 2

0.300
0.654
1.512
0.499

.057
.001
.005
.042

-0.852
-1.227
1.012
0.009
-0.127

.209
.037
.067
.742
.811

S-LANSS

HbA1c
-0.031
.833
FCI
0.080
.624
Hypertension
0.849
.086
Duration of DM
0.394
.070
Exercise
-0.432
.066
Regular
-0.382
.545
Not-regular
-1.205
.027
Treated Dyslipidemia
-0.243
.639
Age
0.072
.006
Gender (Female)
-0.962
.048
Note: FCI: Functional Comorbidity Index; HbA1c: Hemoglobin A1c; S-LANSS: Self-report
Leeds Assessment of Neuropathy Signs and Symptoms; MNSI: Michigan Neuropathy Screening
Instrument.
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